user_input,retrieved_contexts,response,reference,answer_correctness,answer_relevancy,answer_similarity,faithfulness,context_precision,context_recall
What is the primary area of the eye affected by AMD?,"['Age-related macular degeneration primarily damages the macula, the central part of the retina responsible for sharp central vision; this leads to central vision loss, blurring, difficulty reading and driving, and can involve changes in the retinal pigment epithelium and drusen formation.']","Age-related macular degeneration primarily affects the macula, the central part of the retina responsible for sharp central vision.","The macula, located in the central retina, is primarily affected by AMD.",0.9790560321601115,,0.9162241286404459,1.0,0.9999999999,1.0
What distinguishes wet AMD from dry AMD?,"['Dry AMD is the more common, atrophic form marked by buildup of drusen and gradual dysfunction and atrophy of the retinal pigment layer and photoreceptors, leading to slow central vision loss and geographic atrophy with limited proven treatments and several experimental approaches under study. Wet AMD is the neovascular, exudative form in which abnormal new blood vessels grow beneath the macula and leak fluid or blood, causing more rapid and severe central vision loss; it is diagnosed clinically and is treated primarily with intravitreal anti-VEGF injections (for example, brolucizumab) and other anti-angiogenic therapies. Both affect the macula and can cause blindness, but wet AMD tends to be acute and more amenable to current treatments, while dry AMD is degenerative and harder to treat.']","Wet AMD is the neovascular, exudative form characterized by abnormal new blood vessel growth beneath the macula that leaks fluid or blood causing rapid central vision loss and is treatable with anti-VEGF injections, whereas dry AMD is the more common atrophic form marked by drusen accumulation, gradual RPE and photoreceptor degeneration leading to slow central vision loss and geographic atrophy with limited proven treatments.","Wet AMD involves abnormal blood vessel growth and leakage, while dry AMD features drusen deposits and retinal thinning.",0.8899277584205273,,0.919711033682109,1.0,0.9999999999,1.0
What are drusen in the context of AMD?,"['In AMD, drusen are yellowish extracellular deposits that accumulate under the macular retina (often described as subretinal drusenoid deposits); their presence is a hallmark of the disease and indicates retinal damage and increased risk of central vision loss and progression to advanced forms such as geographic atrophy or neovascular AMD.']","Drusen are yellowish extracellular (subretinal) deposits that accumulate under the macular retina in AMD, indicating retinal damage and increased risk of vision loss and progression to advanced forms like geographic atrophy or neovascular AMD.",Drusen are yellowish deposits of lipids and proteins that accumulate under the retina in dry AMD.,0.5732680827358748,,0.9596569170921562,1.0,0.9999999999,0.0
What vision problem is most associated with AMD?,"['Age-related macular degeneration primarily damages the macula and leads to progressive loss of central vision, causing blurred or reduced ability to read, drive, and perform tasks that require fine visual detail and in advanced cases can cause severe visual impairment or blindness.']","Age-related macular degeneration is most associated with progressive loss of central vision, leading to blurred or reduced ability to read, drive, and perform tasks requiring fine visual detail.",AMD most commonly causes central vision loss.,0.5160829041650878,0.8520611763766816,0.864331616660351,1.0,0.9999999999,1.0
What is the leading treatment for wet AMD?,"['The leading treatment for wet AMD is intravitreal anti–vascular endothelial growth factor (anti‑VEGF) therapy delivered by ocular injections; agents such as ranibizumab, aflibercept and bevacizumab (with newer drugs like faricimab) are the standard of care, suppressing VEGF-driven choroidal neovascularization and reducing vision loss while improving visual acuity.']","The leading treatment for wet AMD is intravitreal anti–vascular endothelial growth factor (anti‑VEGF) therapy—agents such as ranibizumab, aflibercept, bevacizumab (and newer drugs like faricimab) delivered by ocular injections to suppress VEGF-driven choroidal neovascularization and reduce vision loss.",Anti-VEGF injections are the leading treatment for wet AMD to reduce blood vessel growth and leakage.,0.8088423577356386,0.9999999999999992,0.927677123250247,1.0,0.9999999999,1.0
What nutrients are included in the AREDS formula?,"['The original AREDS formulation combined high-dose antioxidants and minerals—vitamin C, vitamin E, beta‑carotene, zinc (with copper added to prevent copper deficiency)—while the later AREDS2 formulation replaced beta‑carotene with lutein and zeaxanthin and also evaluated adding omega‑3 fatty acids.']","The original AREDS formulation included high-dose antioxidants vitamin C, vitamin E, beta‑carotene, and zinc (with copper added), while AREDS2 replaced beta‑carotene with lutein and zeaxanthin and also evaluated adding omega‑3 fatty acids.","The AREDS formula includes vitamins C and E, zinc, copper, and beta-carotene (replaced by lutein and zeaxanthin in AREDS2).",0.8838398180603948,0.8993812571487009,0.963930700813008,1.0,0.9999999999,1.0
What visual distortion is a symptom of wet AMD?,"['Wet age-related macular degeneration often causes central visual distortion—objects or straight lines may appear wavy or shapes look misshapen, a symptom known as metamorphopsia.']","A common visual distortion in wet AMD is metamorphopsia, where objects or straight lines appear wavy or shapes look misshapen.","Metamorphopsia, where straight lines appear wavy, is a symptom of wet AMD.",0.8375678563079877,0.9705363642502792,0.9502976513651966,1.0,0.9999999999,1.0
What imaging tool is commonly used to diagnose AMD?,"['Optical coherence tomography (OCT), including OCT angiography (OCT‑A), is the imaging modality most commonly used to diagnose age-related macular degeneration, providing high-resolution cross-sectional and vascular views of the macula to detect drusen, subretinal deposits, exudation and neovascular changes; color fundus photography and other retinal imaging tests are also used for screening and documentation.']","Optical coherence tomography (OCT), including OCT angiography (OCT‑A), is the imaging modality most commonly used to diagnose age-related macular degeneration by providing high-resolution structural and vascular views of the macula.",Optical Coherence Tomography (OCT) is commonly used to image the retina for AMD diagnosis.,0.6095888470453015,0.9203455167945401,0.9383553881812057,1.0,0.9999999999,1.0
What percentage of AMD cases are wet AMD?,"['Neovascular (“wet”) AMD accounts for roughly 10–15% of all AMD cases but is responsible for the majority of severe vision loss from AMD; it is characterized by choroidal neovascularization and exudation, diagnosed on initial exam, and is commonly treated with intravitreal anti‑VEGF therapy (including agents like brolucizumab and loading‑dose injection regimens).']",Neovascular (“wet”) AMD comprises roughly 10–15% of all AMD cases.,Wet AMD accounts for about 10-15% of all AMD cases.,0.7286012535847362,0.9427959600711167,0.9144050143389444,1.0,0.9999999999,1.0
What lifestyle factor most increases AMD risk?,"['Smoking is the single lifestyle factor most strongly linked to increased risk of developing age-related macular degeneration, with other unhealthy factors such as hypertension, poor oral health, systemic inflammation, and generally unfavorable lifestyle changes also contributing but to a lesser degree; quitting smoking reduces that risk.']",Smoking is the single lifestyle factor most strongly linked to increased risk of developing age-related macular degeneration (and quitting smoking reduces that risk).,Smoking is the lifestyle factor that most increases AMD risk.,0.7286564138842637,0.9119519946031233,0.9146256555370551,1.0,0.9999999999,1.0
What is geographic atrophy in AMD?,"['Geographic atrophy is an advanced, non‑neovascular form of age‑related macular degeneration in which well‑defined areas of retinal pigment epithelium and photoreceptor cell loss develop in the central retina, producing decreased autofluorescence on imaging and progressive, often irreversible central vision loss and visual impairment; it is diagnosed with multimodal imaging such as fundus autofluorescence and optical coherence tomography (including OCT‑A) and by functional visual testing, and management focuses on newly available intravitreal therapies that can slow progression alongside rehabilitative measures to help preserve visual function.']","Geographic atrophy is an advanced non‑neovascular form of age‑related macular degeneration characterized by well‑defined central retinal loss of retinal pigment epithelium and photoreceptors causing decreased autofluorescence on imaging and progressive, often irreversible central vision loss, diagnosed with multimodal imaging (fundus autofluorescence, OCT/OCT‑A) and functional testing, with management focused on intravitreal therapies that can slow progression and rehabilitative measures to preserve function.","Geographic atrophy is an advanced form of dry AMD where retinal cells die, causing vision loss.",0.4791008725192636,0.9126372469749727,0.9164034900770545,1.0,0.9999999999,1.0
What mineral in AREDS2 supports retinal health?,"['Zinc is the mineral in AREDS2 that supports retinal health; AREDS2 supplementation raises systemic zinc levels and helps reduce progression to advanced age-related macular degeneration, helping preserve vision.']",Zinc is the mineral in AREDS2 that supports retinal health.,Zinc in the AREDS2 formula supports retinal health.,0.9934561875537143,0.9976376647795441,0.9738247502148575,1.0,0.9999999999,1.0
What is a common early sign of wet AMD?,['A common early sign of wet AMD is a sudden change in central vision—blurring or distortion (straight lines appearing wavy) or a dark/blank spot when looking directly at something.'],A common early sign of wet AMD is a sudden change in central vision—blurring or distortion (straight lines appearing wavy) or a dark/blank spot when looking directly at something.,A common early sign of wet AMD is sudden distortion of central vision.,0.5404896170509965,0.9818005654937575,0.9619584682039857,1.0,0.9999999999,1.0
What demographic group has the highest AMD risk?,"['Older adults—particularly the elderly—carry the highest risk for age-related macular degeneration, with risk further influenced by ethnicity; certain subtypes, such as reticular macular disease, are associated with the highest-risk forms of early AMD.']","Older adults—particularly the elderly—have the highest risk for age-related macular degeneration, with risk further modified by ethnicity and highest-risk early forms seen in subtypes like reticular macular disease.",Caucasians over 60 have the highest risk of developing AMD.,0.6484938921574369,0.8976584962571965,0.8796898543440332,1.0,0.0,0.0
What does fluorescein angiography reveal in AMD?,"['Fluorescein angiography in AMD highlights abnormal macular vasculature and dye leakage, revealing choroidal neovascularization and its subtypes (classic and occult patterns, neovascular/wet AMD, retinal angiomatous proliferation, polypoidal choroidal vasculopathy and other macular neovascularization types), feeder vessels and subretinal neovascular membranes, as well as associated findings such as macular edema, subretinal fibrosis, subtle macular changes and geographic atrophy.']","Fluorescein angiography in AMD reveals abnormal macular vasculature and dye leakage indicating choroidal neovascularization (classic and occult patterns, neovascular/wet AMD, retinal angiomatous proliferation, polypoidal choroidal vasculopathy and other macular neovascularization types), feeder vessels and subretinal neovascular membranes, and associated findings such as macular edema, subretinal fibrosis, subtle macular changes, and geographic atrophy.",Fluorescein angiography reveals blood vessel leakage in wet AMD.,0.32593085033743785,,0.9287234013497514,1.0,0.9999999999,1.0
What pigment in the retina may protect against AMD?,"['The macular pigment—carotenoids concentrated in the macula such as lutein (along with zeaxanthin and meso‑zeaxanthin)—is believed to protect against age-related macular degeneration, and increasing macular pigment through diet or lutein-containing supplements may help prevent or slow AMD.']","The macular pigment—carotenoids concentrated in the macula, primarily lutein (along with zeaxanthin and meso‑zeaxanthin)—may protect against age-related macular degeneration.",Lutein is a retinal pigment that may protect against AMD.,0.7868482168355855,0.8880951437161194,0.8973928673423426,0.75,0.9999999999,1.0
What grid helps monitor AMD progression?,['The Amsler grid (Amsler grid chart) is commonly used to monitor progression of age-related macular degeneration by detecting visual distortions; central visual field tests like the 10-2 grid are also used for diagnosis and monitoring.'],The Amsler grid is commonly used to monitor progression of age-related macular degeneration (with central visual field tests like the 10-2 grid also used for diagnosis and monitoring).,The Amsler grid helps monitor AMD progression by detecting vision distortion.,0.6070199949508084,0.8068450845575663,0.9280799798032338,1.0,0.9999999999,1.0
What defines choroidal neovascularization in AMD?,"['Choroidal neovascularization in AMD is the abnormal growth of new blood vessels from the choroid into the subretinal space that defines the wet (neovascular) form of AMD; these leaky vessels cause exudation, increased central retinal thickness, subretinal fibrosis and damage to the retinal pigment epithelium and photoreceptors, producing central and often severe vision loss. It is detected with imaging such as fluorescein angiography and optical coherence tomography angiography and is treated primarily with intravitreal anti‑VEGF injections, photodynamic therapy, or combination approaches.']","Choroidal neovascularization in AMD is defined by abnormal growth of leaky new blood vessels from the choroid into the subretinal space causing exudation, increased central retinal thickness, subretinal fibrosis, and damage to the retinal pigment epithelium and photoreceptors, leading to central vision loss and detected by imaging such as fluorescein angiography or OCT angiography.",Choroidal neovascularization is the growth of abnormal blood vessels from the choroid into the retina in wet AMD.,0.508435797039881,0.944756652320151,0.9428340972504328,1.0,0.9999999999,1.0
What is the primary risk factor for AMD?,"['Advancing age is the primary risk factor for age-related macular degeneration, with the likelihood and severity increasing as people grow older; other factors such as certain genetic variants, ethnicity, systemic inflammation and health conditions can modify risk but aging remains the dominant driver.']","Advancing age is the primary risk factor for age-related macular degeneration, with likelihood and severity increasing as people grow older.",Aging is the primary risk factor for AMD.,0.9813120589153984,0.9536279736686987,0.9252482356615938,1.0,0.9999999999,1.0
What dietary component may reduce AMD risk?,"['Age, genetics, smoking, hypertension and inflammation contribute to AMD risk, so dietary components with antioxidant and anti‑inflammatory effects—particularly lutein and zeaxanthin, omega‑3 fatty acids, and antioxidant vitamins (C, E) often paired with zinc—may help lower risk and slow progression by supporting retinal health and reducing oxidative stress and inflammation.']","Lutein and zeaxanthin (along with omega‑3 fatty acids and antioxidant vitamins C and E, often paired with zinc) may help reduce AMD risk by supporting retinal health and reducing oxidative stress and inflammation.",Omega-3 fatty acids may reduce AMD risk.,0.4190993116649749,0.9226767791031844,0.9263972466598995,1.0,0.9999999999,1.0
What is a scotoma in relation to AMD?,"['A scotoma in AMD is a localized area of partial or complete vision loss caused by macular damage—commonly a central scotoma—that can be an absolute blind spot in advanced disease, leaving people unable to see what they are directly looking at and producing blurred or missing central vision that impairs reading, driving, and daily activities.']","A scotoma in AMD is a localized area of partial or complete vision loss—most commonly a central scotoma—caused by macular damage that produces an absolute blind spot or blurred/missing central vision, impairing reading, driving, and daily activities.",A scotoma is a blind spot in the central vision caused by AMD.,0.54031955793269,0.9620487514654733,0.96127823173076,0.8571428571428571,0.9999999999,1.0
What type of light exposure is linked to AMD risk?,"['Both cumulative/excessive lifetime light exposure and specifically high-energy blue light are linked to increased risk of age-related macular degeneration. Blue light damages retinal tissues and RPE cells through oxidative stress, inflammation, mitochondrial and ER dysfunction, lipofuscin buildup, and increased cell death, producing morphological and functional impairments that contribute to dry AMD, while chronic or excessive light exposure aggravates photoreceptor degeneration and is associated with earlier onset and higher AMD risk.']","Both cumulative/excessive lifetime light exposure—especially chronic or excessive exposure to high-energy blue light—is linked to increased risk of age-related macular degeneration via oxidative stress, inflammation, mitochondrial/ER dysfunction, lipofuscin buildup, and retinal cell death.",Ultraviolet (UV) light exposure is linked to AMD risk.,0.22196873416034837,0.8829185468113637,0.8878749366413935,1.0,0.0,0.0
What laser therapy treats wet AMD?,"['Laser therapy can be used to treat wet (exudative) age-related macular degeneration by targeting the macula and retina, though intravitreal anti-VEGF treatments (for example brolucizumab and loading injection regimens) are also commonly employed for wet AMD.']","Focal laser photocoagulation (and in some cases photodynamic therapy) can be used to treat certain cases of wet (exudative) AMD, though intravitreal anti-VEGF agents (e.g., brolucizumab with loading regimens) are more commonly employed.",Photodynamic therapy uses lasers and light-sensitive drugs to treat wet AMD.,0.44547774977460913,0.913672435216201,0.9247681419555793,0.5,0.0,0.0
What is an early retinal finding in dry AMD?,"['An early retinal finding in dry age-related macular degeneration is the presence of drusen—yellowish deposits beneath the retinal pigment epithelium, often large and soft—and this is commonly accompanied by early dysfunction of the retinal pigment epithelium.']","An early retinal finding in dry AMD is the presence of drusen—yellowish deposits beneath the retinal pigment epithelium, often large and soft—frequently accompanied by early dysfunction of the retinal pigment epithelium.",Small drusen deposits are an early retinal finding in dry AMD.,0.48419316198357426,0.9999999999999999,0.9367206650248714,1.0,0.9999999999,1.0
What is the purpose of low vision rehabilitation in AMD?,"['Low vision rehabilitation for AMD aims to maximize the use of remaining vision through training, assistive techniques and devices so people can read, move about and perform daily activities more independently, reduce dependence and frustration, and address emotional well-being by preventing or treating depressive symptoms.']","The purpose of low vision rehabilitation in AMD is to maximize use of remaining vision through training, assistive techniques and devices so people can read, move about and perform daily activities more independently, reduce dependence and frustration, and address emotional well-being including preventing or treating depressive symptoms.",Low vision rehabilitation helps AMD patients maximize their remaining vision.,0.5368910387545575,0.9796049596421584,0.9474859808090599,1.0,0.9999999999,1.0
What ethnic group has the highest AMD prevalence?,"['Ethnicity is noted to influence and aggravate age-related macular degeneration, but the information provided does not identify which specific ethnic group has the highest prevalence.']","The provided information states that ethnicity influences and aggravates AMD but does not identify which ethnic group has the highest prevalence, so I cannot determine the most affected group without specific prevalence data by ethnicity.",Caucasians have the highest AMD prevalence.,0.22247434021459692,0.0,0.8899734680785361,1.0,0.0,0.0
What is macular edema in wet AMD?,"['In wet AMD, macular edema is fluid accumulation in the central retina—manifesting as intraretinal and/or subretinal fluid and cystoid spaces—caused by vascular leakage from choroidal neovascularization driven in large part by VEGF; it may be subclinical or cause vision impairment or loss. Diagnosis relies on imaging such as optical coherence tomography and fluorescein angiography, and management typically involves intravitreal anti‑VEGF injections (with several approved agents) alongside other options like corticosteroid treatments, photodynamic therapy or emerging sustained‑delivery and gene‑based approaches.']","Macular edema in wet AMD is accumulation of fluid in the central retina—seen as intraretinal and/or subretinal fluid and cystoid spaces—caused by VEGF‑driven vascular leakage from choroidal neovascularization that can be subclinical or lead to vision impairment and is diagnosed by OCT/fluorescein angiography and typically treated with intravitreal anti‑VEGF agents (and sometimes corticosteroids, photodynamic therapy, or emerging sustained‑delivery/gene approaches).",Macular edema is fluid accumulation in the macula due to leaking blood vessels in wet AMD.,0.9831300266325971,0.9548043918064456,0.9325201065303884,1.0,0.9999999999,1.0
What vision symptom differentiates AMD from glaucoma?,"['Age-related macular degeneration classically produces central vision loss—blurry central vision with trouble reading and driving—whereas glaucoma causes progressive optic nerve/retinal ganglion cell damage that leads to different visual field loss, typically affecting peripheral vision and potentially resulting in blindness.']","AMD primarily causes central vision loss (blurry central vision with trouble reading and driving), whereas glaucoma typically affects peripheral vision first.","Central vision loss differentiates AMD from glaucoma, which affects peripheral vision.",0.6589687587275944,0.9437701975656032,0.9215893206246634,0.8,0.9999999999,1.0
What protein is targeted by anti-VEGF drugs in AMD?,"['Anti‑VEGF drugs target the vascular endothelial growth factor (VEGF) protein; by inhibiting VEGF they treat neovascular (“wet”) age‑related macular degeneration, help prevent vision loss and blindness, and include agents such as bevacizumab, aflibercept, and ranibizumab, though treatment often requires repeated intravitreal injections and carries cost and some ocular adverse effects.']",Anti-VEGF drugs target the vascular endothelial growth factor (VEGF) protein.,Vascular endothelial growth factor (VEGF) is targeted by anti-VEGF drugs in AMD.,0.732418409910608,0.9261969007701666,0.9297634735273528,1.0,0.9999999999,1.0
What lifestyle change most effectively slows AMD progression?,['The most effective lifestyle change to slow AMD progression is adopting targeted nutritional supplementation and related dietary/lifestyle modifications; such interventions have been shown to help prevent early AMD from advancing to late disease and to improve or slow progression of dry AMD.'],Adopting targeted nutritional supplementation together with related dietary and lifestyle modifications is the most effective lifestyle change shown to slow AMD progression.,Quitting smoking most effectively slows AMD progression.,0.2231863766716049,0.9914740798741505,0.8927455066864196,0.8,0.0,0.0
What is the typical schedule for anti-VEGF injections in wet AMD?,"['Anti‑VEGF drugs for wet AMD are given as intravitreal injections, typically started with monthly treatments (often with an initial series of monthly loading doses) to control neovascular activity and improve vision; after that patients are either maintained with regular monthly injections or shifted to individualized retreatment schedules based on disease activity to reduce visit burden, but frequent monthly assessments and any delays in injections can worsen outcomes and create substantial patient, caregiver, and health‑system burden.']","Anti‑VEGF treatment for wet AMD typically begins with monthly intravitreal injections (often an initial series of monthly loading doses) and thereafter is continued either with regular monthly injections or switched to individualized retreatment schedules based on disease activity to reduce visit burden, noting that delays or less frequent monitoring can worsen outcomes.",Anti-VEGF injections are typically given every 4-8 weeks for wet AMD.,0.7769529515739789,0.9359787197106534,0.9259936244777339,1.0,0.9999999999,0.0
What retinal layer nourishes the macula in AMD?,"['The macula’s outer retina and photoreceptors are primarily nourished by the retinal pigment epithelium (RPE) and the underlying choriocapillaris (choroidal blood supply); degeneration of the RPE and choroid is central to macular damage in AMD, which is why strategies often focus on preserving or replacing RPE function.']","The macula’s outer retina and photoreceptors are primarily nourished by the retinal pigment epithelium (RPE) and the underlying choriocapillaris (choroidal blood supply), whose degeneration is central in AMD.",The choroid nourishes the macula and is implicated in AMD.,0.23051290712744904,0.9059207658884819,0.9220516285097962,1.0,0.9999999999,0.0
What clinical trial refined the AREDS formula?,"['The AREDS2 clinical trial refined the original AREDS formula. The original formula had demonstrated prevention of age-related macular degeneration with an absolute risk reduction for severe visual loss but also raised safety concerns, including increased risk of neovascular AMD and other side effects; AREDS2 provided the evidence-based updates to improve the formula’s safety and effectiveness.']",The AREDS2 clinical trial refined the original AREDS formula to improve its safety and effectiveness.,The AREDS2 trial refined the AREDS formula.,0.6168473811706078,0.9298076944079839,0.9673895246824312,1.0,0.9999999999,1.0
What is a rare complication of wet AMD?,"['A rare complication of wet age-related macular degeneration is retinal angiomatous proliferation, a form of retinal neovascularization that can be associated with choroidal neovascularization and may lead to severe vision loss or blindness.']","A rare complication of wet AMD is retinal angiomatous proliferation, a form of retinal neovascularization that can be associated with choroidal neovascularization and may lead to severe vision loss or blindness.",Retinal detachment is a rare complication of wet AMD.,0.22168042105455465,1.0000000000000004,0.8867216842182186,1.0,0.0,0.0
What antioxidants are key in the AREDS formula?,"['The AREDS formulation relies chiefly on antioxidant vitamins—vitamin C and vitamin E—combined with a carotenoid antioxidant (originally beta‑carotene, later replaced in AREDS2 by lutein and zeaxanthin), given alongside zinc (with copper added to prevent zinc‑related deficiency) to reduce progression of age‑related macular degeneration.']","The key antioxidants in the AREDS formulation are vitamin C, vitamin E, and a carotenoid antioxidant—originally beta‑carotene and in AREDS2 replaced by lutein and zeaxanthin—given with zinc (and copper).",Vitamins C and E are key antioxidants in the AREDS formula.,0.535934073939815,0.9853997637325239,0.9437362957592598,1.0,0.9999999999,1.0
What vision symptom is uncommon in AMD?,"['Peripheral (side) vision loss is uncommon in age-related macular degeneration; AMD primarily damages the macula and produces central vision problems such as blurred or distorted central vision, difficulty reading and driving, and loss of fine detail, while the peripheral visual field is typically preserved.']","Peripheral (side) vision loss is uncommon in age-related macular degeneration, which primarily causes central vision problems.","Peripheral vision loss is uncommon in AMD, unlike central vision issues.",0.9837569822317167,0.8407019952788,0.9350279289268667,1.0,0.9999999999,1.0
What retinal layer supports photoreceptors in AMD?,['The retinal pigment epithelium (RPE) is the layer that supports photoreceptors; in age-related macular degeneration RPE dysfunction or loss undermines photoreceptor health and leads to progressive photoreceptor death and central vision impairment.'],The retinal pigment epithelium (RPE) is the layer that supports photoreceptors and whose dysfunction or loss in AMD leads to progressive photoreceptor death and central vision impairment.,The retinal pigment epithelium supports photoreceptors and is damaged in AMD.,0.9816636781051535,0.8913881012535066,0.9266547124206144,1.0,0.9999999999,1.0
What is a side effect of photodynamic therapy for AMD?,"['Photodynamic therapy for age-related macular degeneration can cause visual side effects, including potentially sight‑threatening worsening of vision or acute loss of central vision.']","A side effect of photodynamic therapy for AMD is visual harm, including potentially sight‑threatening worsening of vision or acute loss of central vision.",Temporary light sensitivity is a side effect of photodynamic therapy for AMD.,0.22904318813917068,0.991579346634801,0.9161727525566827,1.0,0.0,0.0
What is the estimated AMD prevalence in people over 80?,"['Age-related macular degeneration is described as a disease of the elderly and is particularly common in people over 80, affecting roughly 200 million people worldwide overall, but no specific percentage prevalence for the over-80 age group is provided.']","The provided information does not include a specific prevalence percentage for people over 80; it only states AMD is particularly common in that age group and that roughly 200 million people worldwide have AMD, so to estimate prevalence in the over‑80s I would need age-stratified prevalence data (number of affected individuals or prevalence percentage specifically for the >80 age group).",About 25% of people over 80 have AMD.,0.4426505657422405,0.0,0.9134594058261047,0.8,0.0,0.0
What nutrient was removed from AREDS in AREDS2?,"['AREDS2 removed beta‑carotene from the original AREDS supplement, replacing it with lutein and zeaxanthin while keeping the other vitamins and minerals to continue reducing progression to advanced AMD.']",Beta‑carotene was removed from the original AREDS formulation in AREDS2 and replaced with lutein and zeaxanthin.,Beta-carotene was removed from AREDS in the AREDS2 formula.,0.6134946013789664,,0.9539784055158654,1.0,0.9999999999,1.0
What happens to photoreceptors in advanced AMD?,"['In advanced age-related macular degeneration, photoreceptors—particularly the central cones—progressively degenerate and are lost as supporting retinal pigment epithelium and choroidal circulation fail and deposits or hemorrhages accumulate, producing structural changes like outer retinal tubulation and disruption of retinal circuitry that result in irreversible central vision loss and, in severe cases, blindness.']","In advanced AMD, photoreceptors—especially central cones—progressively degenerate and are lost as supporting retinal pigment epithelium and choroidal circulation fail and deposits or hemorrhages accumulate, leading to structural changes (e.g., outer retinal tubulation), disruption of retinal circuitry, irreversible central vision loss, and potentially blindness.","Photoreceptors degenerate in advanced AMD, leading to vision loss.",0.501569341507828,0.9999989712026055,0.915368275122221,1.0,0.9999999999,1.0
What visual aid is most used by AMD patients?,['People with age-related macular degeneration most commonly rely on low-vision aid devices—especially low-vision reading aids—to help compensate for central vision loss and difficulty reading.'],People with age-related macular degeneration most commonly use low-vision aid devices—particularly low-vision reading aids—to compensate for central vision loss and reading difficulties.,Magnifiers are the most used visual aid by AMD patients.,0.21194852423833238,0.8565024528004965,0.8477940969533295,1.0,0.9999999999,0.0
What condition forms scar tissue in wet AMD?,"['In wet age-related macular degeneration, abnormal new blood vessel growth beneath the retina (choroidal neovascularization) often leads to bleeding and scarring, producing a disciform scar (scar tissue) that damages central vision.']","In wet AMD, choroidal neovascularization (abnormal new blood vessel growth beneath the retina) often leads to bleeding and scarring that produces a disciform scar.",Macular fibrosis forms scar tissue in wet AMD.,0.22379944080760844,0.9128891958384701,0.8951977632304338,1.0,0.0,0.0
What cardiovascular condition increases AMD risk?,['Cardiovascular conditions—particularly hypertension and ischemic heart disease such as angina—are associated with an increased risk of developing age-related macular degeneration (AMD).'],Hypertension and ischemic heart disease (such as angina) are cardiovascular conditions associated with an increased risk of developing age-related macular degeneration (AMD).,Hypertension increases AMD risk.,0.6571950953731598,,0.914555763379039,1.0,0.9999999999,1.0
What procedure uses light-sensitive drugs for wet AMD?,"['Photodynamic therapy (PDT) is a procedure that uses a light-activated, photosensitizing drug together with a laser to target and close the abnormal choroidal blood vessels that cause wet age-related macular degeneration, helping to limit neovascularization and vision loss alongside established anti-VEGF treatments.']","Photodynamic therapy (PDT) uses a light-activated, photosensitizing drug plus a laser to target and close abnormal choroidal blood vessels in wet AMD.",Photodynamic therapy uses light-sensitive drugs for wet AMD.,0.8378658020843563,0.8569784938369294,0.9514632083374248,1.0,0.9999999999,1.0
What is a common finding in intermediate AMD?,"['A hallmark of intermediate AMD is drusen—yellowish deposits beneath the macula that are often large or numerous (including reticular or subretinal drusenoid forms), with increased drusen area and volume commonly seen on imaging and associated with visual symptoms and higher risk of progression.']","A common finding in intermediate AMD is the presence of large or numerous drusen—often including reticular or subretinal drusenoid types—with increased drusen area and volume on imaging, which associate with visual symptoms and higher progression risk.",Large drusen are a common finding in intermediate AMD.,0.4842841196954373,0.978431904627147,0.9371364787817491,1.0,0.9999999999,1.0
What syndrome causes hallucinations in AMD patients?,"['Age-related macular degeneration can lead to visual hallucinations known as Charles Bonnet syndrome, which occur when loss of visual input from the diseased retina causes the brain to generate complex visual images.']","The syndrome is Charles Bonnet syndrome, in which vision loss from AMD can lead the brain to generate complex visual hallucinations.",Charles Bonnet syndrome causes visual hallucinations in AMD patients.,0.988552206854352,0.9551058545789161,0.9542088274174078,1.0,0.9999999999,1.0
What age is recommended for AMD screening?,"['Because risk rises with age, routine screening for age-related macular degeneration is generally recommended beginning around age 50, with regular eye exams and closer, more frequent monitoring from about age 60 onward; people with additional risk factors such as family history or smoking should start earlier and be followed more closely.']","Routine AMD screening is generally recommended to begin around age 50, with regular exams and closer, more frequent monitoring from about age 60 onward (earlier and more frequent screening is advised for those with family history, smoking, or other risk factors).",Age 50 is recommended for AMD screening.,0.47746171467960075,0.9641690365317349,0.909846858718403,1.0,0.9999999999,1.0
What surgery repositions the macula in severe AMD?,"['The procedure called macular (or retinal) translocation is a complex retinal surgery used to reposition the macula away from diseased tissue in severe, typically neovascular, age-related macular degeneration, relocating the fovea to healthier underlying pigment epithelium to try to preserve or improve central vision.']","The procedure is called macular (or retinal) translocation, a complex surgery that repositions the macula (fovea) away from diseased tissue onto healthier underlying retinal pigment epithelium to try to preserve or improve central vision in severe, typically neovascular, AMD.",Macular translocation repositions the macula in severe AMD.,0.41700611570236745,0.8959096765515261,0.9180244628094699,1.0,0.9999999999,1.0
What is the purpose of sunglasses in AMD prevention?,"['Sunglasses shield the eyes from ultraviolet and other harmful light, reducing UV-related damage to the retina and macula; by limiting this exposure they help lower the risk of developing age-related macular degeneration, which can cause progressive central vision loss and blindness, so wearing sunglasses is a simple preventive measure to help preserve central vision.']","Sunglasses protect the eyes from ultraviolet and other harmful light, reducing UV-related retinal and macular damage and thereby helping lower the risk of developing age-related macular degeneration.",Sunglasses reduce UV exposure to help prevent AMD.,0.6578732274062359,,0.9172071953392292,1.0,0.9999999999,1.0
What gene is most associated with AMD risk?,"['The data indicate that ARMS2 is the gene most strongly associated with increased risk of age-related macular degeneration, with risk variants at the 10q26 locus (including nearby HTRA1) conferring the greatest genetic susceptibility; complement factor H (CFH) is also a major independent risk gene acting through the complement pathway.']","ARMS2 is the gene most strongly associated with increased risk of age-related macular degeneration, with risk variants at the 10q26 locus (including nearby HTRA1) conferring the greatest genetic susceptibility, while CFH is another major independent risk gene.",The CFH gene is most associated with AMD risk.,0.22241801295284827,0.9372394550991024,0.8896720518113931,1.0,0.0,0.0
What condition creates a hole in the macula in AMD?,['A macular hole is the condition that produces a hole in the macula in age-related macular degeneration; it can occur as an AMD complication and may be precipitated by events such as submacular hemorrhage or retinal arterial macroaneurysm.'],"A macular hole is the condition that produces a hole in the macula in AMD, and it can occur as an AMD complication precipitated by events such as submacular hemorrhage or retinal arterial macroaneurysm.",A macular hole can form in the macula in some AMD cases.,0.6638017986854952,0.9258107451487674,0.9409214804562662,1.0,0.9999999999,1.0
What psychological effect can AMD have?,"['Age-related macular degeneration often leads to significant emotional and psychological strain — including anxiety, depression, frustration, loss of confidence and independence, social withdrawal, and reduced quality of life — driven by vision loss that impairs reading, driving, mobility and daily activities and increases reliance on others.']","AMD can cause significant psychological effects including anxiety, depression, loss of confidence and independence, social withdrawal, frustration, and reduced quality of life due to vision loss that impairs daily activities and increases reliance on others.",AMD can lead to depression due to vision loss.,0.3732590328210402,0.9844561766945722,0.9475882926691737,1.0,0.9999999999,1.0
What test evaluates retinal function in AMD?,"['Retinal function in AMD is evaluated with functional and electrophysiological tests such as electroretinography (including full-field ERG), dark-adaptation testing, and optomotor response assessments, while imaging modalities like fundus autofluorescence and optical coherence tomography provide complementary information about retinal health.']","Retinal function in AMD is evaluated using functional and electrophysiological tests such as electroretinography (including full-field ERG), dark-adaptation testing, and optomotor response assessments.",An electroretinogram (ERG) evaluates retinal function in AMD.,0.45043610512412785,0.9469802633009246,0.9446015633536543,1.0,0.9999999999,1.0
What adaptation aids AMD patients with daily tasks?,"['Collaborative low-vision rehabilitation—often incorporating gaze-training strategies to compensate for central vision loss—helps people with age-related macular degeneration perform daily tasks, improving reading, mobility, and reducing dependence on others.']",Collaborative low-vision rehabilitation—often including gaze-training strategies to compensate for central vision loss—helps people with age-related macular degeneration perform daily tasks such as reading and mobility and reduces dependence on others.,High-contrast materials aid AMD patients with daily tasks.,0.2086894542507339,,0.8347578170029356,1.0,0.0,0.0
What condition wrinkles the retina in AMD?,"['Retinal wrinkling in AMD is caused by the neovascular (wet) form of age-related macular degeneration, where abnormal choroidal neovascular membranes, exudation and subsequent fibrosis/traction distort and wrinkle the retinal surface.']","Retinal wrinkling in AMD is caused by the neovascular (wet) form of AMD, in which abnormal choroidal neovascular membranes, exudation, and subsequent fibrosis/traction distort and wrinkle the retinal surface.",An epiretinal membrane wrinkles the retina in AMD.,0.2317937696917211,0.9472422414062343,0.9271750787668844,1.0,0.0,0.0
What nutrient in AREDS2 filters harmful light?,"['The nutrient lutein, included in AREDS2 formulations, helps filter harmful blue light and reduce oxidative damage in the retina, thereby protecting against progression of age-related macular degeneration.']",The nutrient lutein in AREDS2 formulations helps filter harmful blue light and reduce oxidative damage in the retina.,Zeaxanthin in AREDS2 filters harmful blue light.,0.6633330728210649,0.8964381746046186,0.9390465769985451,1.0,0.0,0.0
What causes blood leakage in wet AMD?,"['Blood leakage in wet AMD is caused primarily by abnormal growth of fragile new choroidal blood vessels beneath the retina (choroidal neovascularization) driven mainly by elevated vascular endothelial growth factor (VEGF) and other pro‑angiogenic signals; these leaky vessels and disruption of the blood–retinal barrier allow fluid and blood to escape into the retina. Inflammation and other signaling pathways that destabilize vessels (for example Ang‑2/VE‑PTP and altered VEGFR2 trafficking) further aggravate leakage, which is why therapies that block VEGF and related pathways reduce bleeding and fluid.']","Blood leakage in wet AMD is caused primarily by VEGF‑driven choroidal neovascularization of fragile new vessels beneath the retina, with inflammation and destabilizing pathways (e.g., Ang‑2/VE‑PTP and altered VEGFR2 trafficking) further disrupting the blood–retinal barrier and promoting fluid and bleeding.",Macular hemorrhage causes blood leakage in wet AMD.,0.2315040692513715,,0.9259470110567013,1.0,0.0,0.0
What future therapy might treat dry AMD?,"['Potential future therapies for dry AMD include cell-based approaches such as induced pluripotent stem cells and transplantation of stem-cell–derived retinal pigment epithelium to replace or support damaged RPE; intravitreal therapeutic agents and small molecules (for example MRZ-99030, zafirlukast, tonabersat) that target inflammation, complement activity, or toxic pathways; noninvasive light- and laser-based treatments like photobiomodulation and specialized light-delivery systems or subthreshold diode micropulse laser to improve retinal cell function; and implantable devices such as injectable telescopic intraocular lenses to help visual function—all aimed at slowing RPE and photoreceptor loss and preserving vision.']","Potential future therapies for dry AMD include cell-based approaches (e.g., iPSC-derived RPE transplantation), intravitreal small molecules targeting inflammation/complement/toxic pathways (e.g., MRZ-99030, zafirlukast, tonabersat), noninvasive light- or laser-based treatments (photobiomodulation, subthreshold diode micropulse), and implantable devices such as injectable telescopic intraocular lenses to preserve RPE/photoreceptors and vision.",Stem cell therapy is a potential future treatment for dry AMD.,0.22648365347740462,0.9828224625759271,0.9059346139096185,0.8,0.9999999999,1.0
What layer degenerates in geographic atrophy?,"['Geographic atrophy primarily involves degeneration of the retinal pigment epithelium (RPE), with secondary loss of the overlying photoreceptor layer, resulting in progressive central vision loss.']","In geographic atrophy the primary degeneration is of the retinal pigment epithelium (RPE), with secondary loss of the overlying photoreceptor layer.",The retinal pigment epithelium degenerates in geographic atrophy.,0.7340492207624626,0.9106409447031489,0.9361968830498505,1.0,0.9999999999,1.0
What mobility aid assists AMD patients?,"['Age-related macular degeneration often causes central vision loss and reduced mobility and independence; an implantable miniature telescope (an intraocular telescope) can improve visual function and help with navigation and daily mobility, and emerging treatments such as gene therapy may further support mobility-related tasks.']",An implantable miniature telescope (intraocular telescope) is a mobility-assisting aid for AMD patients that can improve central visual function and support navigation and daily mobility.,A white cane assists AMD patients with mobility.,0.212940375953577,0.8263470817437369,0.8517791569411111,1.0,0.0,0.0
What occupational factor may increase AMD risk?,"['Occupational factors linked to increased AMD risk include aspects of aviation work—particularly cumulative flight time and the type of aircraft flown, with aviators who log long hours or operate certain aircraft appearing to have higher risk.']",Long cumulative flight time and certain types of aircraft operation in aviation work have been associated with an increased risk of age-related macular degeneration.,Prolonged sun exposure may increase AMD risk.,0.21379137444442872,0.8824814038156831,0.8551654977777149,1.0,0.0,0.0
What drug class manages wet AMD?,"['Wet age-related macular degeneration is primarily managed with anti‑vascular endothelial growth factor (anti‑VEGF) medications, typically given as intravitreal injections; agents such as brolucizumab are used clinically, and oral VEGFR‑2 inhibitors are being explored as additional options.']","Wet age-related macular degeneration is primarily managed with anti–vascular endothelial growth factor (anti‑VEGF) medications, typically given as intravitreal injections.",Anti-VEGF drugs manage wet AMD by reducing blood vessel growth.,0.8286751252034128,0.879728974831299,0.9146774673003413,1.0,0.9999999999,1.0
What is seen on OCT imaging in wet AMD?,"['In wet AMD, OCT typically shows macular fluid—both subretinal and intraretinal—often with retinal thickening or localized edema, pigment epithelial and neurosensory detachments, and hyperreflective material corresponding to choroidal neovascularization; the scan also reveals disruption or gaps in the photoreceptor layers and other retinal layer abnormalities, making OCT a key tool to visualize macular neovascularization and monitor disease activity.']","OCT in wet AMD typically shows macular fluid (subretinal and intraretinal), retinal thickening or localized edema, pigment epithelial and neurosensory detachments, hyperreflective material from choroidal neovascularization, and disruption/gaps in the photoreceptor and other retinal layers.",Subretinal fluid is seen on OCT imaging in wet AMD.,0.8553062327155552,0.9570075527709644,0.9212249308622209,1.0,0.9999999999,1.0
What severe condition can wet AMD cause?,"['Wet (neovascular) AMD can lead to rapid, severe central vision loss and significant visual impairment, and in many cases can progress to irreversible blindness, profoundly affecting reading, driving, and independence.']","Wet (neovascular) AMD can cause rapid, severe central vision loss that may progress to irreversible blindness, profoundly impairing activities like reading, driving, and independence.",Retinal detachment is a severe condition wet AMD can cause.,0.8462271893160838,,0.8849087572643349,1.0,0.0,0.0
What dietary habit increases AMD risk?,"['Excessive alcohol consumption—heavy drinking—is linked to a higher risk of developing age-related macular degeneration; conversely, healthier dietary patterns and certain supplements can help reduce AMD prevalence and severity.']",Heavy (excessive) alcohol consumption is associated with an increased risk of developing age-related macular degeneration.,A high-fat diet increases AMD risk.,0.5863193347072709,0.8335165999825621,0.8452773388290837,1.0,0.0,0.0
What test assesses color vision in AMD?,"['Color vision in age-related macular degeneration is evaluated using color vision/contrast tests that measure color recognition and hue discrimination (color contrast sensitivity testing), since AMD commonly impairs color recognition and color contrast.']","Color vision in AMD is assessed using color vision/contrast tests that measure color recognition and hue discrimination, commonly referred to as color contrast sensitivity testing.",The Ishihara test assesses color vision changes in AMD.,0.22596737349367776,0.9417912966119593,0.9038694939747111,1.0,0.0,0.0
What can untreated dry AMD progress to?,"['If left untreated, dry age-related macular degeneration can advance to atrophy of the retinal pigment epithelium and photoreceptors, producing geographic atrophy (including subfoveal involvement) that causes progressive central vision loss and can lead to legal blindness, significant disability, and a marked decline in quality of life; it may also predispose the eye to development of neovascular (wet) changes.']","Untreated dry AMD can progress to geographic atrophy—atrophy of the retinal pigment epithelium and photoreceptors (including subfoveal involvement) causing progressive central vision loss, potential legal blindness, disability, reduced quality of life, and increased risk of neovascular (wet) conversion.",Untreated dry AMD can progress to geographic atrophy.,0.4027907118596589,0.941495535213393,0.9444961807719691,1.0,0.9999999999,1.0
What condition blocks retinal vessels in AMD?,['The blockage is caused by retinal artery or vein occlusion—retinal vascular occlusion of the retinal blood vessels.'],"The provided information indicates that retinal artery or vein occlusion (retinal vascular occlusion) can block retinal vessels, but it is unclear from this context whether this is a primary mechanism in AMD specifically—additional clinical data linking AMD subtype and vascular occlusion would be needed to confirm.",Retinal vascular occlusion blocks retinal vessels in AMD.,0.4836868931358874,,0.9347475725435498,0.5,0.9999999999,1.0
What reading aid benefits AMD patients?,"['Patients with age-related macular degeneration benefit from low-vision reading aids—particularly magnifying devices and dedicated low-vision reading tools; electronic magnifiers, tablets or screen‑reader technology, intraocular telescopes or prosthetic central‑vision devices, and specialized low‑vision training can further improve reading ability and speed.']","AMD patients benefit from low-vision reading aids—especially magnifying devices and dedicated low‑vision tools such as electronic magnifiers, tablets or screen‑reader technology, intraocular telescopes or prosthetic central‑vision devices, combined with specialized low‑vision training to improve reading ability and speed.",Large-print books benefit AMD patients.,0.21834918962791117,0.9433932169258391,0.8733967585116447,0.9090909090909091,0.0,0.0
What causes macular swelling in wet AMD?,"['Macular swelling in wet AMD results from abnormal, VEGF-driven growth of leaky choroidal blood vessels (choroidal neovascularization) beneath and into the retina; these new vessels leak fluid and blood, disrupt the retinal pigment epithelium and retinal architecture, and cause intraretinal and subretinal edema and scarring, which is why anti-VEGF and other anti‑angiogenic treatments aimed at stopping vessel growth and leakage reduce macular swelling.']","Macular swelling in wet AMD is caused by VEGF-driven growth of leaky choroidal neovascular vessels beneath and into the retina, which leak fluid and blood, disrupt the retinal pigment epithelium and retinal architecture, and produce intraretinal and subretinal edema and scarring.",Macular edema causes swelling in the macula in wet AMD.,0.23505811028031748,0.9999999999999997,0.9402427668072851,1.0,0.9999999999,0.0
What is the benefit of regular eye exams for AMD?,"['Regular eye exams allow early detection and diagnosis of age-related macular degeneration, including its subtypes, before severe symptoms develop; identifying disease early enables timely treatments—such as intravitreal medications, photodynamic therapy, or other emerging options—that can slow progression, preserve central vision and daily functioning (reading, driving), reduce risk of severe vision loss or blindness, and help maintain independence and quality of life.']","Regular eye exams enable early detection and diagnosis of AMD and its subtypes, allowing timely treatments (e.g., intravitreal medications, photodynamic therapy, and emerging options) that can slow progression, preserve central vision and daily functioning, reduce the risk of severe vision loss or blindness, and help maintain independence and quality of life.",Regular eye exams allow early detection of AMD.,0.4224372861705657,0.9902713793897785,0.9397491446822628,1.0,0.9999999999,1.0
What retinal change is seen in dry AMD?,"['Dry AMD is marked by accumulation of drusen (often large soft drusen and drusenoid pigment epithelial detachments) with progressive dysfunction and atrophy of the retinal pigment epithelium, leading to geographic (including subfoveal) atrophy, photoreceptor degeneration and retinal cell death that cause vision loss.']","Dry AMD is characterized by accumulation of drusen (often large soft drusen and drusenoid pigment epithelial detachments) with progressive dysfunction and atrophy of the retinal pigment epithelium leading to geographic atrophy, photoreceptor degeneration, and retinal cell death.",Retinal pigment epithelium clumping is seen in dry AMD.,0.21863885400716968,0.8942074090201974,0.8745554160286787,1.0,0.0,0.0
What technology aids AMD patients with reading?,"['Patients with age-related macular degeneration can improve reading using low-vision assistive technologies such as magnifying aids and optical correction, screen‑reader software and tablets (e.g., iPad) with adjustable or dynamic text, prosthetic central‑vision devices or macular add‑on intraocular lenses, and complementary approaches like special low‑vision and oculomotor training to boost reading ability and speed.']","AMD patients can improve reading with low-vision assistive technologies such as magnifying aids and optical correction, screen‑reader software and tablets with adjustable/dynamic text, prosthetic central‑vision devices or macular add‑on intraocular lenses, and complementary low‑vision and oculomotor training.",Screen readers aid AMD patients with reading.,0.4754007413949879,0.9765647820771356,0.9016029655799516,1.0,0.9999999999,1.0
What condition tears the retina in AMD?,"['The condition that tears the retina in AMD is a detached retina (retinal detachment), which can occur particularly with neovascular (“wet”) AMD associated with subretinal exudation.']","In AMD, the retina can be torn due to retinal detachment, which may occur particularly in neovascular (“wet”) AMD associated with subretinal exudation.",A retinal tear can occur in severe AMD cases.,0.7316075957704706,0.9320620874685547,0.9264303830818827,1.0,0.0,0.0
What is the benefit of exercise for AMD patients?,"['Regular physical exercise appears to lower the risk of developing and progressing age-related macular degeneration—frequent vigorous activity is linked to reduced incidence of intermediate and late AMD—while also supporting retinal health by reducing choroidal neovascularization and enhancing the effectiveness of anti‑angiogenic treatments; additionally, exercise improves mood, physical function, and overall well‑being, though very intense endurance exercise may sometimes increase oxidative stress.']","Regular physical exercise reduces the risk of developing and progressing intermediate and late AMD, helps protect retinal health by lowering choroidal neovascularization and improving response to anti‑angiogenic therapy, and also benefits mood and physical function, though very intense endurance exercise may increase oxidative stress.",Exercise improves retinal blood flow for AMD patients.,0.5265851951616736,0.9553026627501592,0.9063407806466939,1.0,0.0,0.0
What condition puckers the macula in AMD?,"['Macular puckering in AMD most commonly results from the neovascular (wet) form, where choroidal neovascular membranes and associated subretinal/scar tissue contract and distort (pucker) the macula.']","Macular puckering in AMD most commonly results from the neovascular (wet) form, where contracting choroidal neovascular membranes and associated subretinal or scar tissue distort the macula.",A macular pucker causes the macula to wrinkle in AMD.,0.4798732251309001,0.9371203769686863,0.9194843389329969,1.0,0.9999999999,1.0
What future diagnostic tool might detect AMD?,"['A likely future diagnostic for AMD will combine blood-based molecular biomarkers—such as miRNA signatures and inflammatory or amyloid-related markers—with advanced retinal imaging (e.g., OCT‑A and fundus photography) analyzed by deep-learning algorithms to provide a sensitive, noninvasive early detection tool.']","A likely future diagnostic for AMD will combine blood-based molecular biomarkers (e.g., miRNA signatures and inflammatory or amyloid-related markers) with advanced retinal imaging (OCT‑A and fundus photography) analyzed by deep‑learning algorithms to enable sensitive, noninvasive early detection.",Artificial intelligence might detect AMD in the future.,0.21957655053437794,0.950884516449528,0.8783062021375118,1.0,0.9999999999,0.0
What condition dilates retinal vessels in AMD?,['The neovascular (wet) form of AMD—characterized by choroidal/pathological neovascularization—is the condition that leads to dilation of the retinal vessels.'],"The neovascular (wet) form of age-related macular degeneration, characterized by choroidal/pathological neovascularization, is the condition that dilates the retinal vessels.",Retinal vascular dilation can occur in AMD.,0.5940088160847267,0.8624191333651533,0.8760352643389065,0.6666666666666666,0.9999999999,1.0
What cooking aid assists AMD patients?,"['Age-related macular degeneration often causes central vision loss that impairs cooking ability, and vision-enhancing devices such as an intraocular telescope can improve visual function and help AMD patients carry out cooking tasks more safely and independently.']","An intraocular telescope is a vision-enhancing device that can assist AMD patients with cooking by improving central vision and enabling safer, more independent task performance.",High-contrast cutting boards assist AMD patients with cooking.,0.21312160221517348,0.8458390643747324,0.8524864088606939,0.8,0.0,0.0
What disrupts photoreceptors in AMD?,"['In AMD, photoreceptors are disrupted mainly by retinal pigment epithelium degeneration (including RPE cell loss and apoptosis), buildup of drusen and subretinal/lipid-rich deposits, impaired choroidal/choriocapillaris blood supply and submacular hemorrhage, and progressive macular atrophy (geographic atrophy), with additional insults like light damage and other degenerative or inflammatory processes accelerating photoreceptor loss and central vision impairment.']","In AMD, photoreceptors are disrupted primarily by retinal pigment epithelium degeneration (including RPE cell loss and apoptosis), accumulation of drusen and subretinal/lipid-rich deposits, impaired choroidal/choriocapillaris blood supply and submacular hemorrhage, progressive macular atrophy (geographic atrophy), and additional insults such as light damage and inflammatory or other degenerative processes that accelerate photoreceptor loss.",Photoreceptor disarray disrupts photoreceptors in AMD.,0.22527342889344146,0.9562035518656656,0.9010937155737658,1.0,0.0,0.0
What is the benefit of quitting smoking for AMD?,"['Quitting smoking lowers your risk of developing and progressing age-related macular degeneration, reduces the chance of late-stage forms such as neovascular AMD and geographic atrophy, can delay onset and lessen disease severity, and is associated with better treatment response and visual outcomes—helping preserve central vision and slow vision loss.']","Quitting smoking reduces the risk of developing and progressing age-related macular degeneration, lowers the chance of late-stage neovascular AMD and geographic atrophy, can delay onset and lessen severity, and is associated with better treatment response and visual outcomes, thereby helping preserve central vision and slow vision loss.","Quitting smoking reduces oxidative stress, slowing AMD progression.",0.22662467898860475,0.9134075271361977,0.906498715954419,1.0,0.9999999999,0.0
What causes blood leakage in the retina in wet AMD?,"['In wet age-related macular degeneration, abnormal growth of new choroidal blood vessels beneath the retina—driven mainly by VEGF and other pro‑angiogenic/diffusible factors and exacerbated by inflammation and related molecular signals—disrupts the blood–retinal barrier so fragile vessels leak blood and fluid into the retinal layers, causing vision loss.']","In wet AMD, abnormal VEGF‑driven growth of fragile choroidal neovascular vessels beneath the retina—exacerbated by inflammation and other pro‑angiogenic signals—disrupts the blood–retinal barrier so these vessels leak blood and fluid into the retinal layers.",Retinal hemorrhage causes blood leakage in wet AMD.,0.47838896633175665,0.89679899824009,0.9136575784651702,1.0,0.9999999999,0.0
What driving aid helps AMD patients?,"['People with age-related macular degeneration benefit from low-vision aids for driving; devices such as intraocular telescopes and electronic travel aids can enhance visual function, improve driving performance, shorten task completion time, and reduce collisions, helping maintain safer driving.']",Intraocular telescopes and electronic travel aids are driving aids that can enhance visual function and improve driving performance for people with age-related macular degeneration.,Bioptic telescopes help AMD patients with driving.,0.4706855956663832,0.9067856111438123,0.8827423826655327,1.0,0.0,0.0
What retinal change occurs in dry AMD over time?,"['In dry AMD the retinal pigment epithelium progressively dysfunctions and atrophies, producing geographic (often subfoveal) atrophy with subsequent photoreceptor degeneration and retinal cell death, leading to progressive vision loss.']","In dry AMD, the retinal pigment epithelium progressively malfunctions and atrophies, leading to geographic atrophy (often affecting the subfoveal region), subsequent photoreceptor degeneration, retinal cell death, and progressive vision loss.",Retinal pigment epithelium hyperplasia can occur in dry AMD over time.,0.22360864029728877,0.906923722551146,0.8943842389548677,1.0,0.0,0.0
What is the benefit of leafy greens for AMD?,['Regular consumption of green leafy vegetables is associated with a lower risk of visual impairment and may help prevent or reduce the development of age-related macular degeneration.'],Regular consumption of green leafy vegetables is associated with a lower risk of visual impairment and may help prevent or slow development of age-related macular degeneration.,Leafy greens provide antioxidants that may reduce AMD risk.,0.6541890257625125,0.8913209515031356,0.9024703887643355,0.6666666666666666,0.9999999999,1.0
What condition folds the retina in AMD?,"['In age-related macular degeneration, retinal detachment—often secondary to neovascular changes—can cause the retina to fold.']","In age-related macular degeneration, retinal detachment—often secondary to neovascular changes—can cause the retina to fold.","A retinal fold, often linked to an epiretinal membrane, can occur in AMD.",0.47678831157575763,0.9162305631395938,0.9071532463030304,1.0,0.0,0.0
What future treatment might address wet AMD?,"['Emerging treatments for wet AMD include novel biologics and targeted agents such as faricimab—which addresses both VEGF and the Ang–Tie pathway—new VEGF antagonists and anti‑VEGF biologics, gene therapies like rAAV‑sFLT‑1 subretinal delivery, investigational drugs such as 4D_150, and retinal pigment epithelium cell transplants from hESCs, all designed to more durably suppress abnormal neovascularization and preserve vision.']","Future wet AMD treatments may include dual-pathway biologics like faricimab (targeting VEGF and Ang–Tie), novel anti‑VEGF agents, gene therapies (e.g., rAAV‑sFLT‑1), investigational drugs such as 4D_150, and hESC-derived RPE cell transplants to more durably suppress neovascularization and preserve vision.",Gene therapy might address wet AMD in the future.,0.22056309503851962,0.9755684545213158,0.8821707786819633,1.0,0.9999999999,1.0
What causes fluid leakage from retinal vessels in AMD?,"['In age-related macular degeneration, especially the neovascular (wet) form, abnormal growth of new blood vessels beneath the retina (choroidal neovascularization) driven by VEGF and other soluble diffusible factors makes those vessels fragile and prone to leakage, resulting in fluid accumulation within and under the retina that can impair central vision.']","In neovascular (wet) age-related macular degeneration, overexpression of VEGF and other soluble diffusible factors drives growth of fragile choroidal neovascular vessels beneath the retina that are prone to leakage, causing fluid accumulation within and under the retina.",Retinal vascular leakage causes fluid leakage in AMD.,0.43710420513874776,0.9043447401991678,0.8912739634121338,0.75,0.9999999999,1.0
What is the goal of occupational therapy for AMD patients?,"['The goal of occupational therapy for patients with AMD is to maximize independence and quality of life by teaching compensatory strategies and using adaptive devices and environmental modifications so patients can manage reading, mobility and other daily tasks, reduce dependence and psychosocial burden, and maintain participation despite central vision loss.']","The goal of occupational therapy for patients with AMD is to maximize independence and quality of life by teaching compensatory strategies, providing adaptive devices and environmental modifications, and training patients to manage reading, mobility, and daily tasks to reduce dependence and psychosocial burden despite central vision loss.",The goal of occupational therapy is to help AMD patients adapt to vision loss.,0.4879451233917014,0.9962661269686836,0.9517804935668055,1.0,0.9999999999,1.0
What kills photoreceptors in AMD?,"['In AMD, photoreceptors are lost primarily when the supporting retinal pigment epithelium breaks down and choroidal blood supply is compromised; accumulated drusen and subretinal/lipid-rich deposits, local inflammation, hemorrhage, light damage and dysregulated cell-death and autophagy pathways further stress and kill photoreceptors, producing geographic atrophy and central vision loss.']","Photoreceptors in AMD are primarily lost when supporting retinal pigment epithelium (RPE) integrity and choroidal blood supply fail, with contributing damage from accumulated drusen and subretinal/lipid-rich deposits, local inflammation, hemorrhage, light-induced injury, and dysregulated cell-death and autophagy pathways leading to geographic atrophy and central vision loss.",Photoreceptor degeneration kills photoreceptors in AMD.,0.22647402038759396,0.9308684613097965,0.9058960815503758,1.0,0.9999999999,0.0
What is the benefit of fish consumption for AMD?,"['Eating fish, especially fatty fish rich in beneficial fats, is associated with a lower risk of age-related macular degeneration — linked to reduced chances of developing early, late, and overall AMD and may help protect retinal health and slow disease progression.']","Eating fish, especially fatty fish rich in beneficial fats, is associated with a lower risk of early, late, and overall age-related macular degeneration and may help protect retinal health and slow disease progression.",Fish consumption provides omega-3 fatty acids that may slow AMD progression.,0.9762604839890031,0.8975381539105834,0.9050419359560126,1.0,0.9999999999,1.0
What detaches the retina in severe wet AMD?,"['In severe wet AMD, abnormal choroidal neovascularization—often including variants such as retinal angiomatous proliferation or polypoidal choroidal vasculopathy—produces leaking blood vessels, hemorrhage and subretinal fluid that can lift and detach the retina.']","In severe wet AMD, abnormal choroidal neovascularization (including variants such as retinal angiomatous proliferation or polypoidal choroidal vasculopathy) produces leaking blood vessels, hemorrhage, and subretinal fluid that can lift and detach the retina.",Retinal detachment can occur in severe wet AMD.,0.439336784073471,0.9138072190259484,0.9002042791510267,1.0,0.9999999999,1.0
What magnifies text for AMD patients?,"['People with age-related macular degeneration who have central vision loss and difficulty reading rely on magnification tools—handheld optical magnifiers and electronic video magnifiers (CCTV), plus smartphone/tablet zoom and screen‑magnification software, large‑print/high‑contrast text, and speech-based readers to make text readable.']","Text for AMD patients can be magnified using handheld optical magnifiers, electronic video magnifiers (CCTV), smartphone/tablet zoom and screen‑magnification software, large‑print/high‑contrast text, and speech-based readers.",Electronic magnifiers magnify text for AMD patients.,0.4866794613203552,0.9765228877841315,0.946725455689456,1.0,0.9999999999,1.0
What blocks retinal vessels in AMD?,"['In age-related macular degeneration, accumulations such as drusen and subretinal drusenoid deposits (reticular pseudodrusen) can block retinal blood vessels, impairing retinal blood flow and contributing to vision loss.']","In AMD, accumulations such as drusen and subretinal drusenoid deposits (reticular pseudodrusen) can block or compress retinal blood vessels, impairing retinal blood flow and contributing to vision loss.",Retinal vascular occlusion blocks retinal vessels in AMD.,0.22205954818263332,0.8864555264862481,0.8882381927305333,1.0,0.0,0.0
What is the benefit of AREDS supplements for AMD?,"['AREDS vitamin/mineral supplements have been shown to slow progression of age‑related macular degeneration—especially in people with intermediate disease or high‑risk eyes (AREDS categories 3 and 4) and with dry AMD—reducing the risk of advancing to severe central vision loss and providing measurable visual and quality‑of‑life benefit, though individual response can vary with genetic factors.']","AREDS vitamin/mineral supplements have been shown to slow progression of age-related macular degeneration—particularly in people with intermediate or high‑risk (AREDS categories 3 and 4) and dry AMD—reducing the risk of advancing to severe central vision loss and improving visual and quality‑of‑life outcomes, though individual response may vary with genetic factors.",AREDS supplements slow the progression of intermediate to advanced AMD.,0.4379441374826739,0.0,0.8946336927878387,1.0,0.9999999999,1.0
What atrophies retinal pigment in dry AMD?,"[""In dry age-related macular degeneration the disease process itself leads to dysfunction and atrophy of the retinal pigment epithelium (loss of RPE cells and geographic atrophy), typically in association with drusen and subretinal deposits; contributing factors include complement-mediated inflammation, impaired autophagy and lysosomal clearance, chronic cellular stress, alterations in Bruch's membrane and the choroidal vasculature, and accumulation of toxic proteins, all of which drive photoreceptor degeneration and vision loss.""]","In dry AMD, retinal pigment epithelium atrophy is driven by RPE cell loss and geographic atrophy resulting from complement-mediated inflammation, impaired autophagy/lysosomal clearance, chronic cellular stress, Bruch's membrane and choroidal changes, and accumulation of toxic proteins associated with drusen and subretinal deposits.",Retinal pigment epithelium atrophy affects retinal pigment in dry AMD.,0.41705180833131184,0.9607289802188973,0.9182072333252473,0.125,0.9999999999,1.0
What writing aid helps AMD patients?,['People with age-related macular degeneration often benefit from low-vision reading aids—specialized low-vision devices that magnify text and improve contrast to help with reading and writing despite central vision loss.'],Specialized low-vision reading aids—devices that magnify text and improve contrast—help people with age-related macular degeneration with reading and writing despite central vision loss.,Bold markers help AMD patients with writing.,0.20459266798429104,0.8439381013971948,0.8183706719371642,1.0,0.0,0.0
What is the role of the macula in vision?,"['The macula is the small central part of the retina responsible for sharp, detailed, straight‑ahead and color vision; it contains yellow pigments (lutein and zeaxanthin) that help filter high‑energy short‑wave light and protect retinal cells. Damage or disease of the macula—such as age‑related macular degeneration, diabetic macular edema, neovascular changes, or other macular disorders—causes blurred or lost central vision and difficulty seeing what one is directly looking at. Clinicians evaluate macular structure and thickness with imaging and examination, and treatments (including intravitreal therapies and other interventions) aim to preserve or improve central vision.']","The macula is the small central retina region responsible for sharp, detailed, straight‑ahead and color vision, using yellow pigments (lutein and zeaxanthin) to filter high‑energy short‑wave light and protect retinal cells.",The macula enables sharp central vision for tasks like reading and recognizing faces.,0.3643375995616567,0.965966887506201,0.9118958527920812,1.0,0.9999999999,1.0
What characterizes early AMD?,"['Early AMD is marked by characteristic retinal changes—most notably drusen and abnormalities in drusen-free areas—along with thinning of the outer retina and photoreceptor outer segments, leading to visual dysfunction such as reduced acuity and impaired dark adaptation. It typically occurs with advancing age and varies by ethnicity, can be detected by imaging and functional tests, and is associated with systemic factors including lipid profiles, metabolic syndrome, kidney disease, and low vitamin D.']","Early AMD is characterized by drusen and drusen-free retinal abnormalities, thinning of the outer retina and photoreceptor outer segments, and associated visual dysfunction (reduced acuity, impaired dark adaptation), with onset typically in older adults and links to ethnicity and systemic factors (lipids, metabolic syndrome, kidney disease, low vitamin D).",Early AMD is characterized by small drusen and no noticeable vision loss.,0.5244415999165435,0.9266754441314798,0.897766399666174,1.0,0.0,0.0
What is the main symptom of intermediate AMD?,"['The main symptom of intermediate AMD is progressive loss of central vision, typically experienced as blurred, distorted, or missing detail in the center of the visual field, leading to difficulty reading, recognizing faces, or driving.']","The main symptom of intermediate AMD is progressive loss of central vision, typically experienced as blurred, distorted, or missing detail in the center of the visual field, causing difficulty reading, recognizing faces, or driving.",The main symptom of intermediate AMD is mild central vision blurriness.,0.2355600197513122,1.0000000000000002,0.9422400790052488,1.0,0.9999999999,0.0
What defines late-stage AMD?,"['Late-stage age-related macular degeneration is defined by severe macular damage with loss of central vision—producing marked central visual impairment that can progress to irreversible vision loss, legal blindness, or blindness. It involves retinal pathology such as drusen, pseudodrusen and subretinal deposits, is linked to genetic and metabolic risk factors, and typically requires rehabilitative measures or implant/surgical interventions to manage the resulting vision loss.']","Late-stage AMD is defined by severe macular damage with loss of central vision—often from extensive drusen, pseudodrusen, subretinal deposits and associated retinal pathology—leading to marked central visual impairment that can progress to irreversible vision loss, legal blindness, or blindness and typically necessitates rehabilitative, implant, or surgical interventions.","Late-stage AMD is defined by significant central vision loss, either dry or wet.",0.6764637941630789,0.9378403396655001,0.9411492942993747,0.6923076923076923,0.9999999999,1.0
What is the purpose of the Amsler grid test?,"['The Amsler grid is used to detect and monitor changes in central vision—particularly visual distortions or blind spots—that can signal early or intermediate age-related macular degeneration; it is typically used repeatedly by patients to track symptoms, and its usefulness depends on patients understanding and accepting the monitoring process.']","The Amsler grid test is used by patients to detect and monitor changes in central vision—especially visual distortions or blind spots—that can signal early or intermediate age-related macular degeneration, with its usefulness depending on repeated self-testing and patient understanding.",The Amsler grid test detects distortions or blind spots in central vision due to AMD.,0.8781406228141306,0.9999980657398669,0.9411339198279512,0.875,0.9999999999,1.0
What is the typical age of onset for AMD?,"['Age-related macular degeneration typically begins in later life — it generally develops after about age 50 and is most common in people over 60–65, with risk rising as people get older.']","Age-related macular degeneration typically begins after about age 50 and is most common in people over 60–65, with risk increasing further as people age.",The typical age of onset for AMD is over 60.,0.9733716805402454,0.9223546183390253,0.8934867221609815,1.0,0.9999999999,1.0
What is the primary goal of wet AMD treatments?,"['The primary goal of wet AMD treatments is to stop the abnormal growth and leakage of blood vessels under the retina to prevent severe vision loss and preserve or improve central visual acuity, typically achieved with intravitreal anti‑angiogenic/anti‑VEGF therapies.']","The primary goal of wet AMD treatments is to stop abnormal growth and leakage of blood vessels under the retina to prevent severe vision loss and preserve or improve central visual acuity, typically using intravitreal anti‑VEGF therapies.",The primary goal of wet AMD treatments is to halt abnormal blood vessel growth and leakage.,0.5408844685827138,1.0000000000000013,0.9635378743308549,1.0,0.9999999999,1.0
What is the function of zinc in the AREDS formula?,"['In the AREDS formula, zinc serves as a protective nutrient that helps prevent and slow the progression of age-related macular degeneration, lowering the risk of developing advanced disease and supporting retinal pigment epithelial cell function; supplementation with zinc has been associated with improved AMD outcomes, while zinc deficiency worsens oxidative stress and promotes macular damage.']","In the AREDS formula, zinc functions as a protective nutrient that supports retinal pigment epithelial cell function, reduces oxidative stress, and helps prevent or slow progression to advanced age-related macular degeneration.",Zinc supports retinal cell health and reduces AMD progression in the AREDS formula.,0.8784723111305683,0.9839195620218454,0.9424606730937023,0.75,0.9999999999,1.0
What is a hallmark of wet AMD on retinal scans?,['The hallmark of wet AMD on retinal scans is choroidal neovascularization—abnormal new blood-vessel growth beneath the macula—which is visible as neovascular changes on OCT and other retinal imaging and defines neovascular (wet) AMD.'],The hallmark of wet (neovascular) AMD on retinal imaging is choroidal neovascularization—abnormal new blood-vessel growth beneath the macula—visible as neovascular changes on OCT and other retinal scans.,A hallmark of wet AMD on retinal scans is subretinal fluid or hemorrhages.,0.23252448281806093,0.9668919619991984,0.9300979312722437,1.0,0.0,0.0
What is the most common visual aid for AMD patients?,"['The most common visual aid for people with age-related macular degeneration is the intraocular telescope, an implantable device used to improve central vision and reading ability impaired by macular degeneration.']","The most common visual aid for people with age-related macular degeneration is the intraocular telescope, an implantable device used to improve central vision and reading ability.",The most common visual aid for AMD patients is a handheld magnifier.,0.2221380756766318,0.940882710945209,0.8885523027065272,1.0,0.0,0.0
What retinal change marks early dry AMD?,"['Early dry AMD is marked by accumulation of drusen—subretinal drusenoid deposits—within the macula of the retina, which can be seen on retinal/fundus examination.']","Early dry AMD is marked by the accumulation of drusen (subretinal drusenoid deposits) within the macula, visible on retinal/fundus examination.",Small drusen deposits mark early dry AMD.,0.5348826664874011,0.9108125614502831,0.9394690114804605,1.0,0.9999999999,1.0
What is the role of copper in AREDS supplements?,"['Copper is included in AREDS formulations as part of the vitamin–mineral mix used to slow progression of intermediate and advanced age-related macular degeneration and to support ocular health; it helps prevent copper deficiency that can contribute to eye lesions, is present alongside carotenoids in some lutein/zeaxanthin-containing preparations, and its metabolism can be influenced by dietary calcium.']","In AREDS formulations, copper is included in the vitamin–mineral mix to prevent copper deficiency (which can contribute to ocular lesions), support overall ocular health, and help slow progression of intermediate and advanced age-related macular degeneration, with its metabolism potentially influenced by dietary calcium.",Copper prevents anemia caused by high zinc levels in AREDS supplements.,0.21886571515429165,0.9817288341364527,0.8754628606171666,1.0,0.0,0.0
What is a frequent complaint of AMD patients?,"['A frequent complaint is difficulty reading — patients often experience blurred or lost central vision that makes seeing fine detail (reading, recognizing faces, driving) difficult, leading to frustration and greater dependence on others.']","A frequent complaint of AMD patients is difficulty reading due to blurred or lost central vision that impairs seeing fine detail (e.g., reading, recognizing faces, driving), causing frustration and increased dependence on others.",A frequent complaint of AMD patients is difficulty seeing in low light.,0.23108423898958885,,0.9243369559583554,1.0,0.0,0.0
What is the purpose of fundus photography in AMD?,"['Fundus photography captures color images of the retina to diagnose and document age-related macular degeneration and its subtypes, reveal features such as drusen (including dot and reticular types), RPE atrophy, geographic atrophy, neovascular changes (including polypoidal choroidal vasculopathy) and fibrosis, and to monitor disease progression over time to guide management.']","Fundus photography in AMD is used to capture color retinal images to diagnose and document AMD and its subtypes, visualize features such as drusen (dot and reticular), RPE atrophy, geographic atrophy, neovascular changes (including PCV) and fibrosis, and to monitor disease progression over time to guide management.",Fundus photography documents retinal changes like drusen or hemorrhages in AMD.,0.6466568352901447,0.9694285965577844,0.9502637047969427,1.0,0.9999999999,0.0
What is the main environmental risk factor for AMD?,"['The strongest modifiable environmental risk factor for age-related macular degeneration is cigarette smoking; environmental exposures such as smoking and poor nutrition promote oxidative stress and intraocular inflammation that increase the risk of developing and progressing AMD, alongside nonmodifiable drivers like age and genetics.']","The main modifiable environmental risk factor for age-related macular degeneration is cigarette smoking, which—along with poor nutrition—promotes oxidative stress and intraocular inflammation that increase AMD risk and progression.",The main environmental risk factor for AMD is prolonged UV light exposure.,0.22913825798652349,0.9481711452177407,0.9165530319460939,1.0,0.0,0.0
What is the definition of legal blindness in AMD?,"['In age-related macular degeneration, legal blindness refers to the severe central vision loss seen in advanced disease (for example from geographic atrophy, neovascularization, or photoreceptor death) that produces profound visual impairment; by standard legal criteria it is best-corrected visual acuity of 20/200 or worse in the better-seeing eye or a visual field of 20 degrees or less.']","In age-related macular degeneration, legal blindness is severe central vision loss—best-corrected visual acuity of 20/200 or worse in the better-seeing eye or a visual field of 20 degrees or less, typically from geographic atrophy, neovascularization, or photoreceptor death.","Legal blindness in AMD is defined as central vision worse than 20/200, even with correction.",0.417623200207311,0.9202275414295104,0.9204928008292439,1.0,0.9999999999,1.0
What is the role of the choroid in AMD?,"['The choroid is central to AMD: structural and functional changes in the choroid and choriocapillaris compromise RPE support, promote drusen and subretinal deposit formation with complement pathway involvement, and underlie both geographic atrophy and macular neovascularization (including choroidal neovascularization and polypoidal choroidal vasculopathy). Regional and inner choroidal alterations influence AMD subtype and severity, affect the posterior segment and visual outcomes, and are both impacted by and targeted with treatments such as anti‑VEGF and suprachoroidal approaches.']","The choroid is central in AMD pathogenesis and progression: structural and functional changes in the choroid and choriocapillaris impair RPE support, promote drusen and subretinal deposits via complement-mediated processes, and underlie both geographic atrophy and macular neovascularization (including CNV and PCV), with regional/inner choroidal alterations influencing AMD subtype, severity, visual outcomes, and response to treatments such as anti‑VEGF and suprachoroidal approaches.",The choroid supplies blood to the retina and is involved in wet AMD’s neovascularization.,0.2262583083596917,0.9690881709688695,0.9050173732344551,1.0,0.9999999999,0.0
What is a common mobility challenge for AMD patients?,"['A common mobility challenge for people with AMD is reduced mobility from central vision loss and impaired spatial perception, which makes reading signs and judging distances difficult, worsens motion sensitivity, leads to driving problems (observation, lane‑keeping and gap‑selection errors), and often increases dependence on others.']","A common mobility challenge for people with AMD is reduced mobility due to central vision loss and impaired spatial perception, which hinders reading signs, judging distances, worsens motion sensitivity, creates driving errors (observation, lane‑keeping, gap selection), and increases dependence on others.",A common mobility challenge for AMD patients is navigating obstacles due to central vision loss.,0.36179436307019414,0.9645949001955914,0.9471774522807765,1.0,0.9999999999,1.0
What is the primary focus of AMD research?,"['Research into age-related macular degeneration is primarily aimed at understanding the causes and disease mechanisms that drive progressive central vision loss and blindness—including genetic, inflammatory, and biomarker contributors—while improving diagnosis and monitoring with imaging, molecular and AI tools, and developing therapies and preventive strategies (from drugs and growth factors to cell transplantation and novel materials) to preserve vision and address impacts on reading, driving, mobility, and emotional wellbeing.']","The primary focus of AMD research is to understand the underlying genetic, inflammatory, and molecular mechanisms driving progressive central vision loss and blindness and to improve diagnosis, monitoring (including imaging and AI), and development of therapies and preventive strategies—from drugs and growth factors to cell transplantation and novel materials—to preserve vision and mitigate functional and emotional impacts.",The primary focus of AMD research is developing treatments to halt or reverse retinal damage.,0.38229667529310396,0.9999999999999997,0.9291867011724156,0.5,0.9999999999,1.0
What is the effect of AMD on night vision?,"['Age-related macular degeneration primarily damages the macula and central vision, causing progressive loss of detailed sight, blurred vision, reading and driving difficulties and impaired spatial perception; while its hallmark is central vision loss, some late-onset or related forms can also reduce night vision, causing difficulty seeing in low light or even night blindness as the disease advances.']","Age-related macular degeneration primarily impairs central, detailed vision but can—particularly in later or related forms—also reduce night vision and cause difficulty seeing in low light or even night blindness as the disease progresses.",AMD can reduce night vision by damaging the macula’s ability to adapt to low light.,0.7197234244908566,0.8613008120938125,0.8788936979634263,1.0,0.9999999999,1.0
What is the purpose of genetic testing in AMD?,"['Genetic testing in age-related macular degeneration is used to identify underlying genetic causes or specific pathogenic variants that may mimic or contribute to AMD, distinguish monogenic inherited retinal dystrophies from typical AMD, and provide personalized risk profiling to inform diagnosis, prognosis, clinical management, trial or therapy eligibility, and family counseling; its practical utility can be limited by costs, unclear referral pathways, and currently limited treatment options for some genetic findings.']","Genetic testing in AMD aims to identify pathogenic variants that may cause or contribute to AMD or mimic inherited retinal dystrophies, enable personalized risk profiling for diagnosis, prognosis, management, trial/therapy eligibility, and family counseling, while its practical utility can be limited by cost, referral pathways, and limited treatment options for some findings.",Genetic testing identifies AMD risk genes like CFH to predict susceptibility.,0.4118493909338676,0.9928139973476758,0.8973975637354701,1.0,0.9999999999,1.0
What is the typical progression rate of dry AMD?,"['Dry age‑related macular degeneration usually progresses slowly but variably; when it evolves to geographic atrophy the lesion enlargement is commonly on the order of about 1–2 mm² per year on average, though rates vary widely. Growth is influenced by baseline lesion size and by features such as soft or reticular pseudodrusen, drusenoid pigment epithelial detachments, foveal involvement, autofluorescence patterns and choroidal thickness, and faster enlargement is associated with greater risk of photoreceptor loss and vision decline.']","Dry AMD progresses slowly and variably, with geographic atrophy lesions typically enlarging on the order of ~1–2 mm² per year on average, though rates vary widely and are influenced by baseline lesion size, drusen/PED features, autofluorescence pattern, foveal involvement, and choroidal thickness.","Dry AMD typically progresses slowly over years, varying by individual.",0.5241421664900945,0.0,0.8965686659603777,1.0,0.9999999999,1.0
What is the role of vitamin E in AMD management?,"['Vitamin E appears to have a supportive role in AMD management: it may help prevent or slow progression, support retinal and retinal pigment epithelium health (including effects on bisretinoid metabolism) and improve photoreceptor resilience, and higher intake has been linked to some improvements in retinal outcomes; late-stage disease is often associated with lower vitamin E levels. It is not a cure but may be a useful adjunct to other treatments, with evidence that is suggestive but not definitive.']","Vitamin E may serve as a supportive adjunct in AMD management by helping to prevent or slow progression, supporting retinal and RPE health (including bisretinoid metabolism) and photoreceptor resilience, and is associated with higher retinal outcome measures though evidence is suggestive rather than definitive.","Vitamin E acts as an antioxidant, protecting retinal cells in AMD management.",0.9338126375290506,0.0,0.9352505501162026,1.0,0.9999999999,0.0
What is a key feature of advanced wet AMD?,"['A hallmark of advanced wet AMD is pathologic choroidal neovascularization — abnormal growth of blood vessels under the retina — which commonly leads to severe, often irreversible central vision loss.']","A key feature of advanced wet AMD is pathologic choroidal neovascularization—abnormal growth of blood vessels beneath the retina that commonly causes severe, often irreversible central vision loss.",A key feature of advanced wet AMD is rapid central vision loss from hemorrhages.,0.7336250781981752,1.0000000000000002,0.9345003127927014,1.0,0.0,0.0
What is the benefit of high-contrast tools for AMD patients?,"['High‑contrast tools boost visual performance for people with AMD by enhancing high‑contrast visual acuity, making reading, object recognition, mobility and spatial tasks easier, reducing dependence and frustration, and improving overall quality of life.']","High-contrast tools improve high-contrast visual acuity in people with AMD, making reading, object recognition, mobility and spatial tasks easier, reducing dependence and frustration, and improving overall quality of life.",High-contrast tools improve visibility for AMD patients with central vision loss.,0.9849857855703242,0.9756993181168799,0.9399431422812969,1.0,0.9999999999,1.0
What is the primary cause of AMD?,"['Age-related macular degeneration is primarily driven by aging-related degeneration of the macula: advancing age is the dominant risk factor, and the disease results from macular changes such as drusen (small deposits beneath the retina) together with inflammation (elevated inflammatory markers), genetic susceptibility (variants like HTRA1 and APOE), and vascular/neovascular abnormalities that collectively cause progressive central vision loss.']","The primary cause of age-related macular degeneration (AMD) is age-related degeneration of the macula, with advancing age as the dominant risk factor compounded by drusen accumulation, inflammation, genetic variants (e.g., HTRA1, APOE), and vascular/neovascular changes leading to progressive central vision loss.",The primary cause of AMD is age-related retinal degeneration.,0.44682203641475193,0.9340089498887276,0.9301455447118446,1.0,0.9999999999,1.0
What is the role of beta-carotene in the original AREDS formula?,"['In the original AREDS formula, beta‑carotene was included as a provitamin A antioxidant intended to help protect against age‑related macular degeneration and reduce the risk of severe vision loss, but it was later associated with safety concerns—including an increased risk of neovascular (wet) AMD in some contexts—which prompted its reconsideration and replacement in subsequent AREDS2 formulations.']","In the original AREDS formula, beta‑carotene was included as a provitamin A antioxidant intended to help protect against age‑related macular degeneration and reduce risk of severe vision loss, but later was associated with safety concerns—including an increased risk of neovascular (wet) AMD in some contexts—which led to its reconsideration and replacement in AREDS2.",Beta-carotene served as an antioxidant in the original AREDS formula to slow AMD.,0.5659996726829245,0.9903986484267667,0.9306653573983644,1.0,0.9999999999,1.0
What is a common early intervention for AMD?,"['A common early intervention for AMD is prompt therapeutic management to preserve central vision—combining eye-directed treatments with control of systemic risk factors like hypertension and use of vision-support measures to improve acuity and near vision—because early, appropriate care can prevent vision impairment, permanent vision loss, or progression to blindness.']","A common early intervention for AMD is prompt therapeutic management combining eye-directed treatments, control of systemic risk factors (e.g., hypertension), and vision-support measures to preserve central acuity and reduce progression to vision impairment or blindness.",A common early intervention for AMD is nutritional supplementation like AREDS.,0.22710807101721714,0.9999999999999997,0.9084035409769485,1.0,0.0,0.0
What is the effect of AMD on depth perception?,"['Age-related macular degeneration impairs depth perception by damaging central vision and blurring the area needed for fine stereoscopic cues, leading to poorer spatial perception and mobility. Affected individuals often have increased difficulty judging distances and motion, show more observation and driving errors, struggle with reading, and may become more dependent on others due to reduced overall visual perception.']","AMD impairs depth perception by damaging central vision and blurring the fine stereoscopic cues needed for accurate spatial judgments, leading to poorer distance and motion perception, increased errors in tasks like driving and reading, and greater dependence on others.",AMD can impair depth perception by distorting central vision.,0.9816595191913744,0.9821513317193346,0.9266101577025746,1.0,0.9999999999,1.0
What is the purpose of visual field testing in AMD?,"['Visual field testing in age-related macular degeneration is used to quantify and monitor loss of central vision and detect scotomas, track disease progression and treatment effects, and assess the functional impact of visual impairment on activities such as reading and driving to guide clinical management and rehabilitation.']","Visual field testing in age-related macular degeneration is used to quantify and monitor central vision loss and scotomas, track disease progression and treatment effects, and assess functional impact on tasks like reading and driving to guide clinical management and rehabilitation.",Visual field testing maps central vision loss caused by AMD.,0.3952402378331398,0.9373988759805286,0.9143580536313424,1.0,0.9999999999,1.0
What is the typical duration of photodynamic therapy effects in AMD?,"['Photodynamic therapy for neovascular AMD typically suppresses lesion activity for about three months, so benefits are usually temporary and retreatment at roughly three-month intervals is often required; combining PDT with anti-VEGF therapy can extend and enhance the effect.']","Photodynamic therapy for neovascular AMD typically suppresses lesion activity for about three months, often requiring retreatment at roughly three-month intervals, and combining PDT with anti-VEGF therapy can extend and enhance the effect.","Photodynamic therapy effects in AMD typically last a few months, requiring repeat treatments.",0.8315313672820065,0.9263859397965198,0.9261254691280256,1.0,0.9999999999,1.0
What is the role of omega-3 fatty acids in AMD?,"['Omega‑3 fatty acids have been linked to influencing age‑related macular degeneration, with evidence that dietary omega‑3s and supplements can support eye health by reducing inflammation, countering oxidative damage, and improving macular pigment density, which may help prevent or slow AMD progression; however, findings are mixed and some reports have associated supplementation with a higher risk of late AMD, so benefits are not uniformly proven.']","Dietary omega‑3 fatty acids may support eye health and help prevent or slow AMD by reducing inflammation, oxidative damage, and improving macular pigment density, but evidence is mixed and some studies have reported no benefit or an association with higher risk of late AMD, so definitive conclusions require further high-quality research.",Omega-3 fatty acids reduce retinal inflammation and may slow AMD progression.,0.37009986345523604,0.0,0.9349449083663989,0.8888888888888888,0.9999999999,1.0
What is a common emotional impact of AMD?,"['Age-related macular degeneration commonly leads to significant emotional distress—patients often experience frustration, reduced emotional well‑being and feelings tied to loss of independence as central vision loss makes reading, driving and daily mobility harder and increases reliance on others.']","A common emotional impact of age-related macular degeneration is significant emotional distress, including frustration, reduced emotional well‑being, and feelings related to loss of independence as central vision loss impairs reading, driving, and daily mobility.",A common emotional impact of AMD is anxiety due to vision loss.,0.22483006815211695,0.914088861502472,0.8993798989165238,1.0,0.0,0.0
What is the purpose of sunglasses in AMD management?,"['Sunglasses are used in AMD management primarily to protect the eyes from ultraviolet and other harmful light exposure, reducing UV-related damage to the retina and helping to lower the risk of developing or slowing progression of age-related macular degeneration.']",Sunglasses in AMD management are used primarily to block ultraviolet and other harmful light exposure to reduce retinal damage and help lower the risk of developing or slowing progression of age-related macular degeneration.,Sunglasses protect the retina from UV damage in AMD management.,0.9893537766050228,0.9883290946515709,0.9574151064200911,1.0,0.9999999999,1.0
What is the effect of AMD on driving ability?,"['Age-related macular degeneration primarily impairs central vision and overall visual function, which reduces driving performance and safety. People with AMD commonly have difficulty reading signs and signals, recognizing hazards and other road users, maintaining lane position and selecting gaps, and they may experience motion sensitivity and slowed or error-prone visual scanning, all of which can lead to poorer safety ratings, increased observation errors, greater dependence on others, and in some cases inability to drive.']","Age-related macular degeneration impairs central vision and overall visual function, leading to difficulties reading signs, recognizing hazards, maintaining lane position and selecting gaps, increased observation errors and slowed visual scanning, and consequently poorer driving performance, reduced safety, greater dependence on others, and in some cases inability to drive.",AMD impairs driving ability by reducing central vision needed for road awareness.,0.9728075041448068,,0.8912300165792273,1.0,0.9999999999,1.0
What is the role of the retinal pigment epithelium in AMD?,"['The retinal pigment epithelium is central to AMD: age- and disease-related dysfunction, loss, detachment and phenotypic changes of RPE cells drive drusen and subretinal deposit formation, compromise photoreceptors and outer retinal function, and lead to geographic atrophy and central vision loss. Disease processes—such as inflammation, toxic protein/lipid accumulation and changes in Bruch’s membrane and the choroid—further injure the RPE, creating a self‑amplifying cycle, and restoring or replacing functional RPE can prevent or slow degeneration, making the RPE a primary site of injury and a key therapeutic target.']","The retinal pigment epithelium (RPE) is the primary site of injury in AMD—age- and disease-related RPE dysfunction, loss, detachment, and phenotypic change drive drusen and subretinal deposit formation, impair photoreceptors and outer retinal function, and lead to geographic atrophy and vision loss, while inflammation, toxic protein/lipid accumulation, and Bruch’s membrane/choroidal changes further damage RPE in a self‑amplifying cycle, making RPE restoration or replacement a key therapeutic target.",The retinal pigment epithelium nourishes photoreceptors and degenerates in AMD.,0.3765178117359967,0.9736724516667478,0.9060712469439867,1.0,0.9999999999,0.0
What is a frequent finding in OCT scans of dry AMD?,"['On OCT imaging of dry AMD, clinicians commonly see drusen (often large soft drusen and drusenoid pigment epithelial detachments) along with retinal pigment epithelium dysfunction and atrophy; these changes are frequently accompanied by geographic atrophy, focal gaps or disruption of the photoreceptor layer, and overall retinal thinning.']","A frequent OCT finding in dry AMD is large soft drusen and drusenoid pigment epithelial detachments with associated RPE dysfunction/atrophy, often accompanied by geographic atrophy, photoreceptor disruption, and retinal thinning.",A frequent finding in OCT scans of dry AMD is drusen beneath the retina.,0.44876547609119977,0.9487437601582828,0.9379190472219421,1.0,0.9999999999,1.0
What is the benefit of bold text for AMD patients?,"['Using bold or otherwise enhanced text can improve reading performance for people with age-related macular degeneration, helping offset central-vision loss and the reading difficulty that commonly accompanies the condition and making reading easier and less frustrating.']",Bold or otherwise enhanced text can improve reading performance for people with age-related macular degeneration by helping offset central-vision loss and making reading easier and less frustrating.,Bold text enhances readability for AMD patients with reduced central vision.,0.9771721095765631,0.8925740139184842,0.9086884383062521,1.0,0.9999999999,1.0
What is the typical prognosis for wet AMD without treatment?,"['Left untreated, wet age‑related macular degeneration typically progresses rapidly from choroidal neovascularization to worsening central visual acuity, causing profound central vision loss and often resulting in severe vision impairment or blindness.']","Left untreated, wet AMD typically progresses rapidly from choroidal neovascularization to worsening central visual acuity, causing profound central vision loss and often resulting in severe vision impairment or legal blindness.","Without treatment, wet AMD typically leads to severe central vision loss within months.",0.9855857386342962,0.8962044170012553,0.9423429545371848,0.75,0.9999999999,1.0
What is the role of lutein in AMD prevention?,"['Lutein, concentrated in the macula and retina, acts as a protective pigment that increases macular pigment optical density and helps filter harmful blue light while providing antioxidant and anti-inflammatory effects that protect retinal cells. Dietary intake or supplementation of lutein (often with zeaxanthin) is associated with improved visual performance—contrast sensitivity and acuity—and with a reduced risk or slower progression of age-related macular degeneration, particularly in early or nonexudative stages. Overall, lutein appears to play a preventive and supportive role in maintaining macular health and reducing AMD-related vision decline.']","Lutein, concentrated in the macula, increases macular pigment optical density and—through blue-light filtering, antioxidant, and anti-inflammatory effects—supports macular health and is associated with improved visual performance and a reduced risk or slower progression of early/nonexudative AMD.",Lutein filters harmful light and protects the macula in AMD prevention.,0.9829311543801568,0.8938326527072454,0.931724617520627,1.0,0.9999999999,1.0
What is a common daily challenge for AMD patients?,"['A common daily challenge for people with age-related macular degeneration is loss of central vision, which makes reading and recognizing faces difficult, impairs driving and other tasks that require detailed sight, reduces spatial perception and mobility, increases dependence on others, and often causes frustration and reduced everyday functioning.']","A common daily challenge for people with age-related macular degeneration is loss of central vision, which makes reading and recognizing faces difficult, impairs driving and other tasks requiring detailed sight, reduces spatial perception and mobility, increases dependence on others, and often causes frustration and reduced everyday functioning.",A common daily challenge for AMD patients is reading small print.,0.20803312297564736,0.9109333340840072,0.8321324919025894,1.0,0.9999999999,0.0
What is the purpose of anti-VEGF drugs in AMD?,"['Anti‑VEGF drugs are used to treat the neovascular (wet) form of age-related macular degeneration by blocking VEGF-driven abnormal blood-vessel growth and leakage in the macula, thereby reducing fluid, stabilizing or improving central vision, and preventing blindness. They are given by intravitreal injection and typically require repeated dosing to maintain benefit; they are generally effective and well tolerated but can be costly and carry risks of ocular or systemic adverse effects and long-term changes such as macular atrophy or fibrosis.']","Anti‑VEGF drugs for neovascular (wet) AMD are intravitreally injected medications that block VEGF to reduce abnormal blood-vessel growth and leakage in the macula, thereby decreasing fluid, stabilizing or improving central vision, and preventing blindness.",Anti-VEGF drugs inhibit blood vessel growth to manage wet AMD.,0.5670130792199239,0.9376655249367308,0.9347189835463621,1.0,0.9999999999,1.0
What is the effect of AMD on face recognition?,"['Age-related macular degeneration (AMD) impairs face recognition, especially in advanced stages: central vision loss, blurred vision and progressive visual impairment reduce the ability to see fine facial details and recognize people, with dry AMD shown to worsen face-recognition performance. These deficits contribute to difficulties with reading, mobility and independence and can have emotional and safety consequences, though interventions such as prosthetic central-vision aids and perceptual training can partially improve face-recognition ability.']","AMD impairs face recognition—especially in advanced and dry stages—because central vision loss and blurring reduce perception of fine facial details, leading to poorer recognition that can partly be improved with prosthetic central-vision aids and perceptual training.",AMD impairs face recognition by blurring central vision details.,0.42416403303097805,0.981139190005193,0.9466561321239121,1.0,0.9999999999,1.0
What is the role of vitamin C in AMD?,"['The evidence is mixed: higher dietary vitamin C intake is associated with lower risk of age-related macular degeneration (including neovascular forms) and late-stage AMD patients often have lower vitamin C intakes, but some studies link supplemental or high-dose vitamin C with increased AMD risk or development; thus adequate dietary vitamin C may be protective while the effects of supplements are inconsistent and require further study.']","Evidence is mixed: adequate dietary vitamin C intake appears associated with lower risk of AMD and late-stage patients often have lower intakes, but some studies link high-dose or supplemental vitamin C with increased risk, so dietary vitamin C may be protective while the effects of supplements remain uncertain and need further study.","Vitamin C acts as an antioxidant, reducing retinal damage in AMD.",0.2261002289518248,0.0,0.9044009158072992,1.0,0.0,0.0
What is a typical feature of geographic atrophy on imaging?,"['Geographic atrophy typically appears on imaging as well‑demarcated areas of decreased fundus autofluorescence reflecting loss of retinal pigment epithelium and overlying photoreceptors, often accompanied on OCT by outer retinal thinning and on OCT angiography by choriocapillaris flow deficits.']","A typical imaging feature of geographic atrophy is well‑demarcated areas of decreased fundus autofluorescence from loss of retinal pigment epithelium and photoreceptors, often with outer retinal thinning on OCT and choriocapillaris flow deficits on OCT angiography.",A typical feature of geographic atrophy on imaging is sharply defined areas of retinal loss.,0.5352183647304772,0.9837264431067756,0.9408734589219087,1.0,0.9999999999,0.0
What is the benefit of large-print books for AMD patients?,"['Because AMD often causes central vision loss and difficulty reading, larger print makes text easier to resolve, enabling patients to read more comfortably and accurately; this improves independence, reduces frustration and reliance on others, and helps preserve everyday functioning and quality of life.']","Large-print books help AMD patients read more comfortably and accurately by making text easier to resolve, which preserves independence, reduces frustration, and improves everyday functioning and quality of life.",Large-print books improve readability by compensating for central vision loss in AMD.,0.610714398963728,0.9897068977422768,0.9428575958549124,1.0,0.9999999999,1.0
What is the purpose of retinal scans in AMD?,"['Retinal scans—particularly OCT—are used in AMD to detect and quantify hallmark macular changes such as drusen, subretinal deposits and retinal pigment epithelium/photoreceptor layer alterations, identify fluid or new abnormal blood vessels (neovascular disease), diagnose and stage the condition, monitor progression and treatment response, and enable automated and low‑cost or home monitoring to guide clinical care.']","Retinal scans—especially OCT—are used in AMD to detect and quantify hallmark macular changes (drusen, subretinal deposits, RPE/photoreceptor alterations), identify fluid or neovascularization, diagnose and stage disease, monitor progression and treatment response, and enable automated or home monitoring to guide clinical care.","Retinal scans monitor drusen, fluid, or hemorrhages to assess AMD progression.",0.9372497949694965,0.9578682984762166,0.9254697681132804,1.0,0.9999999999,1.0
What is the effect of AMD on reading speed?,"['Age-related macular degeneration substantially impairs reading speed and ability by damaging central vision and related visual processing, causing difficulty reading and reduced reading performance; various low-vision interventions—such as magnifying aids, reading and oculomotor training, eccentric viewing training, and newer optical or prosthetic approaches—can partially restore or improve reading speed.']","Age-related macular degeneration substantially reduces reading speed and ability by damaging central vision and related visual processing, though interventions like magnifiers, reading/oculomotor and eccentric viewing training, and newer optical or prosthetic approaches can partially restore or improve reading performance.",AMD slows reading speed by impairing central vision clarity.,0.3577192037728354,0.9078396143319442,0.8854222696367963,1.0,0.9999999999,1.0
What is the role of zeaxanthin in AMD management?,"['Zeaxanthin concentrates in the macula and fovea and, when supplemented, is associated with reduced AMD risk and can help prevent and slow disease progression; it has been used as part of management for early and unilateral neovascular AMD and to lower fellow‑eye incidence, while improving macular pigment density, contrast sensitivity, glare tolerance and overall ocular function, and providing retinal protection by reducing oxidative damage and supporting retinal pigment epithelium structure and mitochondrial health.']","Zeaxanthin concentrates in the macula and fovea and, when supplemented, is associated with reduced AMD risk and slowed progression—used in early and unilateral neovascular AMD to lower fellow‑eye incidence, improve macular pigment density, contrast sensitivity, glare tolerance and overall ocular function, and provide retinal protection by reducing oxidative damage and supporting RPE structure and mitochondrial health.",Zeaxanthin protects the macula from light damage in AMD management.,0.3479956644330028,0.8994881865454328,0.9304441961935497,1.0,0.9999999999,1.0
What is a common adaptation for AMD patients in the kitchen?,"['Because AMD commonly causes central vision loss, people with the condition typically adapt their kitchens by improving lighting and contrast and using large-print or tactile labels, magnifiers and talking devices, simplified layouts, and adaptive utensils to make food prep, reading recipes, and safety tasks easier and more independent.']","A common adaptation for people with AMD is improving kitchen lighting and contrast and using large-print or tactile labels, magnifiers or talking devices, simplified layouts, and adaptive utensils to aid food prep, reading recipes, and safety.",A common adaptation is using high-contrast utensils for better visibility.,0.968154638814021,0.9489453318633309,0.8726185552560839,1.0,0.0,0.0
What is the purpose of macular translocation surgery?,"['Macular translocation surgery repositions the macula to move it away from damaged or bleeding areas beneath the retina—commonly used for submacular hemorrhage and neovascular age-related macular degeneration—to treat retinal disease, preserve or restore central vision, and improve visual function and quality of life.']",Macular translocation surgery repositions the macula away from damaged or bleeding subretinal areas—commonly for submacular hemorrhage and neovascular AMD—to treat retinal disease and preserve or restore central vision and visual function.,Macular translocation surgery repositions the macula to healthier retinal areas in severe AMD.,0.9871891569868998,0.977114737874535,0.9487566279475994,1.0,0.9999999999,0.0
What is the effect of AMD on color contrast?,"['Age-related macular degeneration reduces color contrast and impairs color recognition and overall color vision by damaging central retinal function, making it harder to distinguish hues and subtle differences and affecting everyday tasks like reading and driving; some interventions — for example lutein supplementation, certain blue‑light‑filtering intraocular lenses, retinal-targeted treatments and assistive/processing technologies — can partially improve perceived contrast and color discrimination.']","Age-related macular degeneration reduces color contrast by damaging central retinal function, impairing color recognition and discrimination of hues and subtle differences and thereby worsening everyday tasks like reading and driving, though some interventions (e.g., lutein, blue‑light‑filtering IOLs, retinal therapies, assistive technologies) can partially improve perceived contrast.",AMD reduces color contrast by damaging the macula’s cone cells.,0.3869567476713609,0.8688117512925357,0.8811603240187769,1.0,0.9999999999,1.0
What is the benefit of audio books for AMD patients?,"['Because age-related macular degeneration often causes central vision loss, blurred vision and difficulty reading that can increase dependence and emotional distress, audiobooks restore access to books and information, reduce frustration, support greater independence and mobility, and help maintain quality of life.']","Audiobooks help AMD patients regain access to books and information, reduce frustration, and support greater independence, mobility, and quality of life by mitigating the impact of central vision loss on reading.",Audio books allow AMD patients to access literature without relying on vision.,0.6122364706366057,0.9855558658844088,0.948945882546423,0.8333333333333334,0.9999999999,1.0
What is the role of the CFH gene in AMD?,"['CFH encodes complement factor H, a key negative regulator of the alternative complement pathway; common risk variants (notably the rs1061170/Y402H change) and loss‑of‑function alterations reduce factor H activity or levels, impair complement control, promote local inflammation, RPE dysfunction and deposit formation, and thereby increase susceptibility to AMD and progression to advanced and neovascular forms, while protective CFH alleles lower risk.']","CFH encodes complement factor H, a key negative regulator of the alternative complement pathway, and common risk variants (notably rs1061170/Y402H) or loss‑of‑function changes reduce factor H activity or levels, impair complement control, promote local inflammation, RPE dysfunction and deposit formation, and thereby increase susceptibility to AMD and progression to advanced and neovascular forms, while protective CFH alleles lower risk.","The CFH gene regulates inflammation, and its mutations increase AMD risk.",0.22258816808965315,0.9526740052312944,0.8903415506246957,1.0,0.9999999999,1.0
What is a typical finding in fluorescein angiography for wet AMD?,"['In wet AMD, fluorescein angiography typically demonstrates dye leakage from choroidal neovascularization, often showing classic or occult CNV patterns with progressive vascular leakage and late-phase pooling.']","A typical fluorescein angiography finding in wet AMD is dye leakage from choroidal neovascularization, often appearing as classic or occult CNV with progressive vascular leakage and late-phase pooling.",A typical finding is leakage from abnormal blood vessels in wet AMD.,0.7924982858391141,0.9912314193564069,0.9199931433564565,1.0,0.9999999999,1.0
What is the benefit of quitting smoking for AMD patients?,"['Quitting smoking reduces the risk of developing and worsening age-related macular degeneration, lowers the likelihood of late-stage changes such as geographic atrophy that cause central vision loss and blindness, and is linked to better visual outcomes and treatment response—potentially lessening the need for repeated therapies—so stopping smoking can slow disease progression and help preserve vision.']","Quitting smoking reduces the risk of developing and worsening age-related macular degeneration, lowers the likelihood of late-stage changes such as geographic atrophy that cause central vision loss and blindness, and is associated with better visual outcomes and treatment responses, potentially reducing the need for repeated therapies and slowing disease progression to help preserve vision.","Quitting smoking reduces retinal oxidative stress, slowing AMD progression.",0.22556713515212357,0.9082435842275808,0.9022685406084943,1.0,0.9999999999,0.0
What is the effect of AMD on peripheral vision?,"['Age-related macular degeneration mainly impairs central vision while peripheral vision is largely preserved, though in advanced or atrophic stages peripheral vision may be reduced in resolution or become more broadly affected as vision progressively worsens.']",Age-related macular degeneration mainly spares peripheral vision but can reduce peripheral resolution or more broadly affect peripheral vision in advanced or atrophic stages as vision progressively worsens.,"AMD typically spares peripheral vision, focusing damage on the central field.",0.4621204200536452,0.9192118278840896,0.8484816802145806,1.0,0.9999999999,1.0
What is the purpose of stem cell research in AMD?,"['Stem cell research in age-related macular degeneration aims to develop treatments that replace lost retinal pigment epithelium and photoreceptors, promote tissue repair and regeneration, and restore or preserve central vision, thereby improving visual function and preventing progression to irreversible blindness. By enabling transplantation of functional retinal cells and enhancing therapeutic responses, this work seeks to expand and improve options for AMD and other retinal degenerative diseases.']","The purpose of stem cell research in age-related macular degeneration is to develop therapies that replace lost retinal pigment epithelium and photoreceptors, promote tissue repair and regeneration, and restore or preserve central vision to improve visual function and prevent progression to irreversible blindness.",Stem cell research aims to regenerate damaged retinal cells in AMD.,0.9778850354011064,0.9300095692770064,0.9115740075613601,1.0,0.9999999999,1.0
What is the role of antioxidants in AMD prevention?,"['Antioxidants help counter oxidative stress and photochemical damage in the retina, protecting retinal pigment epithelium cells and reducing risk factors that contribute to age-related macular degeneration (AMD); dietary antioxidants in particular can help lower AMD risk and may slow disease progression and improve clinical management. Their protective effects extend to other ocular conditions such as cataract and glaucoma, although individual responses can vary by factors like genotype and overall diet.']","Dietary and other antioxidants help counter retinal oxidative and photochemical damage, protecting retinal pigment epithelium cells and thereby lowering AMD risk, potentially slowing progression and improving clinical management, though individual responses may vary by genotype and overall diet.","Antioxidants neutralize free radicals, protecting the retina from AMD damage.",0.8086225478881555,0.0,0.9267978838603141,1.0,0.9999999999,1.0
What is a common sign of wet AMD progression?,"['A common sign of progression in wet age-related macular degeneration is worsening central vision, most often seen as a decline in best-corrected visual acuity (patients noticing decreased clarity of what they are directly looking at), which clinicians may confirm with visual acuity testing and retinal imaging.']","A common sign of progression in wet AMD is worsening central vision, typically manifested as a decline in best-corrected visual acuity that clinicians confirm with visual acuity testing and retinal imaging.",A common sign of wet AMD progression is sudden worsening of central vision.,0.4895365782234937,0.9863897070695732,0.9580806585100543,1.0,0.9999999999,0.0
What is the effect of AMD on visual acuity?,"['Age-related macular degeneration progressively reduces visual acuity—especially central vision—causing blurred vision, difficulty reading and driving, and, in advanced or neovascular forms, severe visual impairment or irreversible blindness; visual acuity decline can start in early stages and worsen over time, though treatments such as anti-VEGF intravitreal therapies can often stabilize or improve acuity.']","Age-related macular degeneration progressively reduces visual acuity—particularly central vision—leading to blurred vision, difficulty reading and driving, and in advanced/neovascular stages often severe or irreversible visual impairment, though anti-VEGF intravitreal therapies can frequently stabilize or improve acuity.",AMD reduces visual acuity by damaging the macula’s sharp vision capability.,0.9684242244573228,0.9001419514218362,0.8736968978292912,1.0,0.9999999999,1.0
What is the purpose of bioptic telescopes for AMD patients?,"['Bioptic telescopes are used to magnify images for people with AMD who have central vision loss and cannot see what they’re directly looking at, enabling use of healthier peripheral retina to improve reading, distance viewing, face recognition, mobility and driving; both external and implantable miniaturized telescopes aim to treat AMD-related visual impairment, improving vision and functional independence (implants may have effects on the retina).']","Bioptic telescopes are used to magnify images for AMD patients with central vision loss so they can utilize healthier peripheral retina to improve reading, distance viewing, face recognition, mobility and driving, and implants aim to similarly improve vision and functional independence (though implants may affect the retina).","Bioptic telescopes magnify distant objects, aiding AMD patients with tasks like driving.",0.5339010933968477,0.9706892093380212,0.9356043735873905,1.0,0.9999999999,1.0
What is the role of inflammation in AMD?,"['Inflammation is a central driver of AMD: inflammatory processes are present in the diseased retina, contribute to disease onset and progression, promote drusen and deposit formation, accelerate retinal cell death and choroidal neovascularization, and worsen vision loss. Immune mediators such as cytokines and complement components, as well as systemic or ocular inflammatory states, influence AMD pathogenesis and can affect response to therapies. Because of its key role in disease development and progression, modulating inflammation is a major therapeutic focus for slowing or treating AMD.']","Inflammation is a central driver of AMD, where intraocular and systemic inflammatory processes—mediated by cytokines, complement components, and other immune factors—contribute to disease onset and progression by promoting drusen and deposit formation, accelerating retinal cell death and choroidal neovascularization, worsening vision loss, and influencing therapeutic responses.","Inflammation damages retinal tissues, contributing to AMD development.",0.5761082984789364,0.9586573705219504,0.9198178093003611,1.0,0.9999999999,1.0
What is a typical emotional response to AMD diagnosis?,"['A diagnosis of age-related macular degeneration commonly triggers significant emotional distress—feelings of frustration, anxiety, sadness or depression and a sense of loss and increased dependency—driven by central vision loss that makes reading, driving and everyday tasks harder and reduces independence and mobility; low-vision diagnoses similarly provoke emotional reactions, while practical supports such as magnifying aids and reading training can help improve emotional well-being.']","A typical emotional response to an AMD diagnosis is significant distress—often frustration, anxiety, sadness or depression and a sense of loss and increased dependency—driven by central vision loss that impairs reading, driving and daily activities.",A typical emotional response to AMD diagnosis is fear of vision loss.,0.2368838718823566,0.9925196890490501,0.9475354875294264,1.0,0.0,0.0
What is the effect of AMD on daily independence?,"['Age-related macular degeneration progressively impairs central and overall vision—causing reading problems, blurred vision and eventually severe visual loss or blindness—which undermines daily independence by reducing driving ability, mobility and spatial perception and increasing reliance on others while causing emotional distress. Low-vision rehabilitation and assistive technologies can help restore some daily functioning and independence.']","Age-related macular degeneration progressively reduces daily independence by impairing central and overall vision—causing reading difficulties, blurred vision, loss of driving ability, reduced mobility and spatial perception, increased reliance on others, and emotional distress—though low-vision rehabilitation and assistive technologies can partially restore functioning.",AMD reduces daily independence by limiting vision for tasks like cooking or reading.,0.30294239082781194,,0.8367695633112479,1.0,0.9999999999,1.0
What is the purpose of occupational therapy in AMD?,"['Occupational therapy for people with AMD aims to maximize independence and quality of life by helping them adapt to central vision loss—teaching strategies and use of low-vision aids for reading, daily tasks and mobility, modifying the home and routines to improve safety and spatial functioning, and addressing the emotional and psychosocial challenges to reduce reliance on others and maintain participation in everyday activities.']","The purpose of occupational therapy in AMD is to maximize independence and quality of life by teaching adaptive strategies and low-vision aids for reading, daily tasks and mobility, modifying the home and routines to improve safety and spatial functioning, and addressing emotional and psychosocial challenges to maintain participation and reduce reliance on others.",Occupational therapy teaches adaptive skills to maintain independence in AMD patients.,0.9840270081878235,0.9999999999999997,0.9361080327512942,1.0,0.9999999999,1.0
What is the role of blood vessels in wet AMD?,"['In wet AMD, abnormal growth of new blood vessels from the choroid invades the subretinal space (choroidal neovascularization); these fragile, leaky vessels cause fluid accumulation, bleeding and rapid central vision loss. Vascular endothelial growth factor (VEGF) drives this neovascularization, and current treatments—especially intravitreal anti‑VEGF and other anti‑angiogenic approaches or focal laser—work by stopping vessel growth and reducing leakage to stabilize or improve vision.']","In wet AMD, abnormal choroidal blood vessels grow into the subretinal space (choroidal neovascularization) and, being fragile and leaky, cause fluid accumulation, bleeding, and rapid central vision loss driven largely by VEGF.","Abnormal blood vessels in wet AMD leak fluid or blood, damaging the macula.",0.9783608334749987,0.9112538933379867,0.9133570931426279,1.0,0.9999999999,1.0
What is a common adaptation for AMD patients at home?,['A common adaptation is using magnification aids at home—handheld or electronic magnifiers and large-print materials—to improve reading and daily tasks; many patients also use simple vision home-monitoring tools to track changes and seek care promptly.'],A common home adaptation for AMD patients is using magnification aids—such as handheld or electronic magnifiers and large-print materials—along with simple vision home-monitoring tools to track changes and seek care promptly.,A common adaptation is installing brighter lighting to enhance visibility.,0.20629580467428543,0.9577028941586399,0.8251832186971417,1.0,0.0,0.0
What is the benefit of a Mediterranean diet for AMD?,"['Adherence to a Mediterranean diet — particularly high adherence — is associated with a lower risk of developing age-related macular degeneration and with slower progression to late-stage disease, helping to preserve central vision and reduce the severity of vision loss.']","High adherence to a Mediterranean diet is associated with a lower risk of developing age-related macular degeneration and with slower progression to late-stage disease, helping preserve central vision and reduce severity of vision loss.","A Mediterranean diet provides antioxidants and omega-3s, reducing AMD risk.",0.22561264067045614,0.9375243975384612,0.9024533219088089,1.0,0.9999999999,0.0
What is the effect of AMD on social interactions?,"['AMD often causes central vision loss and other visual impairments that make reading, driving, face recognition, and mobility difficult, increasing dependence on others and emotional strain; these functional and emotional effects commonly lead to social isolation, disengagement, and impaired social interactions.']","AMD commonly impairs central vision and other visual functions needed for reading, face recognition, mobility, and driving, which increases dependence, emotional strain, and frequently leads to social isolation, disengagement, and impaired social interactions.",AMD can reduce social interactions by impairing face recognition and communication.,0.45904188047213285,0.9675951937650747,0.9131546541507695,1.0,0.9999999999,1.0
What is the purpose of gene therapy research in AMD?,"['Gene therapy research in age-related macular degeneration aims to deliver long-lasting, targeted treatments to retinal cells to preserve and improve central vision, prevent or reduce neovascular complications, and lessen the treatment burden by providing sustained therapeutic effects and better long-term visual and functional outcomes; efforts focus on safe, controllable gene delivery to retinal pigment epithelium and photoreceptors (often using viral vectors) while addressing risks such as ocular inflammation, immune responses, vector-related infection and insertional mutagenesis.']","Gene therapy research in AMD aims to deliver safe, long‑lasting, targeted treatments to retinal pigment epithelium and photoreceptors—often via viral vectors—to preserve or improve central vision, prevent or reduce neovascular complications, and lessen treatment burden while addressing risks like ocular inflammation, immune responses, vector infection, and insertional mutagenesis.",Gene therapy research aims to correct genetic defects causing AMD.,0.22990821115462223,0.9438483722308222,0.9196328446184889,0.9090909090909091,0.0,0.0
What is the role of photoreceptors in AMD?,"['Photoreceptors are the primary cells damaged in age-related macular degeneration, and their loss drives the progressive central vision loss and visual impairment characteristic of the disease. RPE dysfunction, subretinal deposits, and local retinal degeneration lead to photoreceptor injury and death, while photoreceptor loss in turn worsens retinal degeneration and disrupts retinal circuitry. Protecting or replacing photoreceptors and restoring RPE support is therefore central to limiting vision loss in AMD.']","Photoreceptors are the primary cells damaged in AMD whose injury and loss—driven by RPE dysfunction, subretinal deposits, and local retinal degeneration—cause progressive central vision loss and further worsen retinal degeneration and circuitry disruption, making their protection or replacement (and restoration of RPE support) central to limiting vision loss.","Photoreceptors detect light and degenerate in AMD, causing vision loss.",0.44292372574009475,0.8867167226338268,0.9146212742766332,1.0,0.9999999999,1.0
What is a typical finding in advanced dry AMD?,"['Advanced dry AMD typically manifests as geographic atrophy of the retinal pigment epithelium with associated photoreceptor degeneration and atrophic neurodegeneration, often producing vision loss; outer retinal tubulation is a common structural finding on imaging.']","A typical finding in advanced dry AMD is geographic atrophy of the retinal pigment epithelium with associated photoreceptor degeneration and atrophic neurodegeneration, often accompanied by outer retinal tubulation on imaging.",A typical finding in advanced dry AMD is geographic atrophy with retinal cell loss.,0.8830771778346747,0.9866665606432227,0.9608801399101274,1.0,0.9999999999,1.0
What is the benefit of voice-activated devices for AMD patients?,"['Voice-activated devices give people with AMD hands-free access to information and tools—reading text aloud, locating high-contrast items, aiding navigation and basic orientation—which makes daily tasks easier, improves mobility and reading performance, and reduces reliance on others.']","Voice-activated devices give people with AMD hands-free access to information and tools—reading text aloud, locating high-contrast items, and aiding navigation and orientation—thereby making daily tasks easier, improving mobility and reading performance, and reducing reliance on others.","Voice-activated devices reduce reliance on vision, aiding AMD patients with daily tasks.",0.5391851030897046,0.964890085763241,0.956740412358818,1.0,0.9999999999,1.0
What is the effect of AMD on fine motor skills?,"['Age-related macular degeneration reduces central vision and the ability to see fine detail, which undermines hand–eye coordination and performance of fine motor tasks; people with AMD often have difficulty reading and handling small objects, make more errors, experience frustration and loss of independence, and may have impaired mobility and driving safety.']","Age-related macular degeneration impairs central vision and fine detail perception, which undermines hand–eye coordination and fine motor task performance, causing more errors, frustration, loss of independence, and potential declines in mobility and driving safety.",AMD can impair fine motor skills by reducing visual precision for tasks like writing.,0.4317306549570997,0.853666570525872,0.8697797626855417,0.9,0.9999999999,1.0
What is the purpose of dietary supplements in AMD?,"['In age-related macular degeneration, dietary supplements—especially antioxidant and xanthophyll (eg, lutein)-containing formulations—are used to slow disease progression, help prevent advanced complications such as geographic atrophy and choroidal neovascularization, support macular pigment and retinal health, and thereby preserve or improve visual function and quality of life.']","Dietary supplements in age-related macular degeneration are used—particularly antioxidant and xanthophyll (e.g., lutein)-containing formulations—to slow disease progression, support macular pigment and retinal health, and help prevent advanced complications (geographic atrophy, choroidal neovascularization) thereby preserving or improving visual function and quality of life.",Dietary supplements provide nutrients to slow AMD progression.,0.39061570389863004,0.9088794039203516,0.8956729110378865,1.0,0.9999999999,1.0
What is the role of the optic nerve in AMD?,"['Age-related macular degeneration primarily damages the macula and retina, causing central and progressive vision loss, but optic nerve integrity still matters for overall visual outcome: oxidative stress and neurodegenerative processes linked to AMD can also affect the optic nerve, and optic nerve damage or disorders (for example atrophy, glaucoma, or inflammation) amplify vision loss and can lead to blindness. Environmental and molecular factors (such as blue light exposure, nitric oxide, extracellular matrix or glymphatic dysfunction) influence optic nerve health, and protective strategies including antioxidants and targeted therapies that preserve the nerve may help maintain vision in patients with AMD.']","The optic nerve influences visual outcomes in AMD by transmitting retinal signals to the brain—while AMD primarily damages the macula and retina causing central vision loss, concurrent optic nerve damage (from neurodegenerative processes, glaucoma, inflammation, or vascular/extracellular dysfunction) can amplify vision loss and risk blindness, and interventions that protect optic nerve health (e.g., antioxidants, targeted therapies) may help preserve vision.","The optic nerve remains unaffected in AMD, as the disease targets the macula.",0.4333319292672976,0.9463915735696283,0.8761848599263331,0.8,0.0,0.0
What is a common sign of AMD progression?,"[""A common sign of AMD progression is worsening central vision—difficulty seeing what you're looking at directly—often accompanied by increasing drusen and drusenoid pigment epithelial detachments that can lead to retinal atrophy; progression is typically monitored with fundus photography and changes in best-corrected visual acuity.""]","A common sign of AMD progression is worsening central vision—difficulty seeing what you're looking at directly—often accompanied by increasing drusen and drusenoid pigment epithelial detachments that can lead to retinal atrophy, typically monitored with fundus photography and changes in best-corrected visual acuity.",A common sign of AMD progression is increased blurriness or distortion in central vision.,0.2352694841201044,0.9888911891163993,0.9410779364804176,1.0,0.9999999999,0.0
What is the benefit of contrast sensitivity testing in AMD?,"['Contrast sensitivity testing in AMD reveals functional vision loss that standard acuity tests can miss, capturing reductions in contrast and central vision that drive difficulties with reading, driving, face recognition and mobility. It is sensitive to disease severity and progression and to treatment effects, so it helps monitor therapeutic response and quantify real-world visual benefit beyond acuity alone.']","Contrast sensitivity testing in AMD detects functional vision loss—particularly reduced contrast and central vision affecting reading, driving, face recognition, and mobility—that standard acuity tests can miss and is sensitive to disease severity, progression, and treatment effects, helping monitor therapeutic response and real-world visual benefit.",Contrast sensitivity testing measures AMD’s impact on distinguishing objects.,0.23239357492353332,0.9559765911673798,0.9295742996941333,1.0,0.9999999999,1.0
What is the effect of AMD on leisure activities?,"['Age-related macular degeneration primarily reduces central vision and causes blurred, progressive visual impairment that undermines many leisure pursuits—especially reading, driving, and visually demanding hobbies. Loss of fine detail, poorer spatial perception and motion sensitivity make navigation and outings harder and less safe, reducing driving performance and confidence. Consequently people often cut back on activities, become more dependent on others, and experience frustration and emotional distress that further limit leisure participation.']","AMD progressively impairs central vision and fine detail, reducing ability and confidence for reading, driving, and visually demanding hobbies, leading to activity withdrawal, increased dependence, and emotional distress that further limit leisure participation.",AMD limits leisure activities like reading or watching TV by impairing central vision.,0.7957059226962664,,0.9328154494978087,1.0,0.9999999999,1.0
What is the purpose of adaptive technology in AMD?,"['Adaptive technology for AMD is intended to compensate for central vision loss and related visual deficits so people can perform everyday tasks more effectively—supporting reading, mobility and driving where possible, preserving independence, reducing reliance on others, and improving overall quality of life and emotional well‑being.']","Adaptive technology for AMD is designed to compensate for central vision loss and related deficits to help people perform everyday tasks (reading, mobility, driving where possible), preserve independence, reduce reliance on others, and improve quality of life and emotional well‑being.","Adaptive technology compensates for vision loss, enhancing AMD patient functionality.",0.4871928342501228,0.9917726441381632,0.9487713370004911,1.0,0.9999999999,1.0
What is the role of drusen in AMD development?,"['Drusen—extracellular deposits that accumulate under and within the macula—are a hallmark of early and intermediate AMD and play a central role in its development and progression. Larger, confluent, or specific drusen subtypes (including sub‑RPE and reticular pseudodrusen) disrupt the retinal pigment epithelium and choriocapillaris, alter retinal architecture, and promote photoreceptor degeneration, thereby increasing the risk of progression to advanced, sight‑threatening AMD such as geographic atrophy. Their composition, which includes complement and other proteins, and their burden are shaped by genetic and systemic factors and correlate with disease severity.']","Drusen—extracellular deposits beneath/within the macula whose size, confluence, and subtype (e.g., sub‑RPE, reticular) and composition (including complement proteins) disrupt the retinal pigment epithelium and choriocapillaris, alter retinal architecture, and promote photoreceptor degeneration, thereby driving progression from early/intermediate AMD toward advanced, sight‑threatening forms such as geographic atrophy.","Drusen accumulate under the retina, disrupting function and contributing to AMD development.",0.4441637878891185,,0.9195122944136169,1.0,0.9999999999,1.0
What is a typical retinal change in wet AMD?,"['A hallmark retinal change in wet AMD is the growth of abnormal new blood vessels under the retina (choroidal neovascularization), which often leads to leakage of fluid into and under the retina, increased retinal thickness, and rapid worsening of central vision.']","A typical retinal change in wet AMD is choroidal neovascularization—abnormal growth of new blood vessels under the retina that often leak fluid, increase retinal thickness, and rapidly worsen central vision.",A typical retinal change in wet AMD is the presence of choroidal neovascularization.,0.48892464086719306,1.0000000000000002,0.9556985634687722,1.0,0.9999999999,1.0
What is the benefit of regular monitoring in AMD?,"['Regular monitoring in AMD enables early detection of recurrence or active exudation—often with imaging like OCT—so treatment (for example anti‑VEGF injections) can be started or adjusted promptly, helping preserve central vision, slow progressive vision loss, maintain reading and mobility abilities and independence, and optimize treatment timing and outcomes.']","Regular monitoring in AMD—often using imaging like OCT—allows early detection of recurrence or active exudation so anti‑VEGF treatment can be started or adjusted promptly to help preserve central vision, slow progressive vision loss, and maintain reading, mobility, and independence.","Regular monitoring tracks AMD progression, enabling timely interventions.",0.5540734112675866,0.9753875216581926,0.882960311737013,1.0,0.9999999999,1.0
What is the effect of AMD on work performance?,"['Age-related macular degeneration causes progressive central and general vision loss, blurred vision and difficulty reading, along with impaired spatial perception, reduced mobility and increased motion sensitivity and emotional distress; these deficits produce observation and driving errors, lower driving safety, greater dependency and frustration, and measurable reductions in productivity and ability to carry out daily work tasks, overall impairing job performance.']","Age-related macular degeneration substantially impairs work performance by causing progressive central and general vision loss, blurred vision, impaired spatial perception and mobility, increased motion sensitivity and emotional distress, which together reduce productivity, increase dependency and errors (including driving/observation mistakes), and limit the ability to perform daily work tasks.",AMD reduces work performance by impairing vision for detailed tasks.,0.49672782366425244,0.8894073505255368,0.8619112946570098,1.0,0.9999999999,1.0
What is the main function of the retina in vision?,"[""The retina's primary role in vision is to capture light and convert it into electrical signals that initiate visual processing, enabling us to see; when the retina is damaged by aging, disease, genetic factors, oxidative stress or vascular problems, that conversion is impaired, causing blurred vision or vision loss, and many treatments—from injections and anti‑VEGF therapies to prostheses and cell or RPE transplants—aim to preserve or restore retinal function and improve vision.""]","The retina's main function in vision is to capture light and convert it into electrical signals that initiate visual processing, enabling perception of images.",The retina converts light into electrical signals for the brain to interpret as vision.,0.48464385419774286,1.0000000000000002,0.9385754167909715,0.8,0.9999999999,1.0
What is the earliest detectable sign of AMD?,"['The earliest detectable sign of AMD is delayed rod-mediated dark adaptation — an early difficulty the eyes have adapting to low light; specialized dark-adaptation testing can reveal this change before more obvious vision loss, and color stereo fundus grading helps detect the earliest stages.']","The earliest detectable sign of AMD is delayed rod-mediated dark adaptation—difficulty adapting to low light detectable with specialized dark-adaptation testing, often alongside early changes seen on color stereo fundus grading.",The earliest detectable sign of AMD is small drusen under the retina.,0.22961834579263932,0.9999999999999996,0.9185171782404757,0.75,0.0,0.0
What is the primary symptom of wet AMD?,"['The primary symptom of wet AMD is a sudden loss or distortion of central vision—people typically notice blurred or wavy vision and an inability to see what they are looking directly at, making reading or recognizing faces difficult.']","The primary symptom of wet AMD is a sudden loss or distortion of central vision, typically experienced as blurred or wavy vision and difficulty seeing what one is directly looking at (e.g., reading or recognizing faces).",The primary symptom of wet AMD is sudden central vision distortion or blurriness.,0.7420019008972731,0.9999999999999996,0.9680209363675054,1.0,0.9999999999,1.0
What is the goal of AREDS2 supplements?,"['AREDS2 supplements are dietary antioxidant-and-zinc formulations intended to slow progression of age-related macular degeneration and reduce the risk of advancing to late or advanced disease, thereby lowering the chance of significant central vision loss.']","The goal of AREDS2 supplements is to slow progression of age-related macular degeneration and reduce the risk of advancing to late/advanced disease, thereby lowering the chance of significant central vision loss.",The goal of AREDS2 supplements is to slow progression from intermediate to advanced AMD.,0.6127363721598651,0.9999999999999996,0.9509454886394602,1.0,0.9999999999,1.0
What is the most common test for AMD diagnosis?,"['The most common test is optical coherence tomography (OCT), a noninvasive retinal scan that gives high‑resolution cross‑sectional images of the macula to detect drusen, subretinal fluid, and neovascular changes; it is routinely used alongside dilated fundus examination and color fundus photography (and OCT angiography when vascular detail is needed) to diagnose and monitor AMD.']","The most common test for AMD diagnosis is optical coherence tomography (OCT), a noninvasive retinal scan that provides high‑resolution cross‑sectional images of the macula to detect drusen, subretinal fluid, and neovascular changes.",The most common test for AMD diagnosis is optical coherence tomography (OCT).,0.5721228116140346,0.9906915102509021,0.955157913122805,1.0,0.9999999999,1.0
What is the typical progression of wet AMD?,"['Wet AMD typically evolves from age‑related (often dry) changes with drusen into a neovascular phase driven by VEGF, when choroidal neovascularization forms and leaks, causing RPE and retinal damage, central visual distortion or a central scotoma and a rapid decline in best‑corrected visual acuity that can progress to severe vision loss or blindness; characteristic choroidal and vascular changes are seen on imaging, and timely repeated intravitreal anti‑VEGF therapy (with other adjunctive options available) is used to control neovascularization and limit further visual deterioration.']","Wet AMD typically progresses from age‑related (often dry) changes with drusen into a neovascular phase driven by VEGF, when choroidal neovascularization forms and leaks, causing RPE and retinal damage with central distortion or scotoma and rapid decline in visual acuity that, without timely repeated intravitreal anti‑VEGF therapy, can lead to severe vision loss.","Wet AMD typically progresses rapidly, often within weeks or months, if untreated.",0.21667018829815313,0.9552070565764357,0.8666807531926125,1.0,0.9999999999,0.0
What is the role of the macula in reading?,"['The macula is the part of the retina responsible for central, high-acuity vision and fine detail needed for recognizing letters and words, so damage or disease of the macula (for example macular degeneration or atrophy) commonly causes difficulty reading, reduced reading performance, and loss of independence and quality of life. Central vision loss from macular pathology impairs the ability to see what one is looking at directly, but reading can often be partially restored or aided through optical correction, magnifiers, low-vision training, oculomotor rehabilitation, assistive technologies and medical or prosthetic interventions; macular pigment and nutritional factors can also influence reading performance.']","The macula provides central, high-acuity vision and fine detail essential for recognizing letters and words, so macular damage (e.g., degeneration or atrophy) commonly causes difficulty reading and reduced reading performance, though reading may be partially aided by optical, rehabilitative, assistive, nutritional, or medical interventions.",The macula provides sharp central vision needed for reading fine print.,0.5015769003252575,0.9339281006023267,0.915398510391939,1.0,0.9999999999,1.0
What is the purpose of fluorescein angiography in AMD?,"['Fluorescein angiography is used in AMD to image the retinal and choroidal circulation so clinicians can detect and characterize choroidal neovascularization and other neovascular subtypes, reveal dye leakage and vascular abnormalities, distinguish lesion types (classic vs occult, polypoidal or quiescent CNV), identify associated macular edema, subretinal neovascular membranes or fibrosis, and assess lesion activity and extent to guide diagnosis and treatment decisions.']","Fluorescein angiography in AMD is used to image retinal and choroidal circulation to detect and characterize choroidal neovascularization and other neovascular subtypes, reveal dye leakage and vascular abnormalities, distinguish lesion types (classic vs occult, polypoidal or quiescent CNV), identify associated macular edema, subretinal neovascular membranes or fibrosis, and assess lesion activity and extent to guide diagnosis and treatment decisions.",Fluorescein angiography identifies leaking blood vessels in wet AMD.,0.22909356826470556,0.9726197857183129,0.916395577437353,1.0,0.9999999999,1.0
What is the primary benefit of anti-VEGF therapy?,"['The primary benefit of anti-VEGF therapy is preservation and improvement of vision: by treating neovascular (wet) AMD, diabetic retinopathy, and retinal vein occlusions it reduces macular and subretinal fluid, improves best-corrected visual acuity and overall visual outcomes, and helps prevent vision loss and blindness.']","The primary benefit of anti-VEGF therapy is preservation and improvement of vision by reducing macular and subretinal fluid in neovascular (wet) AMD (and other retinal vascular diseases), which improves best-corrected visual acuity and helps prevent vision loss and blindness.",The primary benefit of anti-VEGF therapy is reducing vision loss in wet AMD.,0.8369797410006088,0.9999999999999996,0.9479189640024349,1.0,0.9999999999,1.0
What is the most affected vision type in AMD?,"['Age-related macular degeneration primarily damages the macula and most strongly affects central vision, causing blurred or missing vision in the center of sight that impairs reading, recognizing faces, driving, and seeing what one is looking at, and can progress to irreversible central vision loss and blindness.']","Age-related macular degeneration most strongly affects central vision, causing blurred or missing vision in the center of the visual field.",Central vision is the most affected vision type in AMD.,0.9741617386196051,0.8613237533944185,0.8966469544784202,1.0,0.9999999999,1.0
What is the role of vitamin A in retinal health?,"['Vitamin A, which is produced from dietary carotenoids, is essential for retinal function as a key component of the visual cycle; adequate levels support retinal health and can be beneficial in managing macular degeneration, while deficiency (such as insufficient 11‑cis‑retinal) impairs retinal health and leads to vision loss—although abnormal or excess vitamin A exposure has also been linked in some contexts to earlier macular degeneration, so appropriate balance is important.']","Vitamin A, derived from dietary carotenoids, is essential for retinal health as the key component (11‑cis‑retinal) of the visual cycle necessary for phototransduction and maintenance of retinal function, though both deficiency and abnormal/excess exposure can harm the macula, so balanced levels are important.","Vitamin A supports photoreceptor function, maintaining retinal health.",0.5303446792054304,0.9680341476906266,0.9213787168217215,0.5714285714285714,0.9999999999,1.0
What is a frequent visual complaint in early AMD?,"['In early age-related macular degeneration patients commonly notice a subtle decline in central visual acuity—difficulty reading or seeing fine detail—and trouble with dark adaptation or night vision, often accompanying drusen and early outer retinal thinning on imaging.']",A frequent visual complaint in early AMD is a subtle decline in central visual acuity—difficulty reading or seeing fine detail—often accompanied by trouble with dark adaptation or night vision.,A frequent visual complaint in early AMD is slight difficulty with detail perception.,0.4879593982121161,0.9485623595131972,0.9518420715889157,1.0,0.9999999999,1.0
What is the purpose of low vision aids in AMD?,"['Low vision aids for people with age-related macular degeneration are used to maximize remaining vision and compensate for central vision loss so patients can read, move around more safely, recognize faces, and perform daily tasks with less dependence on others; by improving functional ability they help reduce frustration, anxiety and depressive effects and enhance overall vision-related quality of life, even though they do not cure the underlying disease.']","Low vision aids in AMD are intended to maximize remaining vision and compensate for central vision loss so patients can read, navigate more safely, recognize faces, perform daily tasks with less dependence, and thereby reduce frustration, anxiety, depression, and improve vision-related quality of life, though they do not cure the disease.",Low vision aids enhance remaining vision for daily tasks in AMD patients.,0.45130238242824483,0.9889488467405402,0.9480666725701222,1.0,0.9999999999,1.0
What is the main genetic risk factor for AMD?,"['Genetic predisposition—specifically certain gene variants—is the main risk factor for age-related macular degeneration, with APOE ε4 among the reported variants that influence AMD and in some studies appear to have a protective effect.']","The main genetic risk factor for age-related macular degeneration is inherited gene variants—with certain alleles (including variants in complement pathway genes and others) being most influential, and some reports noting APOE ε4 may be associated with reduced AMD risk.",The main genetic risk factor for AMD is variants in the CFH gene.,0.2278582954461066,0.953354356413548,0.9114331817844264,0.6666666666666666,0.0,0.0
What is the typical appearance of drusen on retinal imaging?,"['On retinal imaging drusen characteristically appear as yellow‑white extracellular deposits beneath the retinal pigment epithelium along Bruch’s membrane, seen as sub‑RPE elevations on cross‑sectional scans and as small yellowish spots on fundus views; a variant, reticular (or pseudodrusen), typically has a bluish‑white, reticular appearance.']","Drusen typically appear on retinal imaging as yellow‑white extracellular deposits beneath the retinal pigment epithelium along Bruch’s membrane—seen as sub‑RPE elevations on cross‑sectional scans and as small yellowish spots on fundus views, while reticular (pseudodrusen) have a bluish‑white, reticular appearance.",Drusen appear as yellowish spots under the retina on imaging.,0.6610467665507339,0.9626318589395227,0.9299013519172212,1.0,0.9999999999,1.0
What is the role of sunglasses in AMD prevention?,"['Wearing sunglasses that block ultraviolet radiation helps protect the eyes from UV-related damage and can reduce the risk of developing age-related macular degeneration, making sun protection a simple preventive measure to help preserve retinal health.']","Wearing sunglasses that block ultraviolet radiation helps protect the eyes from UV-related damage and can reduce the risk of developing age-related macular degeneration, making sun protection a simple preventive measure to help preserve retinal health.",Sunglasses block UV light to reduce retinal damage in AMD prevention.,0.8734516546515398,0.8811053475909748,0.922378047177588,1.0,0.9999999999,1.0
What is the primary cause of vision loss in wet AMD?,"['In wet (neovascular) AMD, abnormal growth of new choroidal blood vessels under the macula is the primary cause of vision loss; these vessels leak and bleed, leading to damage and degeneration of the overlying photoreceptors and retinal pigment epithelium and ultimately scarring, which produces rapid central vision loss.']","The primary cause of vision loss in wet (neovascular) AMD is abnormal growth of new choroidal blood vessels under the macula that leak, bleed, damage the overlying photoreceptors and retinal pigment epithelium, and lead to scarring causing rapid central vision loss.",The primary cause of vision loss in wet AMD is macular damage from leaking blood vessels.,0.9871885703682002,0.9919407805294297,0.9487542814728007,1.0,0.9999999999,1.0
What is the benefit of early AMD detection?,"['Early detection of age-related macular degeneration lets clinicians identify drusen and subtle retinal changes with imaging and functional tests and begin treatment and monitoring sooner, which improves visual outcomes, slows progression to advanced disease, can reduce the number and burden of intravitreal treatments, and creates an opportunity for lifestyle, dietary, and medical measures that help preserve vision and quality of life.']","Early detection of AMD allows clinicians to identify drusen and subtle retinal changes sooner via imaging and functional tests, enabling earlier treatment and monitoring that improves visual outcomes, slows progression to advanced disease, can reduce intravitreal treatment burden, and permits lifestyle, dietary, and medical interventions to help preserve vision and quality of life.",Early AMD detection allows timely interventions to slow progression.,0.974294591960998,0.9693165883819325,0.8971783678439917,1.0,0.9999999999,1.0
What is the role of photoreceptors in the macula?,"['Photoreceptors concentrated in the macula are the light-detecting cells that underlie high-acuity central vision and form the first synapses of the retinal circuit; their function depends on support from the retinal pigment epithelium and choroidal circulation, and when they are damaged by aging changes, drusen, subretinal deposits, hemorrhage or RPE loss they drive vision loss and contribute to the progression of macular and other retinal degenerative diseases.']","Photoreceptors in the macula are the light-detecting cells that enable high-acuity central vision by forming the first synapses of the retinal circuit and depend on support from the RPE and choroidal circulation, with damage from aging, drusen, subretinal deposits, hemorrhage, or RPE loss leading to vision loss and progression of macular degeneration.",Photoreceptors in the macula detect light for detailed central vision.,0.461654783492771,0.9269121920355651,0.9235422108941609,1.0,0.9999999999,1.0
What is a common treatment frequency for wet AMD?,"['Wet AMD is most commonly managed with regular intravitreal anti‑VEGF injections, typically given every month during initial treatment; some agents and regimens allow extension to about every eight weeks or longer (using treat‑and‑extend or PRN approaches) while balancing visit burden and visual outcomes.']","A common treatment frequency for wet AMD is intravitreal anti‑VEGF injections given monthly during initial treatment, with some regimens extendable to about every eight weeks or longer using treat‑and‑extend or PRN approaches.",A common treatment frequency for wet AMD is monthly anti-VEGF injections.,0.5418269751284315,0.9982558559088535,0.9673079005137257,1.0,0.9999999999,1.0
What is the purpose of nutritional counseling in AMD?,"['Nutritional counseling for AMD is meant to educate and guide patients on diet and appropriate supplementation to support retinal health, slow disease progression, and help preserve central vision. By explaining which nutrients and supplements can improve eye health, reduce the risk of worsening (especially in intermediate stages), and how lifestyle factors like smoking and other treatments interact, counseling promotes informed choices, adherence to therapy, better monitoring, and ultimately better visual outcomes.']","Nutritional counseling in AMD educates and guides patients on diet, appropriate supplements, and lifestyle factors (e.g., smoking cessation) to support retinal health, slow disease progression—particularly in intermediate AMD—and improve adherence, monitoring, and visual outcomes.",Nutritional counseling promotes a diet to support retinal health in AMD.,0.5383733624870164,0.9530262289596639,0.9534934499480656,1.0,0.9999999999,1.0
What is the effect of AMD on contrast sensitivity?,"['Age-related macular degeneration impairs contrast sensitivity, with more advanced or bilateral disease producing greater reductions. This loss of contrast sensitivity contributes to poorer visual performance and difficulties with tasks like reading, driving, and mobility. Some interventions (for example certain supplements, photobiomodulation, and treatments such as aflibercept) have been shown to help improve contrast sensitivity in affected patients.']","Age-related macular degeneration reduces contrast sensitivity—more so with advanced or bilateral disease—leading to worse visual performance and functional difficulties (e.g., reading, driving, mobility), though some interventions (certain supplements, photobiomodulation, and treatments like aflibercept) can partially improve it.","AMD reduces contrast sensitivity, making it hard to distinguish objects.",0.6677018416274153,0.8290231321981018,0.824653520355815,1.0,0.9999999999,1.0
What is the role of the choroid in retinal health?,"['The choroid is the vascular layer that nourishes the outer retina and retinal pigment epithelium, and its structural and molecular integrity is essential for photoreceptor survival and RPE function. Alterations in choroidal blood flow, extracellular matrix, or immune activity at the RPE–choroid interface can drive or exacerbate disorders such as age-related macular degeneration (including neovascular forms and geographic atrophy), pachychoroid spectrum disease, central serous chorioretinopathy, diabetic choroidopathy and myopia-related changes. Choroidal status therefore influences disease progression, the development of macular neovascularization and treatment responses, and is a key target and biomarker in diagnosis, imaging and therapeutic strategies.']","The choroid supplies vascular nourishment and molecular support to the outer retina and RPE, and its structural, vascular, ECM, and immune integrity is essential for photoreceptor survival and influences progression, neovascularization, and treatment responses in diseases such as AMD.",The choroid supplies oxygen and nutrients to the retina for its health.,0.33588504598326796,0.9402272284206005,0.9149687553616431,0.5,0.9999999999,1.0
What is a typical finding in late dry AMD?,"['A hallmark of late dry age-related macular degeneration is geographic atrophy of the retinal pigment epithelium with overlying photoreceptor loss, often seen alongside large soft drusen or subretinal drusenoid deposits (pseudodrusen) and leading to progressive central visual impairment or blindness.']","A typical finding in late dry AMD is geographic atrophy of the retinal pigment epithelium with overlying photoreceptor loss, often associated with large soft drusen or subretinal drusenoid deposits (pseudodrusen) and progressive central vision loss.",A typical finding in late dry AMD is geographic atrophy with retinal thinning.,0.4511108031135975,0.9869853096884103,0.9473003553115329,1.0,0.9999999999,0.0
What is the benefit of magnifiers for AMD patients?,"['Magnifiers can help people with age-related macular degeneration by preventing loss of central vision, easing reading difficulties, reducing overall visual impairment, and helping preserve independence and everyday functioning.']","Magnifiers help people with age-related macular degeneration by easing reading difficulties, reducing overall visual impairment, preventing further loss of central vision, and supporting independence in daily activities.","Magnifiers enlarge objects, aiding vision for AMD patients.",0.6799192173532221,0.9082074258348353,0.9196768694128887,1.0,0.9999999999,0.0
What is the main dietary recommendation for AMD prevention?,"['The main dietary recommendation for preventing AMD is to adopt dietary changes and/or supplements that boost omega-3 fatty acids (especially EPA and DHA) and antioxidant intake to reduce oxidative stress, which can lower the prevalence and severity of the disease.']",The main dietary recommendation for preventing AMD is to increase intake of omega-3 fatty acids (especially EPA and DHA) and antioxidants—via diet and/or supplements—to reduce oxidative stress and thereby lower AMD prevalence and severity.,The main dietary recommendation for AMD prevention is eating leafy greens rich in antioxidants.,0.23482878162668963,0.9883462736545238,0.9393151265067585,1.0,0.0,0.0
What is the purpose of retinal photography in AMD?,"['Retinal photography is used to detect and document age-related macular degeneration and its subtypes, visualize macular changes such as drusen, pseudodrusen, RPE atrophy, geographic atrophy, fibrosis and exudation, identify neovascular forms including polypoidal choroidal vasculopathy, and provide baseline images for monitoring disease progression and guiding management.']","Retinal photography in AMD is used to detect and document AMD and its subtypes, visualize macular changes (e.g., drusen, pseudodrusen, RPE atrophy, geographic atrophy, fibrosis, exudation), identify neovascular forms including polypoidal choroidal vasculopathy, and provide baseline images for monitoring progression and guiding management.",Retinal photography tracks changes like drusen or hemorrhages in AMD.,0.8772924542109107,0.9720866805634848,0.9377412454150716,1.0,0.9999999999,0.0
What is the effect of AMD on visual field?,"['Age-related macular degeneration primarily impairs the central visual field, producing blurred or missing central vision (central blind spots) and progressive central vision loss that reduces reading ability, driving performance, spatial perception and independence; it leads to overall visual impairment and, in advanced stages, can cause irreversible blindness, with visual-field defects detectable on testing even in earlier disease.']","Age-related macular degeneration primarily causes central visual-field defects—blurred or missing central vision (central scotomas) and progressive central vision loss that impair reading, driving, spatial perception, and can lead to irreversible blindness in advanced stages.","AMD reduces the central visual field, leaving peripheral vision intact.",0.9081536578384086,0.892602208210277,0.8326146313536344,0.875,0.9999999999,1.0
What is the role of anti-inflammatory foods in AMD?,"['Dietary anti-inflammatory foods—rich in phytochemicals such as lutein and other bioactive compounds—can counter the chronic inflammation implicated in AMD, support retinal pigment epithelium health, and may help slow progression of vision loss and geographic atrophy; certain compounds and combinations can enhance this protective effect, making anti-inflammatory diet a useful adjunctive, cytoprotective strategy though not a cure.']","Anti-inflammatory foods rich in phytochemicals (e.g., lutein) may counter chronic inflammation implicated in AMD, support retinal pigment epithelium health, and serve as a cytoprotective adjunct that can help slow progression of vision loss and geographic atrophy, though they are not a cure.","Anti-inflammatory foods reduce retinal inflammation, supporting AMD management.",0.5353017111606319,0.0,0.9412075644362027,1.0,0.9999999999,1.0
What is a common adaptation for AMD patients in reading?,"['A common adaptation for people with age-related macular degeneration is using magnifying aids to read; combined with low-vision training and oculomotor exercises, electronic tools such as tablets and screen-reader software, and optical or prosthetic interventions when appropriate, these measures can markedly improve reading ability and speed and reduce difficulty reading.']","A common adaptation for people with age-related macular degeneration is using magnifying aids, often combined with low-vision training, oculomotor exercises, electronic tools (e.g., tablets, screen-reader software), and optical or prosthetic interventions to markedly improve reading ability and speed.",A common adaptation is using electronic readers with adjustable text size.,0.3582533080270306,0.8736721819083559,0.8332087713364985,1.0,0.0,0.0
What is the purpose of photodynamic therapy in AMD?,"['Photodynamic therapy is used in AMD—particularly the neovascular (wet) form—to target and close abnormal choroidal blood vessels that cause leakage and bleeding, thereby reducing exudation and macular edema, limiting progression, and helping to preserve or improve central visual acuity and reduce the risk of moderate-to-severe vision loss; verteporfin is a commonly used photosensitizer and PDT is also applied for related conditions such as polypoidal choroidal vasculopathy and choroidal neovascularization.']","Photodynamic therapy in neovascular (wet) AMD uses a photosensitizer (commonly verteporfin) and light activation to selectively close abnormal choroidal blood vessels, reducing leakage, hemorrhage, and macular edema to limit progression and help preserve or improve central vision.",Photodynamic therapy targets abnormal blood vessels to slow wet AMD progression.,0.5680747084563883,0.9352138771662211,0.9389655004922197,1.0,0.9999999999,1.0
What is the effect of AMD on object recognition?,"['Age-related macular degeneration, particularly in its advanced or dry forms, impairs object recognition by damaging central vision and reducing visual acuity, leading to poorer face and color recognition, diminished ability to identify details, worse reading and driving performance, increased errors in visual tasks, and greater reliance on others.']","Age-related macular degeneration, especially advanced or dry forms, impairs object recognition by damaging central vision and reducing visual acuity, resulting in poorer face and color recognition, decreased detail discrimination, worse reading and driving performance, increased visual errors, and greater reliance on others.",AMD impairs object recognition by blurring central vision details.,0.49168804274060196,0.840399052302376,0.875843080053317,1.0,0.9999999999,1.0
What is the role of regular exercise in AMD?,"['Regular physical exercise appears to play a protective and therapeutic role in age-related macular degeneration: activity is linked with reduced progression and severity of retinal disease, can lessen oxidative and inflammatory damage, raise beneficial mediators like adiponectin, and improve the effectiveness of anti‑angiogenic treatments and control of choroidal neovascularization. Inactivity is associated with worse ocular outcomes, though extreme endurance exercise may increase oxidative stress, so moderate regular exercise is most likely to benefit vision and overall well‑being.']","Regular moderate physical exercise appears to protect against AMD progression and severity—reducing oxidative and inflammatory damage, increasing beneficial mediators (e.g., adiponectin), and improving response to anti‑angiogenic therapies—whereas inactivity is linked to worse outcomes and extreme endurance exercise may raise oxidative stress.","Regular exercise improves retinal blood flow, aiding AMD management.",0.22394961007281572,0.9525237429056058,0.8957984402912629,1.0,0.9999999999,0.0
What is a frequent finding in wet AMD imaging?,['Imaging of wet age-related macular degeneration most commonly shows choroidal neovascularization—abnormal new blood vessels beneath the retina—often accompanied by retinal neovascularization and increased central retinal thickness from fluid/edema seen on OCT and OCT angiography.'],A frequent finding in wet AMD imaging is choroidal neovascularization—abnormal new blood vessels beneath the retina—often with retinal neovascularization and increased central retinal thickness from fluid/edema on OCT/OCT-A.,A frequent finding in wet AMD imaging is choroidal neovascularization.,0.4893846145606017,0.9771235028385169,0.9575384582424069,1.0,0.9999999999,1.0
What is the benefit of screen magnification for AMD patients?,"['Screen magnification helps people with age-related macular degeneration compensate for central vision loss by improving visual acuity and reading ability, making on-screen text and details easier to see and reducing reading difficulty and dependence on others.']","Screen magnification helps people with age-related macular degeneration by improving visual acuity and reading ability—making on-screen text and details easier to see, reducing reading difficulty, and decreasing dependence on others.","Screen magnification enlarges digital content, improving visibility for AMD patients.",0.6743371057606431,0.9111099410102247,0.8973484230425726,1.0,0.9999999999,1.0
What is the main limitation of current AMD treatments?,"['The main limitation of current AMD treatments is their limited overall efficacy: they largely target neovascular disease but do not adequately prevent or treat non‑neovascular/atrophic forms, often rely on anti‑VEGF approaches that can be undermined by intraocular factors, and require frequent interventions that drive suboptimal patient compliance and ongoing risk of vision loss.']","The main limitation of current AMD treatments is limited overall efficacy—they predominantly target neovascular disease (mostly via anti‑VEGF), inadequately prevent or treat non‑neovascular/atrophic forms, can be undermined by intraocular factors, and require frequent interventions that reduce compliance and leave ongoing risk of vision loss.",The main limitation of current AMD treatments is their inability to reverse existing damage.,0.2219096200796761,0.9875955418580343,0.887664137517896,1.0,0.0,0.0
What is the role of blood pressure control in AMD?,"['Elevated blood pressure is linked to age-related macular degeneration through impaired choroidal blood flow and disturbed vascular homeostasis, so controlling hypertension can help reduce the risk or progression of retinal disease; additionally, some AMD treatments (for example anti-VEGF agents such as aflibercept) can influence systemic blood pressure, making blood-pressure monitoring and management important in patients with or at risk for AMD.']","Controlling blood pressure helps reduce the risk and progression of AMD by preserving choroidal blood flow and vascular homeostasis, and is particularly important to monitor because some AMD treatments (e.g., anti-VEGF agents like aflibercept) can affect systemic blood pressure.",Blood pressure control reduces retinal vascular stress in AMD management.,0.5352538520317995,0.9648389627750582,0.9410154081271977,0.7142857142857143,0.9999999999,1.0
What is a common early symptom of dry AMD?,"['A common early symptom of dry age‑related macular degeneration is trouble with central vision — blurring or a missing spot when looking directly at things, which makes reading, recognizing faces, and seeing fine detail difficult.']","A common early symptom of dry age‑related macular degeneration is trouble with central vision, such as blurring or a missing spot when looking directly at things, making reading, recognizing faces, and seeing fine detail difficult.",A common early symptom of dry AMD is mild blurriness in central vision.,0.4448896227008466,0.9383614787920139,0.9224156336605291,1.0,0.9999999999,1.0
What is the purpose of contrast sensitivity testing in AMD?,"['Contrast sensitivity testing in AMD detects and quantifies the loss of ability to see low-contrast targets that often accompanies macular disease even when acuity is relatively preserved; it provides a practical measure of real-world visual function (reading, mobility, driving), helps monitor disease severity and progression, and evaluates the functional impact of treatments and interventions to guide management and rehabilitation.']","Contrast sensitivity testing in AMD assesses and quantifies loss of ability to see low-contrast targets—providing a practical measure of real-world visual function (e.g., reading, mobility, driving), monitoring disease severity and progression, and evaluating functional impact of treatments to guide management and rehabilitation.",Contrast sensitivity testing assesses AMD’s impact on distinguishing shades.,0.9259974660748189,0.9743808346607871,0.9347590950685063,1.0,0.9999999999,1.0
What is the effect of AMD on navigation?,"['Age-related macular degeneration largely impairs central vision and overall visual function, which reduces spatial perception and motion sensitivity and leads to mobility and navigation difficulties. People with AMD commonly experience trouble reading signs, maintaining lanes, judging gaps, and responding at intersections, which degrades driving performance and safety and increases errors and reliance on others for independent navigation.']","Age-related macular degeneration impairs central vision, spatial perception, and motion sensitivity, causing difficulty reading signs, judging gaps, maintaining lanes, and responding at intersections, which degrades driving performance and overall navigation and increases dependence on others.",AMD impairs navigation by reducing central vision for spatial awareness.,0.4373829388754234,,0.8923888983588364,1.0,0.9999999999,1.0
What is the role of family history in AMD risk?,"['A family history of age-related macular degeneration is a significant risk factor: having affected relatives, whether maternal or paternal, increases an individual’s likelihood of developing AMD and can predispose to earlier onset or more severe forms, including neovascular/exudative disease, so a positive family history is important when assessing personal risk.']",A positive family history of age-related macular degeneration markedly increases an individual’s risk—often predisposing to earlier onset or more severe (including neovascular) forms—so family history is an important factor when assessing AMD risk.,Family history increases AMD risk through inherited genetic variants.,0.6565623247448751,0.9032660701498904,0.9119635846937859,1.0,0.9999999999,0.0
What is a typical retinal finding in intermediate AMD?,['A hallmark retinal finding in intermediate AMD is drusen—often large or confluent with increased drusen area and volume—and reticular pseudodrusen (subretinal drusenoid deposits) are also commonly seen on OCT and fundus imaging.'],"A typical retinal finding in intermediate AMD is the presence of large or confluent drusen with increased drusen area/volume, often accompanied by reticular pseudodrusen (subretinal drusenoid deposits) on OCT and fundus imaging.",A typical retinal finding in intermediate AMD is larger drusen deposits.,0.4879385398226497,0.989779525429347,0.9517541592905988,0.8,0.9999999999,1.0
What is the benefit of voice recognition tech for AMD patients?,"['Voice recognition technology can help people with age-related macular degeneration (AMD) by enabling hands-free control of devices and apps, reading text aloud, facilitating communication, and assisting with navigation and daily tasks, which reduces dependence on others, compensates for central vision and reading difficulties, and improves independence and quality of life.']","Voice recognition technology benefits people with age-related macular degeneration by enabling hands-free device control, reading text aloud, facilitating communication and navigation, and reducing dependence to improve independence and quality of life.",Voice recognition tech allows AMD patients to control devices without visual input.,0.8228041805075968,0.9054690206166622,0.891216722030387,1.0,0.9999999999,1.0
What is the effect of AMD on glare sensitivity?,"['Age-related macular degeneration commonly increases sensitivity to glare, producing photopic glare disability that worsens visual disturbances and impairs everyday tasks like reading and driving. This heightened glare is amplified by short-wavelength (blue) light, while strategies that boost macular pigment or filter blue light—such as lutein and zeaxanthin supplementation or blue-light–filtering lenses—can help reduce glare disability.']","Age-related macular degeneration increases sensitivity to glare—particularly photopic glare worsened by blue light—impairing tasks like reading and driving, and may be mitigated by boosting macular pigment (lutein/zeaxanthin) or using blue‑light–filtering lenses.",AMD increases glare sensitivity by damaging the macula’s light regulation.,0.4092286437198269,0.9267411318864577,0.8869424594601483,1.0,0.9999999999,1.0
What is the purpose of mobility training in AMD?,"['Mobility training for people with age-related macular degeneration helps them learn to use their remaining vision and alternative strategies to navigate safely and independently, improving spatial awareness, task performance, and confidence. By teaching orientation, adaptive techniques, and use of assistive devices, it aims to reduce dependence on others and enhance everyday mobility and safety.']","Mobility training for people with age-related macular degeneration aims to teach orientation, adaptive techniques, and use of assistive devices so they can safely and independently navigate, improve spatial awareness and task performance, and reduce dependence on others.",Mobility training teaches AMD patients to navigate safely with reduced vision.,0.7293934120616044,0.9213767897260269,0.9175736482464174,1.0,0.9999999999,1.0
What is the role of dietary fats in AMD?,"['Dietary fats—especially long-chain omega‑3s (EPA, DPA, DHA)—may play a protective role in age-related macular degeneration: increasing intake via diet or supplements is linked to lower risk and can slow disease progression and severity by supporting retinal health and reducing oxidative stress, and dietary guidance or interventions to boost omega‑3 consumption have been used to achieve these benefits.']","Long-chain omega‑3 fatty acids (EPA, DPA, DHA) in the diet or supplements appear to protect against age-related macular degeneration by supporting retinal health, reducing oxidative stress, and being associated with lower risk and slower disease progression and severity.",Healthy dietary fats like omega-3s support retinal health in AMD.,0.4401457959211419,0.8545851666836913,0.9033843310734886,1.0,0.9999999999,1.0
What is a common late-stage AMD complication?,"['A common complication of late-stage age-related macular degeneration is loss of central vision, leading to severe visual impairment and often legal blindness, with patients unable to see what they are looking at directly.']","A common late-stage complication of age-related macular degeneration is loss of central vision leading to severe visual impairment or legal blindness, with patients unable to see what they are looking at directly.",A common late-stage AMD complication is significant central vision loss.,0.5339111375218266,0.9491191553500805,0.9356445500873063,1.0,0.9999999999,1.0
What is the benefit of UV-protective lenses for AMD?,"['UV-protective lenses reduce ultraviolet exposure that can damage the retina and contribute to early AMD and visual impairment, so wearing them can help lower the risk or slow progression of AMD-related damage and help preserve central vision and visual acuity.']","Wearing UV-protective lenses reduces retinal ultraviolet exposure that can contribute to early AMD and visual impairment, thereby helping lower risk or slow AMD-related damage and preserve central vision and acuity.","UV-protective lenses reduce retinal damage, aiding AMD prevention.",0.6682170441947506,0.9613391097452505,0.9585443380906359,1.0,0.9999999999,1.0
What is the effect of AMD on handwriting?,"['Age-related macular degeneration primarily damages central vision and causes blurred or lost ability to see fine detail and what one is directly looking at, so people with AMD often struggle to form neat, consistent handwriting — letters can become irregular, poorly spaced or misaligned and overall legibility declines, leading to greater reliance on others and frustration.']","AMD damages central vision and fine detail perception, causing handwriting to become irregular, poorly spaced, misaligned, and less legible, often increasing dependence on others and frustration.",AMD impairs handwriting by reducing visual precision for fine movements.,0.7310138447602068,0.9695776266965944,0.924055379040827,1.0,0.9999999999,1.0
What is the purpose of electroretinography in AMD?,"['Electroretinography is used in AMD to objectively assess retinal function—especially macular/central function—helping detect and quantify retinal dysfunction and vision loss, aid diagnosis and monitoring of disease progression, and evaluate functional outcomes or treatment-related retinal toxicity.']","Electroretinography in AMD objectively assesses macular/central retinal function to detect and quantify retinal dysfunction and vision loss, aid diagnosis and monitoring of disease progression, and evaluate functional outcomes or treatment-related retinal toxicity.",Electroretinography measures retinal electrical activity to assess AMD damage.,0.8595239609699693,0.9672841527000101,0.9380958438798772,1.0,0.9999999999,1.0
What is the role of obesity in AMD risk?,"['Obesity increases the risk of developing age-related macular degeneration and can worsen its progression to late-stage disease, exacerbating retinal damage and vision loss. Excess body weight promotes chronic inflammation, oxidative stress, altered lipids, microvascular aging, pathological retinal angiogenesis, and neurodegeneration in the eye, linking obesity and related metabolic or lifestyle factors to higher AMD incidence and poorer outcomes.']","Obesity increases the risk of developing age-related macular degeneration and accelerates progression to late-stage disease by promoting chronic inflammation, oxidative stress, dysregulated lipids, microvascular aging, pathological retinal angiogenesis, and neurodegeneration that exacerbate retinal damage and vision loss.",Obesity increases AMD risk by promoting retinal inflammation.,0.40549616388543513,0.8963826024478562,0.9161023026005641,1.0,0.9999999999,1.0
What is a typical adaptation for AMD patients in lighting?,"['People with AMD commonly adapt by using brighter, evenly distributed, adjustable task lighting while minimizing glare—directional lamps or task lights and higher-contrast illumination for reading and close work help maximize remaining vision.']","A typical adaptation for people with AMD is using brighter, evenly distributed, adjustable task lighting—such as directional lamps or task lights—with higher-contrast illumination and minimized glare to maximize remaining vision.",A typical adaptation is using task lighting to enhance visibility.,0.5991727980832604,0.9471862401394798,0.8966911923330415,1.0,0.9999999999,1.0
What is the benefit of closed-circuit television for AMD?,"['Closed-circuit television can help people with age-related macular degeneration by improving their ability to see details and read despite central and general vision loss, thereby reducing dependence, easing mobility and daily-task difficulties, and improving overall visual function.']","Closed-circuit television can improve detail vision and reading for people with age-related macular degeneration, reducing dependence, easing mobility and daily-task difficulties, and improving overall visual function.","Closed-circuit television magnifies images, aiding AMD patients with visual tasks.",0.41693623197267654,0.8923241701274326,0.9177449278907062,1.0,0.9999999999,0.0
What is the effect of AMD on spatial orientation?,"['Age-related macular degeneration impairs central vision and overall visual function, which reduces spatial perception and the sense of presence in the environment and undermines the cognitive processes needed for spatial orientation. As a result, people with AMD often experience poor mobility and wayfinding, increased motion sensitivity and observation errors, and difficulties with tasks like driving and lane or gap selection, leading to greater dependence on others.']","AMD-related central vision loss and reduced visual function impair spatial perception and cognitive processes for spatial orientation, resulting in poor wayfinding, increased motion sensitivity and observation errors, and greater dependence on others.",AMD impairs spatial orientation by distorting central vision cues.,0.5282278022662508,0.9105039427155525,0.912911209065003,1.0,0.9999999999,0.0
What is the purpose of antioxidant supplements in AMD?,"['Antioxidant supplements—typically vitamin and zinc formulations—are used in age‑related macular degeneration to lower the risk that early or intermediate disease will progress to advanced or late stages, helping preserve central vision and quality of life and, in some cases, improving outcomes in established or unilateral intermediate AMD.']","Antioxidant supplements (typically vitamins and zinc) are used in AMD to reduce the risk that early or intermediate disease progresses to advanced/late stages, thereby helping preserve central vision and quality of life and sometimes improving outcomes in established or unilateral intermediate AMD.",Antioxidant supplements protect retinal cells from oxidative damage in AMD.,0.5645890141476586,0.9505267003169466,0.9250833049946505,1.0,0.0,0.0
What is the role of high cholesterol in AMD?,"['Elevated cholesterol—especially altered levels of high-density lipoprotein—is linked to increased risk of age-related macular degeneration and is found in the lipid-rich drusen that accumulate beneath the retina. High‑fat, high‑cholesterol diets can promote harmful changes in these deposits, and lipid-related factors and genes (such as APOE variants) as well as immune components that drive deposit formation influence individual susceptibility.']","Elevated cholesterol—particularly altered HDL levels—contributes to AMD by accumulating in lipid‑rich drusen beneath the retina, with high‑fat/high‑cholesterol diets, lipid‑related genes (e.g., APOE variants), and immune factors promoting harmful drusen formation and increasing individual susceptibility.","High cholesterol contributes to lipid buildup, increasing AMD risk.",0.38133341419175315,0.9361877423211044,0.9253336567670126,1.0,0.9999999999,1.0
What is a common social challenge for AMD patients?,"['A common social challenge for people with AMD is increased social isolation and disengagement: central vision loss makes reading, recognizing faces, and driving difficult, heightening dependence on others and reducing participation in social activities, which often leads to frustration and emotional strain that impair social interactions.']","A common social challenge for people with AMD is increased social isolation and disengagement due to central vision loss that impairs reading, face recognition, and driving, increasing dependence on others and causing frustration and emotional strain.",A common social challenge for AMD patients is difficulty recognizing people.,0.22966467462051282,0.9632297626761304,0.9186586984820513,1.0,0.9999999999,1.0
What is the benefit of adaptive software for AMD patients?,"['Adaptive software—including AI and deep-learning tools—can aid detection, monitoring, and treatment decisions for age-related macular degeneration, improving retinal disease management and helping achieve better visual outcomes for patients.']","Adaptive software—including AI and deep-learning tools—can improve detection, monitoring, and treatment decisions for AMD, leading to better retinal disease management and potentially improved visual outcomes for patients.","Adaptive software enhances accessibility, aiding AMD patients with digital tasks.",0.22606982788902558,0.9486375771542311,0.9042793115561023,1.0,0.0,0.0
What is the effect of AMD on color discrimination?,"['Age-related macular degeneration impairs color discrimination—especially in advanced stages—because macular damage and central vision loss reduce the ability to recognize and distinguish colors, contributing to overall visual impairment and difficulties with everyday tasks.']","Age-related macular degeneration impairs color discrimination—particularly in advanced stages—because macular damage and central vision loss reduce the ability to recognize and distinguish colors, worsening visual function in everyday tasks.",AMD reduces color discrimination by damaging macular cone cells.,0.887413224025935,0.9242160806677072,0.8829862294370731,1.0,0.9999999999,1.0
What is the purpose of visual rehabilitation in AMD?,"['Visual rehabilitation for age-related macular degeneration aims to maximize remaining vision and help patients adapt to central vision loss so they can read, move about, perform daily tasks, and regain independence and emotional well‑being. Tailored training—including development of a new fixation locus guided by testing, targeted reading practice, and other rehabilitation exercises—can improve visual function and outcomes, with clinical evaluation guiding the best individualized strategies.']","Visual rehabilitation in AMD aims to maximize remaining vision and help patients adapt to central vision loss—using tailored strategies (e.g., training a new fixation locus, targeted reading practice, and other exercises) guided by clinical evaluation to improve functional abilities, independence, and emotional well‑being.",Visual rehabilitation maximizes remaining vision for AMD patients’ daily life.,0.9020502850354363,0.9618578915618028,0.9415344734750781,0.625,0.9999999999,1.0
What is the role of diabetes in AMD risk?,"['Diabetes appears to increase the risk of developing and progressing age-related macular degeneration, contributing to worse retinal health and vision outcomes; its vascular and metabolic effects — such as impaired choroidal blood flow, broader vascular disease, and buildup of advanced glycation end products — likely drive this increased susceptibility and reduce quality of life for affected patients.']","Diabetes increases the risk of developing and progressing age-related macular degeneration, likely via vascular and metabolic mechanisms—impaired choroidal blood flow, systemic micro- and macrovascular disease, and accumulation of advanced glycation end products—that worsen retinal health and visual outcomes.",Diabetes may increase AMD risk by damaging retinal blood vessels.,0.4792161558044392,0.8923413364547462,0.9168646232177569,0.8888888888888888,0.9999999999,0.0
What is a typical OCT finding in early AMD?,"['On OCT, early AMD most commonly shows drusen beneath the RPE accompanied by subtle outer‑retinal changes such as thinning of the outer retina, loss/thinning of photoreceptor outer segments, and focal gaps or disruption of the photoreceptor layer.']","A typical OCT finding in early AMD is sub‑RPE drusen with subtle outer‑retinal changes such as outer retinal thinning, loss or thinning of photoreceptor outer segments, and focal photoreceptor layer disruption.",A typical OCT finding in early AMD is small drusen beneath the retina.,0.48718381662221116,0.9895929118910004,0.9487352664888447,1.0,0.9999999999,0.0
What is the benefit of glare-reducing glasses for AMD?,"['For people with AMD, glare-reducing glasses cut down intense and short‑wavelength (blue) light that worsens photopic glare, reducing glare-related visual disturbances and glare disability and thereby improving visual comfort and functional performance (contrast, reading and mobility) in bright conditions.']","Glare-reducing glasses that cut intense and short‑wavelength (blue) light reduce photopic glare and glare disability in people with AMD, improving visual comfort and functional performance (contrast sensitivity, reading ability, and mobility) in bright conditions.",Glare-reducing glasses improve comfort and visibility for AMD patients.,0.42442315114347157,0.9839580764269603,0.9476926045738863,1.0,0.9999999999,1.0
What is the effect of AMD on visual memory?,"['Age-related macular degeneration leads to central and general vision loss and related visual processing deficits that impair visuospatial working memory and performance on memory-guided search tasks, contributing to difficulties with reading, driving, navigation and other everyday activities; it is also associated with broader neurodegenerative and immune changes that may further influence memory-related function.']","AMD impairs visual memory by degrading central and overall vision and visual processing—leading to deficits in visuospatial working memory and memory-guided search—that worsen tasks like reading, driving, and navigation and may be compounded by associated neurodegenerative and immune changes.",AMD can impair visual memory by reducing clear image perception.,0.34203379022118574,0.958347612370542,0.9065966993462815,1.0,0.9999999999,1.0
What is the purpose of home monitoring in AMD?,"['Home monitoring for age-related macular degeneration is intended to detect early changes in vision so care can be started sooner, supplement conventional hospital assessment, and improve overall management and visual outcomes including acuity. By enabling regular checks at home it can improve access to care and help tailor clinic visits, though its success depends on patient understanding and addressing concerns about the monitoring process.']","Home monitoring in AMD aims to detect early vision changes so care can start sooner, supplement hospital assessments, tailor clinic visits, improve access and overall visual outcomes including acuity, and its success depends on patient understanding and addressing their concerns.",Home monitoring tracks vision changes to catch AMD progression early.,0.6462636771918184,0.9740537607739778,0.9486841933062555,1.0,0.9999999999,1.0
What is the role of inflammation in AMD progression?,"['Inflammation plays a central role in AMD progression: chronic ocular and retinal inflammation promotes cell death, drives complement activation and drusen-related changes, and worsens angiogenesis and choroidal neovascularization, all of which accelerate vision loss and can undermine anti-VEGF therapy. AMD pathology also elicits local inflammatory responses, creating a self-perpetuating cycle, so controlling inflammation is important for slowing disease progression and improving treatment outcomes.']","Chronic ocular and retinal inflammation drives AMD progression by promoting cell death, activating complement and drusen formation, and exacerbating angiogenesis/choroidal neovascularization—creating a self-perpetuating cycle that accelerates vision loss and can reduce anti-VEGF treatment effectiveness.","Inflammation accelerates retinal cell damage, driving AMD progression.",0.39904703745813414,0.9414299178648687,0.9295214831658698,1.0,0.9999999999,1.0
What is a common workplace challenge for AMD patients?,"['A common workplace challenge for people with AMD is loss of central and sharp vision, which makes reading and seeing fine details difficult, impairs spatial perception and observation, increases errors and reliance on others, and can reduce job performance and safety (including difficulties with driving or navigating work environments).']","A common workplace challenge for people with AMD is loss of central and sharp vision that makes reading and seeing fine details difficult, impairs spatial perception and observation, increases errors and reliance on others, and can reduce job performance and safety (including difficulties with driving or navigating work environments).",A common workplace challenge is difficulty reading screens or documents.,0.21775782407469174,0.9634124011902077,0.871031296298767,1.0,0.9999999999,0.0
What is the benefit of tactile markers for AMD patients?,"['Tactile markers give people with AMD nonvisual cues they can feel to identify objects, find controls or page positions, and orient themselves when central vision is impaired; by compensating for lost central vision they can ease reading and daily tasks, improve spatial perception and mobility, reduce dependence and frustration, and help maintain independence and safety.']","Tactile markers provide nonvisual cues that help people with AMD identify objects, locate controls or page positions, and orient themselves, thereby compensating for lost central vision to ease reading and daily tasks, improve mobility and spatial perception, and reduce dependence and frustration.","Tactile markers provide non-visual cues, aiding AMD patients with navigation.",0.3539694805929165,0.9839291721958205,0.9543394608332044,1.0,0.9999999999,1.0
What is the effect of AMD on depth judgment?,"['Age-related macular degeneration damages the macula and causes central and overall vision loss, which impairs spatial perception and mobility and leads to reduced depth perception and poorer depth judgment. This makes everyday tasks that rely on accurate depth cues—such as driving, lane keeping, gap selection and navigating intersections—more error-prone, increases motion sensitivity and observation errors, and can raise dependence on others and safety risks.']","Age-related macular degeneration impairs the macula and reduces central vision, which diminishes depth perception and depth judgment—making spatial tasks like driving, lane-keeping, gap selection, and navigating intersections more error-prone and increasing safety risks.",AMD impairs depth judgment by distorting central vision cues.,0.8453251707806306,0.8485858029564025,0.8813006831225227,1.0,0.9999999999,1.0
What is the purpose of retinal implants in AMD research?,"['Retinal implants in AMD research are being developed to restore or improve visual function and quality of life for people with central vision loss from retinal degeneration; they aim to treat blindness and vision loss, support vision restoration for blind patients, and help regain useful sight for everyday activities.']","Retinal implants in AMD research are being developed to restore or improve visual function and quality of life for people with central vision loss from retinal degeneration by treating blindness, supporting vision restoration, and helping regain useful sight for everyday activities.",Retinal implants aim to restore vision by replacing damaged photoreceptors in AMD.,0.8362584521845243,0.9999999999999994,0.9451108920050413,1.0,0.9999999999,1.0
What is the role of smoking in AMD development?,"['Smoking is a major modifiable risk factor for age-related macular degeneration: it increases the likelihood of developing AMD—especially late and neovascular forms—tends to bring earlier onset and faster progression, worsens disease severity and visual outcomes, and can impair response to treatments; quitting smoking reduces risk and disease progression.']","Smoking is a major modifiable risk factor for AMD: it increases the likelihood—particularly of late and neovascular AMD—promotes earlier onset and faster progression, worsens severity and visual outcomes, can reduce treatment response, and smoking cessation lowers risk and disease progression.","Smoking increases oxidative stress, contributing to AMD development.",0.980356956223567,0.9198998837963451,0.9214278248942678,1.0,0.9999999999,0.0
What is a typical adaptation for AMD patients in mobility?,"['People with AMD commonly adopt eccentric-viewing strategies—training to use saccadic eye movements and peripheral vision—combined with mobility rehabilitation and assistive technologies; these approaches (including, for some, devices such as an implantable miniature telescope) help compensate for central vision loss, improve navigation and spatial awareness, and reduce dependence.']","A typical adaptation for AMD patients in mobility is eccentric-viewing training—learning to use saccadic eye movements and peripheral vision—combined with mobility rehabilitation and assistive technologies (e.g., orientation aids or, for some, an implantable miniature telescope) to improve navigation, spatial awareness, and reduce dependence.",A typical adaptation is using a cane to detect obstacles.,0.20719117512855886,0.9870500178655792,0.8287647005142355,0.8888888888888888,0.0,0.0
What is the benefit of blue-light filters for AMD?,"['By reducing exposure to high-energy blue light, blue-light filters can lessen photochemical injury to the retina and retinal pigment epithelium, decreasing oxidative stress, inflammation, lipofuscin buildup and cell death that contribute to development and worsening of age-related macular degeneration, and thus may help slow disease progression and preserve central vision.']","Blue-light filters may reduce photochemical retinal injury by lowering exposure to high-energy blue light, thereby decreasing oxidative stress, inflammation, lipofuscin accumulation, and retinal cell death that contribute to AMD progression, and thus may help slow disease progression and preserve central vision.","Blue-light filters reduce retinal damage, aiding AMD prevention.",0.5113807533329711,0.0,0.9546139224227933,1.0,0.9999999999,1.0
What is the effect of AMD on visual processing speed?,"['Age-related macular degeneration slows visual processing, degrading the quick interpretation of central visual information and leading to poorer reading and driving performance, increased motion sensitivity and spatial-perception problems, and more observation and lane-keeping errors; some retinal therapies can partly restore processing speed, but AMD generally results in slowed visual information processing.']","Age-related macular degeneration slows visual processing speed, impairing rapid central visual interpretation and leading to poorer reading and driving performance, increased motion- and spatial-perception difficulties, and more observation and lane-keeping errors, with some retinal therapies partially restoring processing speed in some cases.",AMD slows visual processing speed by impairing central vision clarity.,0.3560900291801433,0.9297118577511686,0.878905571266028,1.0,0.9999999999,1.0
What is the purpose of support groups for AMD patients?,"['Support groups give people with age-related macular degeneration emotional and practical support to cope with vision loss, frustration, and reduced independence; they provide companionship and family-like backing, share strategies for daily tasks (reading, mobility, driving), offer information about monitoring and treatments, and overall help improve quality of life and acceptance of care.']","Support groups for people with age-related macular degeneration provide emotional and practical support—offering companionship, coping strategies for daily tasks (reading, mobility, driving), information about monitoring and treatments, and overall help to improve quality of life and acceptance of care.",Support groups provide emotional and practical coping strategies for AMD patients.,0.5595007757219554,0.8964165544865161,0.9046697695544884,1.0,0.9999999999,1.0
What is the role of oxidative stress in AMD?,"['Oxidative stress is a central driver of AMD: it is prominent in the retina and RPE and induces mitochondrial dysfunction, DNA damage, cell senescence and death, promoting RPE degeneration, drusen/deposit formation and both atrophic and neovascular disease, thereby accelerating AMD pathogenesis and vision loss; it is worsened by aging and environmental insults (e.g., blue light) and linked to inflammatory activation, while antioxidants, dietary supplements (such as zeaxanthin) and compounds like resveratrol can reduce oxidative damage and may help slow progression.']","Oxidative stress drives AMD by causing mitochondrial dysfunction, DNA damage, cell senescence and death in the retina and RPE—promoting RPE degeneration, drusen/deposit formation, inflammation and both atrophic and neovascular changes—worsened by aging and environmental insults (e.g., blue light) and potentially mitigated by antioxidants, dietary supplements (e.g., zeaxanthin) and compounds like resveratrol.","Oxidative stress damages retinal cells, promoting AMD onset.",0.40896555592497247,0.9572049387446099,0.9299798707587135,1.0,0.9999999999,1.0
What is a common visual distortion in wet AMD?,['A common visual distortion in wet age-related macular degeneration is central visual distortion—patients often notice blurring or warping of central vision (straight lines appearing wavy) and may be unable to clearly see what they are looking at directly.'],"A common visual distortion in wet age-related macular degeneration is central visual distortion, in which patients experience blurring or warping of central vision (straight lines appearing wavy) and difficulty seeing objects they look at directly.",A common visual distortion in wet AMD is seeing straight lines as wavy.,0.7229141923686067,0.9534359560291567,0.8916567694744268,1.0,0.9999999999,1.0
What is the benefit of adjustable lighting for AMD patients?,"['Adjustable lighting can improve visual sensitivity and reduce the lighting-related problems people with AMD experience, making tasks like reading, mobility and other daily activities easier and helping preserve functional use of the macula under varied light conditions.']","Adjustable lighting can improve visual sensitivity, reduce lighting-related difficulties, and thereby make reading, mobility, and daily activities easier while helping preserve functional macular use under varied light conditions.","Adjustable lighting optimizes visibility, aiding AMD patients with tasks.",0.9769176220389221,0.9154364612366542,0.9076294725689038,1.0,0.9999999999,1.0
What is the effect of AMD on pattern recognition?,"['Age-related macular degeneration primarily damages central vision and causes blurred or lost central sight, which reduces the ability to resolve fine detail and impairs recognition of faces and other visual patterns, leading to difficulties with tasks like reading, driving and spatial judgments; some interventions such as prosthetic central vision or perceptual training can partially improve face- and pattern-recognition performance.']","Age-related macular degeneration primarily impairs central vision, causing blurred or lost central sight that reduces the ability to resolve fine detail and thereby worsens pattern recognition (e.g., faces and other visual patterns), though interventions like prosthetic central vision or perceptual training can partially improve performance.",AMD impairs pattern recognition by blurring central vision details.,0.7231810052074289,0.8311183134349235,0.8927240208297156,0.8571428571428571,0.9999999999,1.0
What is the purpose of laser therapy in AMD?,"['Laser therapy for AMD is used to treat neovascular (wet) disease and, in subthreshold forms, to target non‑exudative AMD by reducing drusen and slowing progression to advanced disease; the overall aims are to preserve or improve central vision (helping reading and face recognition), and in some approaches to address geographic atrophy by directly affecting the macula and retina.']","The purpose of laser therapy in AMD is to treat neovascular (wet) disease and, in subthreshold forms for non‑exudative AMD, to reduce drusen, slow progression to advanced disease (including targeting geographic atrophy in some approaches), and thereby preserve or improve central vision for tasks like reading and face recognition.",Laser therapy seals leaking blood vessels to slow wet AMD progression.,0.4137669124655201,0.9658973930709805,0.9050676498620804,1.0,0.9999999999,0.0
What is the role of sunlight in AMD risk?,"['Sunlight exposure has been linked to an increased risk of age-related macular degeneration: both past and current exposure, particularly high cumulative levels, are associated with the development and progression of early and late AMD, indicating that sunlight is a contributing environmental factor in AMD risk.']","Epidemiologic evidence indicates that past and current sunlight exposure—especially high cumulative levels—is associated with increased risk and progression of both early and late age-related macular degeneration, identifying sunlight as a contributing environmental risk factor.",Sunlight increases AMD risk by causing retinal oxidative damage.,0.8654547743550501,0.8812595134553652,0.8905126385844319,1.0,0.9999999999,0.0
What is a typical emotional reaction to AMD progression?,"['A typical emotional reaction to AMD progression is significant emotional distress, often including anxiety, frustration, and low mood as vision worsens.']","A typical emotional reaction to AMD progression is significant emotional distress, commonly including anxiety, frustration, and low mood as vision worsens.",A typical emotional reaction to AMD progression is frustration over vision loss.,0.4559157393120056,0.9947800457914276,0.9665201001051651,1.0,0.9999999999,1.0
What is the benefit of handheld scanners for AMD patients?,"['Handheld scanners make retinal imaging convenient and accessible, allowing easier, more frequent screening and monitoring of macular changes even for patients with central vision loss or difficulty fixating; this enables earlier detection of progression, timelier treatment decisions, and better chances of preserving vision and independence.']","Handheld retinal scanners improve accessibility and frequency of imaging for AMD patients—including those with central vision loss or fixation difficulty—enabling earlier detection of progression, timelier treatment decisions, and better chances of preserving vision and independence.","Handheld scanners magnify text, aiding AMD patients with reading.",0.22746921963710465,0.9655549560958369,0.9098768785484186,1.0,0.0,0.0
What is the effect of AMD on visual attention?,"['Age-related macular degeneration mainly damages central vision and often makes it hard to see what a person is directly looking at; this loss of central clarity and altered motion sensitivity disrupts visual attention and scanning, producing more observation errors and poorer spatial perception and mobility, with consequences such as difficulty reading, impaired driving performance (lane keeping, gap selection, traffic-light errors), increased dependence, and greater frustration.']","Age-related macular degeneration impairs visual attention by reducing central clarity and altering motion sensitivity, which disrupts visual scanning and attention, leading to more observation errors, poorer spatial perception and mobility, and functional difficulties such as reading and driving.",AMD reduces visual attention by impairing central focus.,0.33408969035880537,0.9190493620900176,0.87482029989676,1.0,0.9999999999,1.0
What is the primary function of cone cells in the macula?,"['Cone photoreceptors concentrated in the macula provide high-resolution, color central vision—the fine-detail, daylight vision used for reading, recognizing faces, and tasks requiring sharp acuity—and when macular cones are damaged (as in age-related macular degeneration and other macular disorders) this leads to loss of central vision and impaired ability to see what one is looking at.']","Cone photoreceptors concentrated in the macula mediate high-resolution, color central vision used for fine-detail, daylight tasks such as reading and face recognition, and damage to these cones (as in AMD) causes loss of central vision.",Cone cells in the macula enable color vision and sharp detail perception.,0.6373086123696448,0.9115119258540566,0.9130147915052872,1.0,0.9999999999,1.0
What is the earliest stage of AMD called?,['The earliest stage of age-related macular degeneration is called early-stage (or early) AMD; it can be detected with fundus photo grading and may be associated with subtle functional changes such as delayed rod‑mediated dark adaptation.'],"The earliest stage of age-related macular degeneration is called early-stage (or early) AMD, detectable by fundus photo grading and sometimes associated with subtle functional changes like delayed rod-mediated dark adaptation.",The earliest stage of AMD is called early AMD.,0.6533903092431311,0.9168091479102319,0.8992755226868102,0.8,0.9999999999,1.0
What is the most noticeable symptom of late AMD?,"['The most noticeable symptom of late age-related macular degeneration is loss of central vision—people have difficulty seeing what they are directly looking at, causing significant central visual impairment that can progress to blindness.']","The most noticeable symptom of late age-related macular degeneration is loss of central vision, causing marked difficulty seeing what one is directly looking at and potentially progressing to blindness.",The most noticeable symptom of late AMD is significant central vision loss.,0.602610470955184,0.9363131091413174,0.9104418838207363,1.0,0.9999999999,1.0
What is the main purpose of the AREDS clinical trials?,"['The AREDS clinical trials were designed to evaluate whether prophylactic, evidence-based nutritional supplementation can prevent or slow progression from early and intermediate age-related macular degeneration to advanced AMD.']","The main purpose of the AREDS clinical trials was to determine whether prophylactic, evidence-based nutritional supplementation can prevent or slow progression from early and intermediate age-related macular degeneration to advanced AMD.",The main purpose of the AREDS clinical trials is to test supplements for slowing AMD progression.,0.9892444525465575,0.9939088661583607,0.9569778101862298,1.0,0.9999999999,1.0
What is the most widely used imaging technique for AMD?,"['Optical coherence tomography (OCT) is the most widely used imaging technique for age-related macular degeneration, providing high-resolution cross-sectional views of the retina that reveal drusen, subretinal deposits, exudation, and neovascular changes and serving as a central tool for diagnosis and monitoring, often alongside color fundus photography.']","Optical coherence tomography (OCT) is the most widely used imaging technique for age-related macular degeneration, providing high-resolution cross-sectional retinal views that reveal drusen, subretinal deposits, exudation, and neovascular changes for diagnosis and monitoring.",The most widely used imaging technique for AMD is optical coherence tomography (OCT).,0.4195399606509581,0.8837910396784617,0.9281598426038324,1.0,0.9999999999,1.0
What is the typical timeframe for wet AMD symptom onset?,"['Symptoms of wet AMD usually appear suddenly and progress rapidly—most commonly developing over days to weeks after the disease converts to the wet form, often following years of dry-AMD changes such as drusen, so sudden central distortion or blurring should prompt urgent evaluation.']","Symptoms of wet AMD typically appear suddenly and progress rapidly, most commonly developing over days to weeks after conversion from dry-stage changes such as drusen.",Wet AMD symptoms typically onset within days to weeks.,0.48069996580086943,0.9232035550656778,0.9227998632034777,1.0,0.9999999999,1.0
What is the role of rod cells in retinal function?,"['Rods are the retina’s photoreceptors specialized for low‑light (scotopic) vision and for driving the rod‑to‑bipolar cell circuitry that underlies night and contrast sensitivity; when rods become dysfunctional or degenerate—due to RPE impairment, light damage, genetic defects, or other insults—overall retinal function declines and secondary pathology (including vascular changes) can follow, while therapies that protect or replace rods help preserve or restore retinal function and electrophysiological visual responses.']","Rods mediate low‑light (scotopic) vision and drive the rod→bipolar cell circuitry underlying night and contrast sensitivity, so their dysfunction or loss (from RPE impairment, light damage, genetics, etc.) leads to impaired retinal function, secondary pathology (including vascular changes), and reduced electrophysiological visual responses, while therapies that protect or replace rods can help preserve or restore function.",Rod cells enable vision in low light and peripheral detection.,0.37119510054157645,0.8992875792505365,0.8847804021663056,1.0,0.9999999999,1.0
What is the purpose of the Amsler grid in daily use?,"['The Amsler grid is a simple daily self‑check for people at risk of or with macular degeneration: by looking at the grid and noting any wavy, missing, or distorted lines it helps detect early central vision changes and visual distortion (metamorphopsia), so problems can be noticed promptly and brought to a clinician for assessment and management.']","The Amsler grid is used daily by people at risk of or with macular degeneration to self‑check for early central vision changes—reporting any wavy, missing, or distorted lines (metamorphopsia) so problems can be promptly brought to a clinician for assessment and management.",The Amsler grid monitors daily vision changes to detect AMD progression.,0.8860965565861301,0.9740096252566626,0.9193862263445196,1.0,0.9999999999,1.0
What is the primary outcome of untreated wet AMD?,"['If left untreated, wet age-related macular degeneration typically leads to abnormal choroidal neovascularization that damages the central retina and results in severe, often irreversible loss of central visual acuity, potentially progressing to legal blindness.']","The primary outcome of untreated wet AMD is progressive abnormal choroidal neovascularization that damages the central retina and leads to severe, often irreversible loss of central visual acuity, potentially progressing to legal blindness.",The primary outcome of untreated wet AMD is severe central vision loss.,0.9200124079711446,0.9999999999999997,0.9527769046118512,1.0,0.9999999999,1.0
What is the most common age group affected by AMD?,"['Age-related macular degeneration primarily affects older adults, becoming increasingly common after age 50 and most prevalent among the elderly, particularly those aged 65 and older.']","Age-related macular degeneration is most common among elderly individuals, particularly those aged 65 and older.",The most common age group affected by AMD is people over 60.,0.9772395098693987,0.9241706604059573,0.9089580394775949,1.0,0.9999999999,1.0
What is the role of carotenoids in AMD prevention?,"['Carotenoids, particularly lutein and zeaxanthin, concentrate in the macula and retinal pigment epithelium where they act as antioxidants and light filters, protecting retinal cells from oxidative damage and the cytotoxic effects of lipofuscin; higher dietary intake or targeted supplementation is associated with reduced risk and slower progression of age-related macular degeneration and improvements in vision-related measures, although their effectiveness depends on factors such as bioavailability, diet, and esterification.']","Carotenoids (especially lutein and zeaxanthin) accumulate in the macula and RPE where, by filtering blue light and acting as antioxidants against oxidative damage and lipofuscin cytotoxicity, higher dietary intake or supplementation is associated with reduced AMD risk, slower progression, and improved vision-related measures—though effectiveness varies with bioavailability, diet, and esterification.",Carotenoids like lutein protect the retina from light damage in AMD prevention.,0.6627187560548748,0.9584018942679761,0.9365893099337849,0.9,0.9999999999,1.0
What is a frequent visual issue in intermediate AMD?,"['A common visual problem in intermediate AMD is loss of central vision, often experienced as blurred vision and difficulty reading or performing tasks that require fine detail.']","A frequent visual issue in intermediate AMD is loss of central vision, commonly experienced as blurred vision and difficulty reading or performing tasks requiring fine detail.",A frequent visual issue in intermediate AMD is mild difficulty with fine details.,0.23419499167551547,0.9789177649933113,0.9367799667020619,1.0,0.0,0.0
What is the purpose of telescopic lenses in AMD?,"['Telescopic lenses are used in age-related macular degeneration to treat vision loss by improving visual acuity, helping compensate for central vision impairment and the inability to see directly, and thereby easing problems such as difficulty reading, driving, and dependence on others.']","Telescopic lenses for AMD are used to improve visual acuity by compensating for central vision loss—enabling patients to see more clearly, read better, and perform tasks like driving with less dependence on others.",Telescopic lenses magnify distant objects to aid vision in AMD patients.,0.42436002193088684,0.9701998039770322,0.9474400877235475,1.0,0.9999999999,1.0
What is the main environmental contributor to AMD?,"['Poor oral health—specifically periodontal disease—appears to be a major environmental contributor to age-related macular degeneration, likely acting via chronic systemic inflammation (elevated CRP) and related biologic changes from environmental exposures.']","Based on the provided data, poor oral health—specifically periodontal disease—is identified as a major environmental contributor to age-related macular degeneration, likely via chronic systemic inflammation (elevated CRP).",The main environmental contributor to AMD is chronic sun exposure.,0.20973460708712832,0.8909520250119963,0.8389384283485133,1.0,0.0,0.0
What is the typical appearance of geographic atrophy?,"['Geographic atrophy typically appears as well‑demarcated patches of retinal pigment epithelium and photoreceptor loss that show decreased autofluorescence on fundus autofluorescence imaging, commonly occurring in non‑neovascular (dry) age‑related macular degeneration and often associated with subretinal drusenoid deposits.']","Geographic atrophy typically appears as well‑demarcated patches of retinal pigment epithelium and photoreceptor loss with decreased autofluorescence on fundus autofluorescence imaging, commonly seen in non‑neovascular (dry) AMD and often associated with subretinal drusenoid deposits.",Geographic atrophy appears as well-defined areas of retinal loss on imaging.,0.48033534461195576,0.9205186510748389,0.921341378447823,1.0,0.9999999999,1.0
What is the benefit of yellow-tinted glasses for AMD patients?,"['Yellow-tinted glasses filter blue light, reducing blue-light–induced photochemical and oxidative damage to the retina, which can help protect against or slow progression of age-related macular degeneration and improve visual comfort, contrast and glare sensitivity; they may also have secondary benefits for sleep and mood.']","Yellow-tinted glasses filter blue light, which can reduce blue-light–induced photochemical and oxidative retinal damage and thereby may help protect against or slow progression of AMD while also improving visual comfort, contrast, glare sensitivity, and possibly sleep and mood.","Yellow-tinted glasses reduce glare, improving comfort for AMD patients.",0.38524244709517974,0.9423734695664504,0.9409697883807189,1.0,0.9999999999,1.0
What is the primary source of retinal nourishment?,"['The retina is fed by two vascular systems: the outer retina and photoreceptors are primarily nourished by the choroidal circulation across the retinal pigment epithelium, while the inner retinal layers are supplied by the retinal (central retinal artery) circulation; disruption of the choroid, RPE, or retinal vasculature (for example VEGF-driven neovascular changes) impairs nourishment and leads to retinal degeneration.']","The primary source of nourishment for the outer retina and photoreceptors is the choroidal circulation across the retinal pigment epithelium, while the inner retina is supplied by the retinal (central retinal artery) circulation.",The primary source of retinal nourishment is the choroid’s blood supply.,0.7316330504319006,0.9346827791365374,0.9264553256483874,1.0,0.9999999999,1.0
What is the effect of AMD on straight-line perception?,"['Age-related macular degeneration primarily damages central vision, producing blurred or distorted central images so that straight lines can appear wavy, bent, broken, or even partially missing; this loss of accurate straight-line perception impairs reading, mobility, driving, and other tasks that rely on precise spatial judgments.']","Age-related macular degeneration impairs straight-line perception, causing straight lines to appear wavy, bent, broken, or partially missing and thereby degrading tasks that require precise spatial judgments.",AMD can make straight lines appear wavy due to macular distortion.,0.410601051401861,0.8652549884026102,0.892404205607444,1.0,0.9999999999,1.0
What is the role of genetic predisposition in AMD?,"['Genetic predisposition strongly influences AMD risk and progression: inherited variants—particularly polymorphisms in complement and other retinal‑relevant genes—contribute to disease pathogenesis by promoting complement dysregulation, altered autophagy and retinal parainflammation, thereby increasing susceptibility to AMD, aggravating its course and raising the likelihood of central vision loss and advanced disease.']","Genetic predisposition plays a major role in AMD by increasing susceptibility and worsening disease course—especially via inherited polymorphisms (notably in complement and other retinal genes) that drive complement dysregulation, impaired autophagy, and retinal parainflammation, thereby raising the risk of central vision loss and progression to advanced AMD.",Genetic predisposition increases AMD likelihood through inherited risk factors.,0.7301946891007125,0.9443975534026144,0.9207787564028502,0.625,0.9999999999,1.0
What is a common anti-VEGF drug used for wet AMD?,"['Ranibizumab (Lucentis) is a commonly used anti‑VEGF drug for treating wet age-related macular degeneration; aflibercept (Eylea) and bevacizumab (Avastin, often used off‑label) are also widely used alternatives.']","A common anti‑VEGF drug used for wet age‑related macular degeneration is ranibizumab (Lucentis), with aflibercept (Eylea) and bevacizumab (Avastin, often used off‑label) also widely used alternatives.",A common anti-VEGF drug for wet AMD is ranibizumab.,0.4476091337701699,0.9547443757017179,0.9332936779378226,1.0,0.9999999999,1.0
What is the purpose of dietary antioxidants in AMD?,"['The purpose of dietary antioxidants in AMD is to protect the retina and retinal pigment epithelium from oxidative and photochemical damage, thereby reducing cell loss, lowering risk, and helping to slow or prevent the development and progression of AMD while supporting overall ocular health and clinical management.']","The purpose of dietary antioxidants in AMD is to protect the retina and retinal pigment epithelium from oxidative and photochemical damage, thereby reducing cell loss, lowering risk, and helping to slow or prevent the development and progression of AMD while supporting overall ocular health and clinical management.",Dietary antioxidants protect retinal cells from oxidative damage in AMD.,0.8371416101180247,0.9646783462712393,0.9485664404720983,1.0,0.9999999999,1.0
What is the effect of AMD on light adaptation?,"['Age-related macular degeneration disrupts adaptation to changes in illumination, most notably causing impaired dark adaptation — delayed and reduced ability to regain sensitivity in low light — which leads to night-vision difficulties and contributes to problems with reading, driving and other tasks that depend on rapid adjustment to changing light levels.']","AMD impairs adaptation to changes in illumination—especially dark adaptation—causing delayed and reduced recovery of low-light sensitivity, leading to night-vision difficulties and problems with tasks (e.g., reading, driving) that require rapid adjustment to changing light levels.",AMD slows light adaptation by impairing macular function.,0.3721709833418615,0.942808205812339,0.8886839333674459,1.0,0.9999999999,1.0
What is the role of the retinal pigment epithelium in vision?,"['The retinal pigment epithelium (RPE) is a pigmented cell layer in the outer retina that is essential for normal vision: it nourishes and supports photoreceptors by transporting nutrients (including glucose), clearing waste and shed photoreceptor material, and maintaining retinal function and structure. Loss, detachment, or dysfunction of RPE leads to photoreceptor degeneration and contributes to macular diseases such as age-related macular degeneration and geographic atrophy, causing blurred vision and vision loss. Preserving or restoring healthy RPE—for example with cell therapies or subretinal transplantation of functioning RPE—can help protect or improve vision.']","The retinal pigment epithelium (RPE) is a pigmented outer-retina cell layer that supports and nourishes photoreceptors by transporting nutrients (including glucose), clearing waste and shed photoreceptor material, and maintaining retinal structure and function, with RPE loss or dysfunction leading to photoreceptor degeneration and vision loss as seen in AMD and geographic atrophy.",The retinal pigment epithelium supports photoreceptors and recycles visual pigments.,0.37924988523176656,0.9583450758826663,0.9169995409270661,1.0,0.9999999999,0.0
What is a typical sign of early wet AMD?,['A typical early sign is the presence of drusen—small yellowish deposits beneath the retina visible on fundus exam or OCT.'],A typical sign of early wet AMD is the presence of drusen—small yellowish deposits beneath the retina visible on fundus exam or OCT.,A typical sign of early wet AMD is sudden vision distortion.,0.22727036973466372,0.9999999999999994,0.9090814789386549,0.75,0.0,0.0
What is the benefit of prism lenses for AMD patients?,"['Prism lenses for people with AMD can improve visual acuity and help compensate for central vision loss, reducing difficulty reading and the problem of not seeing what they are looking directly at and thereby improving everyday visual functioning.']","Prism lenses for people with AMD can improve visual acuity and compensate for central vision loss, reducing difficulty reading and helping them see objects they look directly at, thereby improving everyday visual functioning.",Prism lenses shift images to usable vision areas for AMD patients.,0.39879644726120655,0.9341345026679844,0.9285207040207193,1.0,0.9999999999,1.0
What is the main lifestyle risk factor for AMD?,"['Cigarette smoking is the single most important lifestyle risk factor for age-related macular degeneration, substantially increasing both the risk of developing AMD and its progression; quitting smoking and adopting healthier habits such as a balanced diet, maintaining a healthy weight, and regular physical activity can help lower risk.']","Cigarette smoking is the single most important lifestyle risk factor for age-related macular degeneration, substantially increasing both the risk of developing AMD and its progression.",The main lifestyle risk factor for AMD is smoking.,0.9848895460091037,0.9439573771177615,0.9395581840364149,1.0,0.9999999999,1.0
What is the purpose of fundus autofluorescence in AMD?,"['Fundus autofluorescence in AMD is used to detect and map retinal pigment epithelium dysfunction and atrophy, identify and quantify geographic atrophy (including early non‑foveal lesions) and reticular pseudodrusen, monitor lesion progression and size over time, and provide prognostic information to guide monitoring and therapeutic decisions aimed at protecting central vision.']","Fundus autofluorescence in AMD is used to detect and map retinal pigment epithelium dysfunction and atrophy, identify and quantify geographic atrophy (including early non‑foveal lesions) and reticular pseudodrusen, monitor lesion progression and size over time, and provide prognostic information to guide monitoring and therapeutic decisions to protect central vision.",Fundus autofluorescence assesses retinal pigment health in AMD.,0.9190305936624704,0.978324517157486,0.9488496473771546,1.0,0.9999999999,0.0
What is the effect of AMD on central visual acuity?,"['Age-related macular degeneration damages the macula and reduces central visual acuity, producing blurred or lost central vision that is often progressive and can become permanent, markedly impairing activities like reading and driving and leading to greater dependence and emotional distress; in advanced forms it may cause irreversible central vision loss or blindness.']","Age-related macular degeneration damages the macula and progressively reduces or destroys central visual acuity, causing blurred or lost central vision that can become permanent and markedly impair activities like reading and driving.","AMD reduces central visual acuity, blurring detailed vision.",0.5914050233213768,0.8620443246931496,0.865626676075163,1.0,0.9999999999,1.0
What is the role of fish oil in AMD management?,"['Fish oil is used as a therapeutic option in managing age-related macular degeneration, with anti-inflammatory and systemic vascular benefits that may help reduce disease severity and progression; it has also been applied for related ocular conditions like dry eye, so it is generally considered a supportive adjunct to other AMD treatments.']","Fish oil is used as a supportive adjunct in AMD management for its anti-inflammatory and systemic vascular benefits that may help reduce disease severity and progression, though it is not a standalone treatment.",Fish oil provides omega-3s to reduce retinal inflammation in AMD.,0.8087897219204516,0.9765193277443448,0.9274665799894992,1.0,0.9999999999,0.0
What is a common adaptation for AMD patients with technology?,"['Patients with age-related macular degeneration commonly turn to assistive technologies—such as optical or electronic magnifiers, screen‑magnification and high‑contrast/large‑text settings, text‑to‑speech and screen‑reader apps, and other low‑vision devices—to compensate for central vision loss and help with reading, daily activities, mobility and independence, thereby improving quality of life.']","A common adaptation for AMD patients is using assistive technologies—such as optical or electronic magnifiers, screen‑magnification and high‑contrast/large‑text settings, text‑to‑speech/screen‑reader apps, and other low‑vision devices—to compensate for central vision loss and improve reading, daily activities, mobility, and independence.",A common adaptation is using text-to-speech software.,0.2047108665008449,0.9322479760263124,0.8188434660033796,1.0,0.9999999999,1.0
What is the purpose of laser photocoagulation in AMD?,"['Laser photocoagulation is used mainly for the neovascular (wet) form of AMD to seal or destroy well‑defined choroidal neovascular membranes and leaky blood vessels, reducing exudation and helping to stabilize or improve central vision in selected cases; it can also be applied to related retinal conditions such as polypoidal choroidal vasculopathy or chronic serous retinal disorders and is sometimes combined with anti‑VEGF treatments, though it carries risks of adverse effects and may worsen neovascular or retinal pigment epithelium damage in some patients.']","The purpose of laser photocoagulation in AMD—primarily the neovascular (wet) form—is to seal or destroy well‑defined choroidal neovascular membranes and leaky blood vessels to reduce exudation and help stabilize or improve central vision in selected cases, sometimes adjunctively with anti‑VEGF therapy, although it carries risks of worsening neovascular or RPE damage.",Laser photocoagulation seals leaking blood vessels in wet AMD.,0.6825298705338847,,0.9301194821355391,1.0,0.9999999999,1.0
What is the effect of AMD on shape recognition?,"['Age-related macular degeneration (AMD) notably impairs shape recognition: as central vision and visual acuity decline—especially in advanced stages—people have more trouble recognizing faces, objects and colors and show poorer spatial perception and motion sensitivity. This progressive central-vision loss leads to difficulties with reading, driving, and everyday recognition tasks, though interventions such as prosthetic central-vision devices and perceptual training can partially improve face and object recognition in some cases.']","AMD progressively impairs shape recognition—especially in advanced stages—because central-vision and visual acuity loss reduce ability to recognize faces, objects, colors, spatial relations and motion, though interventions like prosthetic central-vision devices and perceptual training can partially restore recognition in some cases.",AMD impairs shape recognition by distorting central vision.,0.3641453422512544,0.9592669167994994,0.9111268235504723,1.0,0.9999999999,1.0
What is the role of weight management in AMD?,['Maintaining a healthy weight or losing excess weight can help prevent ocular complications and thus supports overall management of age-related macular degeneration as part of broader strategies to protect vision.'],Maintaining a healthy weight or losing excess weight may help prevent ocular complications and support overall management of age-related macular degeneration as part of broader vision-protective strategies.,"Weight management reduces inflammation, aiding AMD prevention.",0.9674086836037861,0.8860384698036862,0.8696347344151443,1.0,0.0,0.0
What is a frequent retinal finding in advanced AMD?,"['Outer retinal tubulation is a common retinal finding in advanced age-related macular degeneration, often occurring alongside retinal pigment epithelium degeneration, drusen, choroidal changes, and the atrophic or neovascular processes that lead to vision loss.']","A frequent retinal finding in advanced age-related macular degeneration is outer retinal tubulation, commonly occurring alongside retinal pigment epithelium degeneration, drusen, choroidal changes, and atrophic or neovascular processes.",A frequent retinal finding in advanced AMD is photoreceptor loss.,0.2216364655671858,0.9471402188676336,0.8865458622687432,1.0,0.0,0.0
What is the benefit of audio descriptions for AMD patients?,"['Because AMD often causes central vision loss, blurred vision and difficulty reading, driving and recognizing scenes—leading to reduced independence, mobility problems and emotional distress—audio descriptions that narrate visual information let patients follow films, events and visual environments more easily, helping them understand content, maintain independence, reduce frustration and improve overall participation and quality of life.']","Audio descriptions help AMD patients follow visual content by narrating scenes, which improves understanding, maintains independence, reduces frustration, and enhances participation and quality of life.","Audio descriptions narrate visuals, aiding AMD patients with media access.",0.4076117557583375,0.9849107697807952,0.9637803563666835,1.0,0.9999999999,0.0
What is the main challenge of dry AMD treatment?,"['The main challenge is that treating dry AMD often requires frequent, ongoing intraocular interventions—which places a heavy burden on patients and clinicians—and must contend with a progressive disease characterized by retinal pigment epithelium dysfunction, geographic atrophy, and photoreceptor loss.']","The main challenge of dry AMD treatment is providing effective, often frequent, ongoing intraocular interventions to manage a progressive disease marked by retinal pigment epithelium dysfunction, geographic atrophy, and photoreceptor loss, which imposes substantial burden on patients and clinicians.",The main challenge of dry AMD treatment is the lack of options to reverse damage.,0.22406615375111488,0.9879107716871461,0.8962646150044595,1.0,0.0,0.0
What is the role of cardiovascular health in AMD?,"['Cardiovascular health is closely linked to AMD: poor vascular health and cardiovascular disease are associated with higher risk and with the retinal vascular changes seen in AMD, while ideal cardiovascular health is associated with lower odds of eye disease. Shared contributors—aging, high blood pressure, inflammation, abnormal lipids and other systemic vascular/metabolic factors—appear to drive both heart and retinal damage, so managing cardiovascular risk factors may help reduce the risk or slow progression of AMD.']","Cardiovascular health plays a key role in AMD: poor vascular health and cardiovascular disease—through shared factors like aging, hypertension, inflammation, and abnormal lipids—are associated with higher AMD risk and retinal vascular changes, while maintaining ideal cardiovascular health may lower the risk or slow progression.","Cardiovascular health supports retinal blood flow, impacting AMD risk.",0.5342366110976084,0.9526290297526492,0.9369900511890915,1.0,0.9999999999,1.0
What is a common symptom of geographic atrophy?,"['A common symptom of geographic atrophy is progressive loss of central vision, causing difficulty seeing fine details and trouble seeing what you are directly looking at.']","A common symptom of geographic atrophy is progressive loss of central vision, leading to difficulty seeing fine details and trouble seeing what you are directly looking at.",A common symptom of geographic atrophy is fixed blind spots in central vision.,0.23932343324335015,,0.9572937329734006,1.0,0.0,0.0
What is the purpose of visual acuity testing in AMD?,"['Visual acuity testing is used in AMD to quantify and monitor central vision loss and overall visual impairment, detect new or worsening disease such as neovascular (wet) changes, guide diagnosis and treatment decisions, and track response to therapy. Regular acuity checks provide a simple, objective measure of functional vision important for activities like reading and driving, and explaining their purpose to patients helps ensure acceptance and adherence to monitoring.']","Visual acuity testing in AMD quantifies and monitors central vision loss to detect new or worsening disease (including neovascular changes), guide diagnosis and treatment decisions, track response to therapy, and provide an objective measure of functional vision important for daily activities.",Visual acuity testing measures central vision loss in AMD.,0.5113059745265649,0.9702906252152438,0.9543148071971685,1.0,0.9999999999,1.0
What is the effect of AMD on motion detection?,"['Age-related macular degeneration (AMD) impairs motion detection: people with AMD commonly experience altered motion sensitivity and motion-related artifacts, which degrade spatial perception and mobility and can worsen driving performance and safety, producing observation errors, lane-keeping and gap-selection problems, and difficulties at traffic-light-controlled intersections.']","AMD impairs motion detection, causing altered motion sensitivity and motion-related artifacts that degrade spatial perception and mobility and can worsen driving performance and safety (e.g., observation errors, lane-keeping and gap-selection problems, and difficulties at traffic-light-controlled intersections).",AMD can impair motion detection in the central field.,0.3519645783340121,,0.9078583133360485,1.0,0.9999999999,0.0
What is the role of siblings in AMD risk assessment?,"['A sibling with AMD raises your likelihood of developing the disease because family members share inherited susceptibility and common lifestyle or health risk factors; knowing sibling status helps clinicians judge whether earlier or more frequent screening, attention to modifiable risks (like smoking and blood pressure), and consideration of genetic counseling or testing are warranted, though it does not guarantee disease.']","A sibling with AMD increases an individual's risk because shared genetics and lifestyle factors raise susceptibility, so clinicians may recommend earlier/more frequent screening, management of modifiable risks (e.g., smoking, blood pressure), and consideration of genetic counseling or testing, though it does not guarantee disease.","Siblings indicate genetic risk, aiding AMD risk assessment.",0.8292579021006588,0.0,0.9170316084026348,1.0,0.9999999999,1.0
What is a typical feature of wet AMD on OCT?,"['On OCT, wet AMD typically shows macular fluid—subretinal and intraretinal fluid from choroidal neovascularization—often with retinal thickening and disruption of the retinal layers.']",A typical OCT feature of wet AMD is macular fluid—subretinal and intraretinal fluid from choroidal neovascularization—often with retinal thickening and disruption of the retinal layers.,A typical feature of wet AMD on OCT is fluid pockets under the retina.,0.44995938848083206,0.9745420855812069,0.9426946967804709,1.0,0.9999999999,1.0
What is the benefit of smartphone apps for AMD patients?,"['Smartphone apps that enable retinal imaging and automated analysis give patients and clinicians a convenient way to detect and monitor AMD sooner and more frequently, helping identify new disease activity that prompts timely treatment, preserve central vision, reduce vision loss and dependence, and expand access to testing while potentially cutting the need for some clinic visits.']","Smartphone apps that enable retinal imaging and automated analysis allow earlier and more frequent detection and monitoring of AMD, prompting timely treatment that helps preserve central vision, reduce vision loss and dependence, expand access to testing, and potentially decrease some clinic visits.",Smartphone apps offer magnification and audio support for AMD patients.,0.22065736276096037,0.9254185255998902,0.8826294510438415,1.0,0.0,0.0
What is the effect of AMD on brightness perception?,"['Age-related macular degeneration impairs brightness perception by damaging central vision and reducing light perception, producing blurred vision and altered sensitivity to motion and contrast that interfere with reading, driving, and everyday tasks; regions with choroidal neovascularization often show distinct changes in apparent brightness, and advanced disease can markedly diminish perceived light, though interventions such as retinal prostheses, optogenetic approaches and certain transplants or therapies may partially restore light or brightness perception.']","Age-related macular degeneration reduces central light and brightness perception—producing blurred vision, altered contrast and motion sensitivity, and localized brightness changes (especially with choroidal neovascularization)—though some interventions (retinal prostheses, optogenetics, transplants/therapies) may partially restore perceived light.",AMD can dull brightness perception by damaging macular cells.,0.3412746946065827,0.8484638289752509,0.8650987784263309,1.0,0.9999999999,1.0
What is the purpose of orientation training in AMD?,"['Orientation training for people with age-related macular degeneration helps them adapt to central vision loss by teaching ways to use remaining vision and improve spatial orientation and mobility, boosting confidence and task performance (for example reading and navigation), speeding visual recognition, reducing dependency on others, and supporting participation in monitoring and rehabilitation to maintain safety and independence.']","Orientation training in AMD teaches people to use their remaining vision and spatial strategies to improve mobility, reading, visual recognition, confidence, independence, and participation in monitoring and rehabilitation to maintain safety and function.",Orientation training helps AMD patients adapt to vision loss for navigation.,0.44805503882617614,0.9572516900003446,0.9350772981618475,0.9,0.9999999999,1.0
What is the role of nuts in AMD prevention?,"['Evidence is mixed: nuts consumed as part of a diet rich in fruits, vegetables and fish are linked with absence of AMD and better cardiovascular health, which may help reduce AMD risk, but high intake of nuts—especially alongside greater meat consumption—has been associated with increased oxidative stress that can worsen eye disease. Overall, moderate nut intake within a balanced, plant-forward diet appears potentially protective, while excessive consumption in less healthy dietary contexts could be harmful.']","Moderate nut intake as part of a balanced, plant-forward diet rich in fruits, vegetables, and fish may be protective against AMD, whereas high nut consumption—especially alongside greater meat intake—has been linked to increased oxidative stress and could worsen eye disease, so evidence is mixed and context-dependent.",Nuts provide antioxidants and healthy fats for AMD prevention.,0.2285789130137645,0.0,0.914315652055058,1.0,0.9999999999,0.0
What is a common complication of advanced wet AMD?,"['A common complication of advanced wet age-related macular degeneration is choroidal neovascularization, which often leads to severe, sometimes irreversible central vision loss and can result in blindness.']","A common complication of advanced wet age-related macular degeneration is choroidal neovascularization, which often causes severe, sometimes irreversible central vision loss and can lead to blindness.",A common complication of advanced wet AMD is permanent scarring.,0.22347044549263378,0.9631069061306891,0.8938817819705351,1.0,0.0,0.0
What is the benefit of polarized lenses for AMD patients?,"['For patients with age-related macular degeneration, polarized lenses can improve visual acuity and comfort by reducing glare and eye fatigue and by blocking harmful UV and excessive blue‑light exposure, which may help limit photochemical/oxidative damage and thereby support better reading, mobility, and overall functional vision.']","Polarized lenses can benefit patients with age-related macular degeneration by reducing glare and eye fatigue and blocking UV/excessive blue light, which may limit photochemical/oxidative damage and thereby improve visual comfort, reading, mobility, and overall functional vision.","Polarized lenses reduce glare, enhancing vision for AMD patients.",0.5019314927554994,0.9214027628401958,0.9167189959295043,1.0,0.9999999999,1.0
What is the effect of AMD on texture perception?,"['Age-related macular degeneration impairs texture perception by degrading central and overall vision—causing central vision loss, blurred vision and reduced spatial perception—which lowers the ability to resolve fine details and textures and contributes to difficulties with reading, mobility and driving.']","Age-related macular degeneration impairs texture perception by degrading central and overall vision, causing central vision loss, blurring, and reduced spatial resolution that lowers the ability to resolve fine details and textures, contributing to difficulties with reading, mobility, and driving.",AMD impairs texture perception by blurring central vision details.,0.339400776508287,0.9088640846345507,0.8960646444946864,1.0,0.9999999999,1.0
What is the purpose of microperimetry in AMD?,"['Microperimetry is a psychophysical test used in AMD to map and quantify macular (foveal and parafoveal) retinal sensitivity and fixation, detect central visual field defects such as geographic atrophy or neovascular changes, and monitor functional change and disease progression. By linking structure and function, it helps assess visual impairment, evaluate treatment effects, and guide visual rehabilitation and monitoring.']","Microperimetry in AMD maps and quantifies macular (foveal and parafoveal) retinal sensitivity and fixation to detect central visual field defects (e.g., geographic atrophy or neovascular changes), monitor functional change and disease progression, link structure with function to assess visual impairment and treatment effects, and guide visual rehabilitation and monitoring.",Microperimetry maps retinal sensitivity to assess AMD progression.,0.4651421659596052,0.9760835087134544,0.9374007581161194,0.8888888888888888,0.9999999999,1.0
What is the role of alcohol in AMD risk?,"['Alcohol consumption has been implicated as a risk factor for age-related macular degeneration, with drinking linked to both early and late stages of the disease; heavier intake appears especially relevant, and alcohol use is also associated with other ocular conditions and can worsen visual outcomes and quality of life for people with AMD.']","Alcohol consumption, particularly heavier intake, is implicated as a modifiable risk factor for both early and late age-related macular degeneration and is associated with worse visual outcomes and quality of life in people with AMD.",Excessive alcohol may increase AMD risk by causing oxidative stress.,0.9743057669940718,,0.8972230679762873,1.0,0.9999999999,0.0
What is a typical adaptation for AMD patients in communication?,"['Because AMD commonly causes central vision loss and creates barriers to clinical interactions, a typical adaptation is emphasis on enhanced communication: clinicians use clearer verbal explanations, reassurance and tailored information to improve patients’ understanding and reduce anxiety, supported by specialist training for optometrists and digital referral platforms to strengthen trust and provider–patient coordination.']","A typical adaptation for AMD patients is enhanced communication—clinicians provide clearer verbal explanations, reassurance, and tailored information, supported by specialist optometrist training and digital referral platforms to improve understanding, reduce anxiety, and strengthen provider–patient coordination.",A typical adaptation is using audio messaging instead of text.,0.19920896342479635,0.9344848422674884,0.7968358536991854,1.0,0.0,0.0
What is the benefit of wearable magnifiers for AMD?,"['Wearable magnifiers can help people with AMD by preventing or compensating for central vision loss, improving reading and other near-visual tasks, enhancing independence and mobility, reducing reliance on others and frustration, and helping maintain better overall visual function.']","Wearable magnifiers can help people with AMD by compensating for central vision loss to improve reading and other near-visual tasks, enhance independence and mobility, reduce reliance on others and frustration, and maintain better overall visual function.",Wearable magnifiers provide hands-free vision support for AMD patients.,0.504608009055139,0.9564705695825874,0.9275229453114651,1.0,0.9999999999,0.0
What is the effect of AMD on visual scanning?,"['Age-related macular degeneration primarily damages central vision and causes blurred or missing detail at fixation, reduced motion sensitivity and poorer spatial perception, so people struggle to fixate and scan scenes efficiently; this leads to difficulty reading, impaired driving performance and safety (lane-keeping, gap selection, traffic-light detection), increased observation errors, reduced mobility and greater dependence on others.']","AMD impairs visual scanning by damaging central vision and reducing fixation stability, motion sensitivity, and spatial perception, causing people to struggle to fixate and efficiently scan scenes, which leads to increased observation errors and functional deficits (e.g., reading, driving, mobility).",AMD slows visual scanning by impairing central vision efficiency.,0.3261016569745248,0.972701213289629,0.9044066278980992,1.0,0.9999999999,1.0
What is the purpose of bionic eye research in AMD?,"['Bionic eye research for AMD aims to restore vision lost from macular damage—particularly central vision—by using implantable devices to recreate useful sight; this work seeks to improve reading, mobility, driving safety, independence and overall quality of life for people facing progressive, often irreversible central vision loss where current treatments are limited.']","Bionic eye research in AMD aims to restore useful central vision lost from macular damage by implanting devices that recreate sight to improve reading, mobility, driving safety, independence, and overall quality of life.",Bionic eye research aims to restore vision via artificial retinal stimulation in AMD.,0.509145178994933,0.9851984143879258,0.9456498710528383,1.0,0.9999999999,0.0
What is the role of hypertension in AMD progression?,"['Hypertension is a common comorbidity that both predisposes to and accelerates AMD, increasing the risk of neovascular (wet) disease and driving early progression. Elevated blood pressure promotes microvascular aging and impairs the choriocapillaris and RPE/Bruch membrane complex, can trigger retinal and choroidal vascular events that worsen retinal damage, and may influence response to anti‑VEGF therapy, so blood‑pressure management is an important consideration in AMD care.']","Hypertension is a common comorbidity that predisposes to and accelerates AMD by promoting microvascular aging and choriocapillaris/RPE–Bruch membrane dysfunction, increasing risk of neovascular (wet) conversion, worsening retinal/choroidal vascular injury, and potentially affecting anti‑VEGF response, so blood‑pressure management is an important aspect of AMD care.","Hypertension stresses retinal vessels, worsening AMD progression.",0.9803640456824045,0.9343541424579836,0.9214561827296182,1.0,0.9999999999,1.0
What is a common difficulty for AMD patients in public spaces?,"['People with age-related macular degeneration often have central and blurred vision loss that impairs spatial perception and mobility in public spaces, making it hard to navigate, read signs, spot hazards or faces, and drive safely, which increases dependence on others and causes frustration.']","A common difficulty for AMD patients in public spaces is impaired spatial perception and mobility due to central and blurred vision loss, making it hard to navigate, read signs, spot hazards or faces, and drive safely.",A common difficulty is reading signs due to central vision loss.,0.39178757440876466,0.9847417431714093,0.9004836309683921,1.0,0.9999999999,1.0
What is the benefit of high-visibility markers for AMD patients?,"['High-visibility markers make retinal changes easier to see, helping clinicians detect and monitor AMD earlier and more accurately, guide timely treatment decisions, and ultimately improve the effectiveness of interventions and patient outcomes.']","High-visibility markers make retinal changes easier to see, enabling earlier and more accurate detection and monitoring of AMD, guiding timely treatment decisions, and potentially improving intervention effectiveness and patient outcomes.",High-visibility markers improve object detection for AMD patients.,0.4009380806571237,0.9515364828588492,0.9370856559618281,1.0,0.0,1.0
What is the effect of AMD on visual focus?,"['Age-related macular degeneration damages the central retina (macula) and leads to progressive loss of central vision and an impaired ability to fixate on or clearly see what one is directly looking at. This commonly causes blurred or distorted central vision, difficulty reading, driving, recognizing faces and resolving fine detail, and can progress to severe or irreversible central vision loss with increased dependence and mobility challenges.']","Age-related macular degeneration impairs visual focus by damaging the macula, causing progressive loss of central vision that leads to blurred or distorted central vision and difficulty fixating on or clearly seeing what one is directly looking at.",AMD impairs visual focus by disrupting central macular function.,0.4385248551553399,0.8443669891057509,0.8969565634785025,1.0,0.9999999999,1.0
What is the purpose of home safety modifications in AMD?,"['Home safety modifications are intended to compensate for the central vision loss, blurred vision and impaired spatial perception and mobility caused by AMD, reducing accident and injury risk, preserving independence, and improving overall safety and daily functioning despite progressive visual impairment.']","Home safety modifications for AMD aim to compensate for central and blurred vision and impaired spatial perception and mobility to reduce accidents and injuries, preserve independence, and improve safety and daily functioning despite progressive visual impairment.",Home safety modifications reduce hazards for AMD patients with vision loss.,0.23783786116279224,0.9633133642788709,0.9513553776568345,1.0,0.9999999999,1.0
What is the role of sleep in AMD management?,"['Sleep is relevant to AMD management because the disease can disrupt sleep and, conversely, sleep disturbances and circadian misalignment can negatively affect ocular health and potentially influence AMD outcomes. Preserving sleep quality and circadian balance is therefore an important adjunct to care: interventions that improve sleep—such as melatonin supplementation, managing light exposure (timed light therapy or light masks), and using blue‑blocking strategies including lens choices—can help restore sleep and support visual health alongside standard treatments.']","Sleep plays a supportive role in AMD management because the disease can both disrupt sleep and be worsened by sleep disturbances and circadian misalignment, so preserving sleep quality and circadian balance—via interventions like melatonin, timed light therapy or masks, and blue‑blocking strategies—may help restore sleep and support visual health alongside standard AMD treatments.","Adequate sleep supports retinal repair, aiding AMD management.",0.39543139027116814,0.9726382359340778,0.9157491631427347,1.0,0.9999999999,0.0
What is a typical retinal change in early dry AMD?,"['A hallmark of early dry AMD is drusen—small yellowish deposits beneath the retina—often accompanied by thinning of the outer retina and loss of photoreceptor outer segments with early retinal pigment epithelium dysfunction, which can cause subtle visual changes such as impaired dark adaptation.']","A typical retinal change in early dry AMD is the formation of drusen beneath the retina, often accompanied by thinning of the outer retina, loss of photoreceptor outer segments, and early retinal pigment epithelium dysfunction leading to subtle visual changes such as impaired dark adaptation.",A typical retinal change in early dry AMD is small drusen accumulation.,0.4490414810566602,0.9903729541507711,0.9390230670837838,1.0,0.9999999999,1.0
What is the benefit of anti-glare screens for AMD patients?,"['Anti‑glare screens cut down screen glare and short‑wavelength (blue) light that worsen glare-related visual disturbances in people with AMD, so they can reduce visual discomfort and glare disability and make tasks like reading or using devices easier, even though they do not treat the underlying disease.']","Anti‑glare screens reduce screen glare and short‑wavelength (blue) light that exacerbate glare-related visual disturbances in people with AMD, thereby decreasing visual discomfort and glare disability and making tasks like reading or using devices easier, although they do not treat the underlying disease.","Anti-glare screens reduce strain, improving visibility for AMD patients.",0.23459121098411542,0.982634029629795,0.938469113539852,1.0,0.9999999999,1.0
What is the effect of AMD on visual alignment?,"['Age-related macular degeneration damages the macula and central vision, undermining precise fixation and spatial alignment; this leads to blurred or lost central sight, poor spatial perception and motion sensitivity, difficulty reading and driving, and increased observation, lane‑keeping and other spatial‑judgment errors that reduce mobility and safety.']","Age-related macular degeneration impairs the macula and central vision, causing loss of precise fixation and spatial alignment that produces blurred or missing central sight and poor spatial perception, increasing errors in tasks requiring visual alignment such as reading, driving, lane‑keeping, and other mobility-related judgments.",AMD disrupts visual alignment by distorting central perception.,0.8340863110961656,0.8562479690478054,0.8363452443846624,1.0,0.9999999999,1.0
What is the purpose of retinal sensitivity testing in AMD?,"['Retinal sensitivity testing—often performed with microperimetry or tablet-based tools—maps localized light-detection across the macula to quantify functional loss in AMD, revealing reduced sensitivity in early, neovascular, and geographic-atrophy stages that correlates with structural damage (photoreceptor/RPE disruption, subretinal fluid, atrophy, fibrosis). It aids diagnosis of functional impairment and, importantly, tracks disease progression and treatment response, helping guide clinical management.']","Retinal sensitivity testing maps localized macular light-detection (e.g., via microperimetry) to quantify functional loss in AMD—detecting reduced sensitivity across early, neovascular, and geographic atrophy stages that correlates with structural photoreceptor/RPE damage, guides diagnosis, tracks progression, and monitors treatment response.",Retinal sensitivity testing evaluates macular function in AMD.,0.35027471640195884,0.995071855807327,0.9395604040693738,1.0,0.9999999999,1.0
What is the role of stress in AMD progression?,"['Cellular and ER stress play central roles in driving AMD progression by disrupting retinal pigment epithelium function and viability: stress promotes RPE dedifferentiation and increased VEGF secretion, and induces ER stress with accumulation of misfolded proteins that triggers unfolded protein responses, oxidative stress, inflammation, autophagy and ultimately apoptosis and cell loss. Environmental and systemic factors (e.g., blue light, compromised proteostasis, high‑glycemic diets and other lifestyle diseases) amplify this stress burden, while protective mechanisms such as autophagy, molecular chaperones and intact intercellular communication can mitigate damage; when protection fails, stress-driven pathways accelerate retinal degeneration and disease progression.']","Cellular and ER stress drive AMD progression by impairing RPE function and viability—promoting dedifferentiation, VEGF overproduction, misfolded protein accumulation and unfolded protein responses that trigger oxidative stress, inflammation, autophagy dysfunction and apoptosis—while environmental/systemic factors (e.g., blue light, poor proteostasis, high‑glycemic diets) amplify these effects and overwhelmed protective mechanisms accelerate retinal degeneration.",Chronic stress may worsen AMD by increasing inflammation.,0.21606570903793182,0.8665872047893117,0.8642628361517273,0.9375,0.9999999999,1.0
What is a common travel challenge for AMD patients?,"['A common travel challenge for AMD patients is difficulty traveling independently: central vision loss and poor spatial perception impair mobility, obstacle detection, route-finding and driving performance, reducing driving safety and increasing reliance on others, with geographic atrophy and neovascular disease worsening the travel burden, though electronic travel aids can help with obstacle detection and route guidance.']","A common travel challenge for AMD patients is reduced independence due to central vision loss and impaired spatial perception that compromise mobility, obstacle detection, route-finding and driving safety—particularly in geographic atrophy and neovascular disease—often increasing reliance on others (though electronic travel aids can help).",A common travel challenge is difficulty seeing directional signs.,0.21441954527235865,0.9718782196631746,0.8576781810894346,0.8666666666666667,0.9999999999,0.0
What is the benefit of contrast-enhancing filters for AMD?,"['Contrast-enhancing filters can boost contrast sensitivity and chromatic contrast for people with AMD, improving visual performance and making everyday tasks such as reading, face recognition and driving easier, partially compensating for central vision loss and reducing functional dependence.']","Contrast-enhancing filters can improve contrast sensitivity and chromatic contrast in people with AMD, thereby enhancing visual performance for tasks like reading, face recognition, and driving, partially compensating for central vision loss and reducing functional dependence.","Contrast-enhancing filters sharpen images, aiding AMD patients’ vision.",0.9333309308953206,0.9765190108974139,0.9333237235812823,1.0,0.9999999999,0.0
What is the effect of AMD on visual continuity?,"['Age-related macular degeneration breaks up visual continuity by damaging central vision, producing blurring, blind spots and loss of detail that make scenes appear fragmented or unreliable. This progressive central loss and distorted perception interferes with reading, recognizing faces, driving and tracking motion, increases observation and lane-keeping errors, and often leads to greater dependence and reduced ability to perform everyday tasks.']","Age-related macular degeneration disrupts visual continuity by damaging central vision, causing blurring, blind spots and distortion that fragment scenes and impair tasks like reading, face recognition, driving and motion tracking.",AMD disrupts visual continuity with central blind spots.,0.5619144240246646,0.8541619027141084,0.863042311483274,1.0,0.9999999999,1.0
What is the purpose of peer counseling in AMD?,"['In age-related macular degeneration, peer counseling helps people cope with progressive central vision loss and its practical and emotional consequences—such as difficulty reading, driving, reduced mobility, dependence on others, frustration, and emotional distress—by providing emotional support, shared experience, practical coping strategies, and clearer understanding of monitoring and treatment, all to improve adaptation, acceptance, and quality of life.']","The purpose of peer counseling in age-related macular degeneration is to help people cope with progressive central vision loss and its practical and emotional consequences—such as difficulty reading, driving, reduced mobility, dependence, frustration, and distress—by providing emotional support, shared experience, practical coping strategies, and clearer understanding of monitoring and treatment to improve adaptation, acceptance, and quality of life.",Peer counseling offers emotional support and coping tips for AMD patients.,0.4919352186207132,0.9263000916466334,0.8768317835737619,1.0,0.9999999999,1.0
What is the role of blue light in AMD risk?,"['Exposure to blue light increases the risk and progression of age-related macular degeneration by causing photochemical damage to the retina and retinal pigment epithelium, promoting oxidative stress, inflammation, mitochondrial and ER dysfunction, lipofuscin buildup, and cell death. These effects impair retinal structure and function, reduce RPE viability and phagocytic capacity, aggravate dry AMD, and contribute to central vision loss.']","Exposure to blue light increases AMD risk and progression by causing photochemical retinal and RPE damage that promotes oxidative stress, inflammation, mitochondrial and ER dysfunction, lipofuscin accumulation, reduced RPE viability and phagocytosis, and ultimately RPE/photoreceptor cell death leading to impaired retinal structure, function, and central vision loss.","Blue light damages retinal cells, increasing AMD risk.",0.4176091837446275,0.9541272365000774,0.92043673497851,1.0,0.9999999999,1.0
What is a typical emotional impact of late AMD?,"['Late AMD commonly causes significant emotional distress — increased anxiety, depression and reduced emotional well‑being — driven by central vision loss, functional limitations and loss of independence; low‑vision rehabilitation and supportive measures such as magnifying aids and reading training can help improve emotional status.']","A typical emotional impact of late AMD is significant distress—manifesting as increased anxiety, depression, and reduced emotional well‑being—driven by central vision loss, functional limitations, and loss of independence, which may improve with low‑vision rehabilitation and supportive measures.",A typical emotional impact of late AMD is grief over vision loss.,0.23985873660398246,0.9872678048234461,0.9594187201296445,1.0,0.9999999999,0.0
What is the benefit of portable lighting for AMD patients?,"['Portable lighting improves visibility for people with age-related macular degeneration by reducing the problems caused by poor or variable lighting, making it easier to see text and details, aiding reading and mobility, increasing independence and safety, and reducing frustration with everyday tasks.']","Portable lighting helps people with age-related macular degeneration by improving visibility—reducing issues from poor or variable lighting—to make reading and mobility easier, increase independence and safety, and lessen frustration with everyday tasks.",Portable lighting improves visibility for AMD patients in dim settings.,0.37732879518224627,0.9101504535661015,0.9092624881650879,1.0,0.9999999999,1.0
What is the effect of AMD on visual tracking?,"['Age-related macular degeneration impairs central vision and motion sensitivity, causing blurred and progressive visual loss that reduces spatial perception and the ability to follow moving targets. As a result, people with AMD show poorer visual tracking, more observation and lane‑keeping errors, impaired gap selection and traffic‑signal responses, and overall worse driving performance and safety, leading to greater difficulty with everyday tasks that require dynamic visual tracking and increased dependency.']","AMD impairs visual tracking by reducing central vision and motion sensitivity, leading to poorer tracking performance, increased observation and lane-keeping errors, and greater difficulty following moving targets.",AMD impairs visual tracking by reducing central vision accuracy.,0.429396131985048,0.9828546647225481,0.9675845279401919,1.0,0.9999999999,1.0
What is the purpose of retinal gene therapy in AMD?,"['Retinal gene therapy for AMD is intended to deliver therapeutic genes directly to the retina to address underlying disease processes—especially neovascular complications—in order to preserve or improve central vision and overall visual function, extend long-term vision outcomes and mobility, and reduce the need for frequent treatments by providing sustained, localized therapeutic effects, though delivery and immune/safety challenges are under active study.']","Retinal gene therapy for AMD aims to deliver therapeutic genes directly to the retina to treat underlying disease processes—particularly neovascular complications—to preserve or improve central vision and visual function, extend long-term vision outcomes and mobility, and reduce the need for frequent treatments by providing sustained, localized therapeutic effects, while addressing delivery and immune/safety challenges.",Retinal gene therapy aims to correct genetic defects in AMD.,0.23558194015953055,0.9849701224133111,0.9423277606381222,0.7777777777777778,0.0,0.0
What is the role of aging in AMD onset?,"['Aging is a central driver of AMD onset: cumulative age-related changes in the retina and retinal pigment epithelium — including cellular senescence, mitochondrial decline, impaired autophagy and proteostasis, increased oxidative stress and inflammation, complement activation, lipid accumulation, and loss of vascular and barrier integrity — promote drusen formation and other pathogenic processes that initiate and accelerate macular degeneration, increasing susceptibility and driving disease development.']","Aging is the central driver of AMD onset, as cumulative age-related changes in the retina and RPE—such as cellular senescence, mitochondrial decline, impaired autophagy/proteostasis, increased oxidative stress and inflammation, complement activation, lipid accumulation, and loss of vascular/barrier integrity—promote drusen formation and other pathogenic processes that increase susceptibility and accelerate macular degeneration.","Aging triggers retinal degeneration, leading to AMD onset.",0.31941895836211975,0.9194068320627139,0.9247346569778907,1.0,0.9999999999,1.0
What is a common leisure activity challenge for AMD patients?,"['A common leisure activity challenge for people with age-related macular degeneration is reading, because central vision loss and blurred or distorted sight make it hard to see fine print and details, which also hampers hobbies that require precise vision (and can affect driving), often causing frustration and greater dependence on others.']","A common leisure activity challenge for people with age-related macular degeneration is reading, because central vision loss and blurred or distorted sight make it hard to see fine print and details, which also impairs hobbies needing precise vision and can increase frustration and dependence on others.",A common challenge is difficulty watching TV due to central vision loss.,0.8473225314759805,0.9304625024750518,0.8892901259039218,1.0,0.0,0.0
What is the benefit of bold-line paper for AMD patients?,"['Bold-line paper makes text lines and writing guides easier to see and follow for people with central vision loss and reading difficulty from macular degeneration, which can reduce frustration, support greater independence and confidence in daily tasks, and make it easier to complete paper-based assessments or screening tools used for monitoring and education.']","Bold-line paper helps people with central vision loss from macular degeneration by making text lines and writing guides easier to see and follow, which can reduce frustration and support greater independence, confidence, and completion of paper-based assessments or screening tools.","Bold-line paper enhances visibility, aiding AMD patients with writing.",0.5008670620759145,0.9120775325112166,0.9125591573945669,1.0,0.9999999999,0.0
What is the effect of AMD on visual perception speed?,"['Age-related macular degeneration slows visual perception and processing, mainly by degrading central vision and motion sensitivity. This slower processing leads to delayed detection, more observation and driving errors, difficulty reading and reduced spatial mobility. Emerging prosthetic and restorative therapies can partly improve processing speed, but central vision loss from AMD remains a primary cause of slowed visual perception.']","Age-related macular degeneration slows visual perception and processing—primarily by degrading central vision and motion sensitivity—leading to delayed detection, more observation and driving errors, difficulty reading, and reduced spatial mobility, with prosthetic/restorative therapies offering only partial improvements.",AMD slows visual perception speed by impairing central processing.,0.514606963771526,0.8974523927058368,0.8584278550861039,1.0,0.9999999999,1.0
What is the primary role of the macula in the eye?,['The macula is the small central area of the retina that provides high-resolution central and color vision—enabling tasks like reading and recognizing faces—thanks to a dense concentration of cone photoreceptors and protective pigments such as lutein and zeaxanthin.'],The macula’s primary role is to provide high-resolution central and color vision—enabling detailed tasks like reading and face recognition—through a dense concentration of cone photoreceptors and protective pigments (lutein and zeaxanthin).,The macula provides sharp central vision for detailed tasks.,0.8744215053815908,0.9796664928253914,0.9262693904404292,1.0,0.9999999999,1.0
What is the first clinical sign of AMD?,"['The earliest clinical sign of age-related macular degeneration is a change in central vision—typically blurred or distorted vision (difficulty reading or seeing what you are looking at directly), reflecting early impairment of the macula that can progress to central vision loss.']","The first clinical sign of age-related macular degeneration is a change in central vision—typically blurred or distorted vision (difficulty reading or seeing things directly), reflecting early macular impairment.",The first clinical sign of AMD is small drusen deposits.,0.21714966880295947,0.9424721584324106,0.8685986752118379,1.0,0.0,0.0
What is the key symptom of advanced wet AMD?,"[""The hallmark of advanced wet AMD is severe central vision loss—difficulty seeing what you're directly looking at—which causes marked reduction in visual acuity, impaired contrast and object/face/color recognition, and can progress to irreversible blindness.""]","The key symptom of advanced wet AMD is severe central vision loss—difficulty seeing what you directly look at—leading to markedly reduced visual acuity and impaired recognition of faces, objects, contrast, and color, and potentially irreversible blindness.",The key symptom of advanced wet AMD is rapid central vision loss.,0.23951786696617122,0.9954295104674057,0.9580714678646849,1.0,0.0,0.0
What is the main objective of AREDS2 trials?,['The AREDS2 trials were designed to test whether specific nutritional supplement formulations could slow or prevent progression to advanced age-related macular degeneration and thereby reduce the risk of vision loss.'],The main objective of the AREDS2 trials was to determine whether specific nutritional supplement formulations could slow or prevent progression to advanced age-related macular degeneration and thereby reduce the risk of vision loss.,The main objective of AREDS2 trials is to refine supplements to slow AMD.,0.7356546579781167,0.9902754446152469,0.9425480116404947,1.0,0.9999999999,0.0
What is the standard diagnostic tool for AMD?,"['Optical coherence tomography (OCT) is the standard diagnostic tool for age-related macular degeneration, commonly used alongside color fundus imaging and OCT angiography to detect drusen, subretinal deposits, exudation and neovascular subtypes and to monitor disease progression.']","Optical coherence tomography (OCT) is the standard diagnostic tool for age-related macular degeneration, typically used alongside color fundus imaging and OCT angiography to detect drusen, subretinal deposits, exudation, neovascular subtypes, and monitor progression.",The standard diagnostic tool for AMD is optical coherence tomography (OCT).,0.39695837688002483,0.8713809803919244,0.9211668408534327,1.0,0.9999999999,1.0
What is the usual speed of dry AMD progression?,"['Dry (non‑neovascular) AMD most often progresses slowly and gradually over years, though the pace is highly variable between individuals; features such as large soft drusen, drusenoid pigment epithelial detachments, RPE dysfunction and complement‑driven inflammation or cellular stress tend to increase risk of faster progression to geographic atrophy and vision loss, and clinicians monitor change with imaging (fundus photography) and visual‑acuity testing while using supplements and other interventions to try to modify the course.']","Dry (non‑neovascular) AMD usually progresses slowly over years, though the pace varies widely between individuals and is accelerated by features like large soft drusen, drusenoid PEDs, RPE dysfunction, and complement‑driven inflammation.",Dry AMD usually progresses slowly over several years.,0.4929111569421404,0.9164777357257514,0.8807355368594707,1.0,0.9999999999,1.0
What is the function of the choroid in the retina?,"['The choroid is the vascular layer beneath the retina that supplies oxygen and nutrients to the outer retina and retinal pigment epithelium, supports photoreceptor function, and helps remove metabolic waste and dissipate heat; changes in the choroid influence the health of the RPE and outer retina and are central to conditions such as macular degeneration, choroidal neovascularization, central serous and pachychoroid disorders, diabetic choroidopathy, and myopia.']","The choroid is the vascular layer beneath the retina that supplies oxygen and nutrients to the outer retina and retinal pigment epithelium, supports photoreceptor function, removes metabolic waste, and helps dissipate heat, with its integrity critically influencing diseases such as macular degeneration and choroidal neovascularization.",The choroid delivers blood and nutrients to the retina.,0.4815228002385833,0.9754899522004895,0.9260912009543331,1.0,0.9999999999,1.0
What is the purpose of checking vision with an Amsler grid?,"['An Amsler grid is used to check for central visual distortion or missing areas (metamorphopsia and scotomas), helping detect early or worsening macular problems such as age-related macular degeneration so changes can be noticed promptly and appropriate diagnosis and treatment arranged to reduce the risk of further vision loss.']",An Amsler grid is used to detect central visual distortion or missing areas (metamorphopsia and scotomas) so early or worsening macular problems such as AMD can be noticed promptly and appropriate diagnosis and treatment arranged.,Checking vision with an Amsler grid detects early AMD-related distortions.,0.9845587140615204,0.9659579728928316,0.9382348562460817,1.0,0.9999999999,1.0
What is the primary goal of laser therapy in wet AMD?,"['The primary goal of laser therapy in wet AMD is to treat the condition by targeting abnormal choroidal neovascularization in the macula and retina to limit disease progression and preserve central visual function (reading, face recognition), thereby preventing further vision loss.']","The primary goal of laser therapy in wet AMD is to target and treat abnormal choroidal neovascularization in the macula and retina to limit disease progression and preserve central visual function (e.g., reading, face recognition) to prevent further vision loss.",The primary goal of laser therapy in wet AMD is to stop vessel leakage.,0.23375108711139697,0.9999999999999994,0.9350043484455879,1.0,0.0,0.0
What is the most affected population by AMD?,"['Age-related macular degeneration primarily affects older adults—the elderly—with risk rising markedly with advancing age, leading to central vision loss, blindness, difficulty reading and driving, and increased dependence.']","Older adults—especially the elderly—are the most affected population by age-related macular degeneration, with risk rising markedly with advancing age.",The most affected population by AMD is adults over 60.,0.8270546875899545,0.9344707857160336,0.9082187503598174,1.0,0.9999999999,1.0
What is the role of flavonoids in AMD prevention?,"['Dietary flavonoids have been associated with a reduced likelihood of developing age-related macular degeneration and appear to have potential therapeutic and preventive effects, suggesting that higher intake of total flavonoids may lower AMD risk and help mitigate disease progression.']","Observational evidence suggests dietary flavonoids are associated with a reduced likelihood of developing age-related macular degeneration and may have therapeutic and preventive effects, implying higher total flavonoid intake could lower AMD risk and slow progression, though randomized trials are needed to confirm causality and optimal doses.","Flavonoids act as antioxidants, protecting the retina in AMD prevention.",0.7298022147599237,0.0,0.9192088590396945,0.6666666666666666,0.0,0.0
What is a common visual difficulty in late dry AMD?,"['Late (dry) AMD commonly causes loss of central vision, producing poor central vision and a central blind spot that makes reading difficult and prevents patients from seeing what they are looking directly at, often leading to significant visual impairment or even blindness.']",A common visual difficulty in late (dry) AMD is loss of central vision with a central blind spot that makes reading difficult and prevents patients from seeing what they are directly looking at.,A common visual difficulty in late dry AMD is seeing blank spots.,0.23449512954001533,0.9928865114482243,0.9379805181600613,1.0,0.9999999999,1.0
What is the purpose of eccentric viewing in AMD?,"['Eccentric viewing trains people with age-related macular degeneration, who have lost central vision and cannot see what they look at directly, to use a healthier part of their peripheral retina by looking slightly away from a target; this compensatory strategy creates a new preferred viewing location and can improve reading speed and everyday visual function.']","Eccentric viewing trains people with AMD to use a healthier part of their peripheral retina by looking slightly away from targets, creating a new preferred viewing location that can improve reading speed and everyday visual function.",Eccentric viewing trains AMD patients to use peripheral vision effectively.,0.6126767058847602,0.9700500028349012,0.9507068235390408,1.0,0.9999999999,1.0
What is the top preventable risk factor for AMD?,"['The leading preventable risk factor for age-related macular degeneration is cigarette smoking; other modifiable contributors include poor diet, high cholesterol, air pollution and inflammatory conditions such as periodontal disease.']",The top preventable risk factor for age-related macular degeneration is cigarette smoking.,The top preventable risk factor for AMD is smoking.,0.9861205619993001,0.9572662208828401,0.9444822479972004,1.0,0.9999999999,1.0
What is the typical look of wet AMD on imaging?,"['On imaging, wet AMD characteristically shows choroidal neovascularization beneath the macula with leakage and often associated hemorrhage, subretinal and intraretinal fluid, and pigment epithelial detachments; OCT typically demonstrates subretinal hyperreflective material, intraretinal cysts, increased retinal thickness and disruption of the outer retina/RPE, fluorescein angiography reveals leaking classic or occult lesions, indocyanine green angiography can highlight polypoidal lesions and dilated choroidal vessels, and OCT angiography visualizes the abnormal neovascular network.']","Wet (neovascular) AMD typically shows choroidal neovascularization beneath the macula with leakage and often hemorrhage, associated subretinal hyperreflective material, intraretinal cysts and subretinal/intraretinal fluid with increased retinal thickness and outer retina/RPE disruption on OCT, leaking classic or occult lesions on fluorescein angiography, polypoidal or dilated choroidal vessels on indocyanine green angiography, and an abnormal neovascular network on OCT angiography.",Wet AMD typically shows fluid or blood under the retina on imaging.,0.22982649557057902,0.9347015264502169,0.9193059822823161,1.0,0.9999999999,1.0
What is the benefit of amber lenses for AMD patients?,['Amber (AMD) lenses can provide therapeutic benefit for people with age-related macular degeneration by improving visual acuity and helping manage the condition; by filtering blue light they may reduce photochemical and oxidative damage to the retina and can also lessen eye fatigue and improve sleep quality.'],"Amber lenses may benefit people with age-related macular degeneration by filtering blue light to reduce photochemical and oxidative retinal damage, improving visual acuity, lessening eye fatigue, and potentially improving sleep quality.","Amber lenses filter blue light, reducing glare for AMD patients.",0.41768784809884074,0.9357485440657637,0.9207513923953631,1.0,0.9999999999,1.0
What is the primary nutrient source for the macula?,"['The macula receives most of its nutrients and oxygen from the choroidal circulation—particularly the choriocapillaris—which nourishes the outer retina and photoreceptors, while the inner retinal layers are supported by the retinal (central retinal) circulation; vascular disturbances can reduce this nutrient flux, and factors like zinc and macular pigments (lutein/zeaxanthin) influence nutrient delivery and macular health.']",The primary nutrient and oxygen source for the macula is the choroidal circulation—especially the choriocapillaris—which nourishes the outer retina and photoreceptors.,The primary nutrient source for the macula is the choroid’s blood flow.,0.5353787384195436,0.9696282159519832,0.9415149536781746,1.0,0.9999999999,1.0
What is the effect of AMD on line straightness perception?,"['Age-related macular degeneration damages the macula and produces central vision loss, blurred vision and reduced spatial and motion perception; these deficits degrade fine-detail discrimination and cause visual distortions, so people with AMD commonly have impaired judgment of line straightness and may misperceive straight lines.']","Age-related macular degeneration impairs perception of line straightness, causing people to misperceive or judge straight lines as distorted due to central vision loss and reduced spatial and motion perception.",AMD can make straight lines appear bent or wavy.,0.7473123418420936,,0.8074311855501928,1.0,0.9999999999,1.0
What is the role of inherited traits in AMD?,"['Inherited and familial factors substantially influence AMD risk and course: genetic variants that alter immune complement activity, lipid handling, and retinal pigment epithelium function promote drusen and deposit formation and shape whether disease progresses to atrophic or neovascular forms. Some alleles increase susceptibility while others may be protective, and overlap with other inherited retinal disorders exists. Epigenetic changes and interactions with broader complex-disease traits and environmental exposures further modify individual risk, impacting diagnosis, prognosis, and targets for therapy.']","Inherited traits substantially influence AMD risk and clinical course by coding variants that alter complement-mediated immunity, lipid metabolism, and retinal pigment epithelium function—promoting drusen and deposit formation and modulating progression to atrophic or neovascular forms—while some alleles are protective, overlap with other retinal disorders exists, and epigenetic and gene–environment interactions further modify individual risk.",Inherited traits increase AMD risk through genetic susceptibility.,0.4273185725096564,0.9515417423956684,0.9092742900386254,1.0,0.9999999999,1.0
What is a widely used treatment for wet AMD?,"['A widely used treatment for wet age-related macular degeneration is intravitreal anti–vascular endothelial growth factor (anti‑VEGF) therapy—administered by eye injections—with agents such as ranibizumab, aflibercept, bevacizumab and newer drugs like faricimab, which target abnormal blood-vessel growth and can stabilize or improve vision.']","A widely used treatment for wet age-related macular degeneration is intravitreal anti–vascular endothelial growth factor (anti‑VEGF) therapy—administered by eye injections using agents such as ranibizumab, aflibercept, bevacizumab, and newer drugs like faricimab—to target abnormal blood-vessel growth and stabilize or improve vision.",A widely used treatment for wet AMD is anti-VEGF injections.,0.4808122020645419,0.9477991390285321,0.9232381823582798,1.0,0.9999999999,1.0
What is the purpose of zinc supplements in AMD?,['Zinc supplements are used in AMD to reduce the risk of developing or progressing to advanced disease; given as part of antioxidant formulations they can slow progression—especially in intermediate or early stages—and help preserve central vision and lower the chance of severe vision loss.'],"Zinc supplements in AMD are used as part of antioxidant formulations to slow progression—particularly in early or intermediate stages—help preserve central vision, and reduce the risk of advancing to severe vision loss.",Zinc supplements support retinal health and slow AMD progression.,0.44765738061978116,0.9468794228908685,0.9334866653362675,1.0,0.9999999999,1.0
What is the effect of AMD on dim light vision?,"['Age-related macular degeneration progressively impairs central vision and overall visual function, making it harder to see fine detail and to detect motion or objects in low-light conditions; this diminished dim-light vision contributes to difficulty reading, driving, mobility and increased dependence, and can progress to irreversible central blindness in advanced stages.']","Age-related macular degeneration progressively impairs dim-light (low-luminance) vision, reducing the ability to detect motion and fine detail in low light, which worsens reading, driving, mobility, and can contribute to increased dependence and eventual central vision loss.",AMD reduces dim light vision by impairing macular sensitivity.,0.9725885399685477,0.8840712151101172,0.8903541598741904,1.0,0.9999999999,1.0
What is the role of the Bruch’s membrane in AMD?,"['Bruch’s membrane is the thin multilayered barrier between the retinal pigment epithelium (RPE) and the choroid that regulates nutrient and waste exchange; with aging and chronic inflammation it thickens, accumulates lipids and cholesterol, and forms drusen, which impairs RPE function and cell health. Dysfunction of Bruch’s membrane disrupts the outer blood–retina barrier, promotes deposit formation, and drives progression of both dry (including geographic atrophy) and neovascular AMD, contributing to central vision loss. Because of this central role, therapies that restore RPE, modify deposits, or provide scaffolds targeting Bruch’s membrane are key strategies to slow or treat AMD.']","Bruch’s membrane is the multilayered barrier between the RPE and choroid that, when thickened and lipid/cholesterol-laden with age and chronic inflammation, impairs RPE function, promotes drusen and deposit formation, disrupts the outer blood–retina barrier, and thereby drives progression of both dry (including geographic atrophy) and neovascular AMD leading to central vision loss.",Bruch’s membrane supports the retina and thickens with drusen in AMD.,0.22964616254717862,0.9340021896818523,0.9185846501887145,1.0,0.9999999999,1.0
What is a noticeable sign of intermediate wet AMD?,"['A noticeable sign of intermediate AMD is the presence of drusen—visible deposits under the retina that often present as increased drusen size, area or volume, including large drusen, reticular pseudodrusen and subretinal drusenoid deposits.']","A noticeable sign of intermediate wet AMD is the presence of drusen—visible subretinal deposits characterized by increased size, area or volume, including large drusen, reticular pseudodrusen, and subretinal drusenoid deposits.",A noticeable sign of intermediate wet AMD is worsening central blurriness.,0.22621111974830826,0.9916189452379099,0.9048444789932331,0.8333333333333334,0.0,0.0
What is the benefit of optical aids for AMD patients?,"['Optical aids—such as magnifiers and electronic vision devices—help people with age-related macular degeneration make the most of their remaining vision, improving reading ability and speed and reducing the functional impact of central vision loss so daily activities and independence are easier to manage.']","Optical aids (e.g., magnifiers and electronic vision devices) help people with age-related macular degeneration maximize remaining vision by improving reading ability and speed and reducing the functional impact of central vision loss, thereby making daily activities and independent living easier to manage.","Optical aids magnify images, assisting AMD patients with vision tasks.",0.39455888894046776,0.9108619421953694,0.9115688890952045,1.0,0.9999999999,1.0
What is the main behavioral change to reduce AMD risk?,"['The single most important behavioral change to reduce the risk of age-related macular degeneration (AMD) is to quit smoking, as smoking is a major modifiable risk factor; additionally, adopting heart-healthy habits—controlling blood pressure and cardiovascular risk—can further lower the chance of developing AMD.']","The single most important behavioral change to reduce the risk of age-related macular degeneration is to quit smoking, with additional benefit from controlling blood pressure and other cardiovascular risk factors.",The main behavioral change to reduce AMD risk is quitting smoking.,0.6030703338723131,0.9383938783611167,0.9122813354892526,1.0,0.9999999999,1.0
What is the purpose of indocyanine green angiography in AMD?,"['Indocyanine green angiography is used in AMD to identify and characterize choroidal and neovascular lesions underlying wet/neovascular disease—detecting choroidal neovascularization, type 1 MNV, polypoidal choroidal vasculopathy, retinal angiomatous proliferation, quiescent or occult CNV, abnormal vascular networks, polypoidal lesions and feeder vessels—thereby aiding subtype classification and improving diagnostic accuracy when used alongside fluorescein angiography and OCTA.']","Indocyanine green angiography in AMD is used to identify and characterize choroidal and neovascular lesions—such as choroidal neovascularization including type 1 MNV, polypoidal choroidal vasculopathy, retinal angiomatous proliferation, quiescent/occult CNV, abnormal vascular networks, polypoidal lesions, and feeder vessels—to aid subtype classification and improve diagnostic accuracy alongside fluorescein angiography and OCTA.",Indocyanine green angiography visualizes choroidal vessels in AMD.,0.798715620993846,0.9747273623100009,0.9448624839753841,1.0,0.9999999999,1.0
What is the effect of AMD on fine detail vision?,"['Age-related macular degeneration (AMD) damages the macula and central vision, markedly reducing the ability to see fine detail—causing blurred or missing central vision that makes reading, recognizing faces and other fine-vision tasks difficult; it typically progresses over time and can lead to severe or irreversible visual impairment and loss of independence.']","AMD damages the macula and central vision, causing blurred or missing central vision that markedly reduces the ability to see fine detail, making reading, recognizing faces, and other fine-vision tasks difficult and potentially leading to severe, irreversible impairment.",AMD blurs fine detail vision by damaging the macula.,0.9830018804749209,0.9547574607860264,0.9321652215567058,1.0,0.9999999999,1.0
What is the role of leafy greens in AMD management?,"['Including green leafy vegetables—especially dark leafy greens, often together with some fruits—in the diet is associated with a lower risk of age-related macular degeneration and reduced risk of visual impairment, and may help prevent or slow disease development, so regular consumption of these foods is a valuable dietary strategy in managing AMD alongside medical care.']","Regular consumption of green leafy vegetables—especially dark leafy greens, often with some fruits—is associated with lower risk of age-related macular degeneration, reduced risk of visual impairment, and may help prevent or slow AMD progression as a valuable dietary strategy alongside medical care.",Leafy greens provide lutein and zeaxanthin for AMD management.,0.22541217023976753,0.8574697423688994,0.9016486809590701,1.0,0.9999999999,0.0
What is a common technological aid for AMD patients?,"['Common aids for AMD patients include intraocular telescopes and electronic travel devices, which help compensate for central vision loss and improve tasks like reading and navigation, increasing safety and reducing collisions while moving about.']","A common technological aid for AMD patients is an intraocular telescope, which compensates for central vision loss and can improve tasks like reading and navigation.",A common technological aid is a digital magnifier.,0.2122717906793043,0.9999999999999997,0.8490871627172172,1.0,0.0,0.0
What is the purpose of thermal laser therapy in AMD?,"['Thermal laser therapy is used in neovascular (wet) forms of age-related macular degeneration—including polypoidal choroidal vasculopathy—to ablate or seal abnormal retinal and choroidal blood vessels, reducing leakage and exudation and helping to control disease progression and preserve central vision.']","Thermal laser therapy in neovascular (wet) AMD—including polypoidal choroidal vasculopathy—aims to ablate or seal abnormal retinal and choroidal blood vessels to reduce leakage and exudation, thereby helping control disease progression and preserve central vision.",Thermal laser therapy destroys abnormal vessels in wet AMD.,0.8994921856086623,0.9745559789685437,0.9313020757679823,1.0,0.9999999999,1.0
What is the effect of AMD on edge detection?,"['Age-related macular degeneration damages the macula and central vision, producing blurred and lost central vision and reduced ability to perceive fine detail and contrast; as a result, edge detection and motion sensitivity are impaired, causing difficulties with reading, driving, spatial perception and increased observation and lane‑keeping errors.']","Age-related macular degeneration impairs edge detection, leading to reduced ability to perceive fine detail and contrast and contributing to blurred or lost central vision.",AMD impairs edge detection by blurring central vision boundaries.,0.4408856631415241,0.8335199109028714,0.9064008913285642,1.0,0.9999999999,1.0
What is the role of stress management in AMD?,"['Stress management plays a supportive role in age-related macular degeneration care by helping patients cope with the emotional burden—frustration, loss of independence, difficulty reading and driving—and by preserving mental well-being, daily functioning, and engagement with monitoring and treatment plans; as a complement to medical and technological management approaches, it can improve quality of life even though it does not directly reverse the retinal damage.']","Stress management in AMD serves as a supportive, non-curative adjunct that helps patients cope with emotional burdens (frustration, loss of independence, difficulty reading/driving), preserves mental well‑being and daily functioning, and promotes engagement with monitoring and treatment plans to improve quality of life.","Stress management reduces inflammation, supporting AMD care.",0.48137460365284107,,0.9254984146113643,1.0,0.0,0.0
What is a frequent finding in early AMD imaging?,['Drusen are a common imaging finding in early age-related macular degeneration; spectral-domain OCT often demonstrates these deposits and may also reveal outer retinal and photoreceptor outer-segment thinning and other retinal or choroidal abnormalities.'],"A frequent imaging finding in early AMD is drusen, often seen on spectral-domain OCT alongside outer retinal and photoreceptor outer-segment thinning and other retinal or choroidal abnormalities.",A frequent finding in early AMD imaging is small drusen spots.,0.42184128931968035,0.9405579331252651,0.9373651572787214,1.0,0.9999999999,1.0
What is the benefit of talking devices for AMD patients?,"['Talking devices give people with AMD auditory cues that help them locate objects, navigate and orient themselves, and read more effectively, improving independence, mobility, and everyday functioning despite central vision loss.']","Talking devices provide people with AMD auditory cues that improve object location, navigation, orientation, and reading, thereby enhancing independence, mobility, and everyday functioning despite central vision loss.","Talking devices provide audio output, aiding AMD patients with tasks.",0.5057648503946504,0.9740182228679538,0.9321503106695106,1.0,0.9999999999,0.0
What is the main barrier to curing AMD?,"['The main barrier to curing age-related macular degeneration is breakdown of the retinal barrier—particularly degeneration of the retinal pigment epithelium and its microvascular support—driven by cellular senescence, inflammation, protein deposits and endothelial dysfunction, making the disease complex and resistant to current therapies and restoration of normal barrier function the central challenge.']","The main barrier to curing AMD is failure to restore the retinal barrier—primarily degeneration of the retinal pigment epithelium and its microvascular support—driven by cellular senescence, inflammation, protein deposits, and endothelial dysfunction.",The main barrier to curing AMD is the inability to regenerate lost retinal cells.,0.23380353585047997,0.9999999999999997,0.9352141434019199,0.8571428571428571,0.0,0.0
What is the role of heart health in AMD prevention?,"['Heart health appears closely tied to age-related macular degeneration: cardiovascular disease, atherosclerosis and other blood-vessel problems are associated with macular pathology, and systemic inflammation (for example raised CRP or chronic infections) also links to AMD. Maintaining vascular and inflammatory health and controlling cardiovascular risk factors such as smoking may therefore help reduce the risk or slow progression of AMD.']","Heart health appears to play a key preventive role in AMD, as cardiovascular disease, atherosclerosis, and systemic inflammation (e.g., elevated CRP, chronic infections) are associated with increased AMD risk and progression, so maintaining vascular and inflammatory health and controlling cardiovascular risk factors such as smoking may help reduce risk or slow AMD progression.","Heart health maintains retinal circulation, aiding AMD prevention.",0.4767732098479974,0.9497266435651794,0.9070928393919897,0.75,0.9999999999,0.0
What is a common visual change in advanced dry AMD?,"['A common visual change in advanced dry AMD is progressive central vision loss that impairs face and object recognition and often reduces contrast sensitivity and color perception, potentially leading to severe or irreversible vision loss.']","A common visual change in advanced dry AMD is progressive central vision loss that impairs face and object recognition and often reduces contrast sensitivity and color perception, potentially leading to severe or irreversible vision loss.",A common visual change in advanced dry AMD is large central blind spots.,0.234601145924132,0.9744570770890784,0.938404583696528,1.0,0.0,0.0
What is the purpose of color vision testing in AMD?,"['Color vision testing in AMD helps detect and monitor macular dysfunction by revealing deficits in color recognition and contrast that accompany central and progressive vision loss, allowing clinicians to identify early changes, track disease progression or response to treatment, and assess functional impact on reading, driving, and daily activities.']","Color vision testing in AMD detects and monitors macular dysfunction by revealing deficits in color recognition and contrast associated with central/progressive vision loss, thereby identifying early changes, tracking disease progression or treatment response, and assessing functional impact on activities like reading and driving.",Color vision testing assesses macular cone damage in AMD.,0.8999489487865665,0.9472656459659565,0.9331246523803938,1.0,0.9999999999,0.0
What is the effect of AMD on dynamic vision?,"['Age-related macular degeneration damages the macula and central vision, producing blurred, progressive loss of vision that reduces motion sensitivity and other dynamic visual functions. These deficits impair reading, spatial perception and mobility, worsen driving performance and safety by increasing observation, lane‑keeping and gap‑selection errors, and often lead to greater dependence on others.']","AMD impairs dynamic vision by reducing motion sensitivity and other dynamic visual functions, leading to blurred, progressive central vision loss that degrades reading, spatial perception, mobility, and driving performance.",AMD reduces dynamic vision by impairing central tracking.,0.5493207162226575,0.9927796972886043,0.911505759094471,0.8888888888888888,0.9999999999,1.0
What is the role of parental history in AMD risk?,"['A parental history of age-related macular degeneration markedly raises an individual’s risk: having a parent with AMD suggests a heritable predisposition that increases the likelihood of developing the disease and may be associated with earlier onset or greater severity, especially when combined with other risk factors such as advancing age, smoking, or cardiovascular conditions.']","A parental history of age-related macular degeneration indicates a heritable predisposition that substantially increases an individual's risk of developing AMD and may be associated with earlier onset or greater severity, particularly when combined with age, smoking, or cardiovascular risk factors.",Parental history signals genetic risk factors for AMD.,0.5649916549957317,0.8976845189888986,0.926633286649593,1.0,0.9999999999,1.0
What is a typical sign of late wet AMD on scans?,"['On retinal imaging, late (wet) AMD is typically marked by choroidal neovascularization, which on OCT often manifests as features like the double‑layer sign or sub‑RPE/subretinal deposits (for example, the onion sign or pseudodrusen).']","A typical sign of late (wet) AMD on retinal imaging is choroidal neovascularization, which on OCT often appears as features such as the double‑layer sign or sub‑RPE/subretinal deposits (e.g., the onion sign or pseudodrusen).",A typical sign of late wet AMD on scans is extensive subretinal fluid.,0.2319483328696798,0.9599208733867579,0.9277933314787192,1.0,0.0,0.0
What is the benefit of tablet accessibility features for AMD?,"['Tablet accessibility features help people with AMD by making reading and device use easier despite central vision loss, enabling tablet-based vision tests and monitoring of retinal sensitivity, supporting greater independence and safer mobility, and improving access to care and digital tools—including AI-enhanced accessibility—that streamline monitoring and treatment.']","Tablet accessibility features help people with AMD by enlarging text and images, enabling tablet-based vision tests and retinal monitoring, supporting independent device use and safer mobility, and improving access to care and AI-enhanced tools that streamline monitoring and treatment.",Tablet accessibility features like zoom aid AMD patients with digital use.,0.6833139814444879,0.9666549145668882,0.9332559257779515,0.8,0.9999999999,0.0
What is the effect of AMD on light intensity perception?,"['Age-related macular degeneration, including intermediate, geographic atrophy and neovascular forms, reduces sensitivity to light intensity and impairs the ability to perceive changes in illumination, contributing to central vision loss, blurred vision, decreased visual acuity and problems with motion, reading, driving and mobility; some treatments and adaptive devices can partially restore or improve light perception.']","AMD reduces sensitivity to light intensity and impairs the ability to perceive changes in illumination, contributing to central vision loss and related functional deficits.",AMD dulls light intensity perception by damaging macular cells.,0.5992636327194154,0.919927606076084,0.8970545308776616,1.0,0.9999999999,1.0
What is the purpose of daily living skills training in AMD?,"['Daily living skills training helps people with age-related macular degeneration adapt to central and overall vision loss so they can carry out everyday tasks—like reading, mobility and driving—more independently; by teaching practical strategies and visual techniques it reduces dependency, frustration and emotional distress, slows decline in daily functioning, and can lessen associated depressive symptoms.']","Daily living skills training for people with age-related macular degeneration teaches practical strategies and visual techniques to help them adapt to central and overall vision loss so they can perform everyday tasks (e.g., reading, mobility, driving) more independently, reduce dependency and frustration, slow decline in daily functioning, and lessen associated depressive symptoms.",Daily living skills training helps AMD patients adapt to vision loss.,0.5310514257192271,0.8996694726576208,0.9242057028769083,1.0,0.9999999999,1.0
What is the role of seeds in AMD prevention?,"['The provided information only references seeds in the context of golden rice, and offers no link between seeds and prevention of age‑related macular degeneration, so based on these data seeds have no established role in preventing AMD.']","The provided information contains no evidence linking seeds to prevention of age-related macular degeneration, so based on these data seeds have no established role in preventing AMD (additional clinical or epidemiological studies would be needed to evaluate any potential effect).",Seeds offer antioxidants and healthy fats for AMD prevention.,0.21964308231734914,0.0,0.8785723292693965,0.6666666666666666,0.0,0.0
What is a common issue in untreated advanced AMD?,"['Untreated advanced age-related macular degeneration commonly leads to irreversible vision loss, often causing severe central visual impairment that can progress to blindness and markedly reduce abilities like face and object recognition and contrast sensitivity.']",A common issue in untreated advanced age-related macular degeneration is irreversible central vision loss leading to severe impairment of face and object recognition and reduced contrast sensitivity.,A common issue in untreated advanced AMD is legal blindness.,0.22275494979208377,0.932427266037247,0.8910197991683351,1.0,0.9999999999,1.0
What is the benefit of tinted visors for AMD patients?,"['Tinted visors that filter blue light can protect the light-sensitive cells at the back of the eye from photochemical and oxidative damage and reduce light-induced toxicity, which may help preserve retinal health, lessen further cell injury, and potentially slow or lessen AMD-related vision loss while improving comfort and visual function.']","Tinted visors that filter blue light may protect retinal photoreceptors from photochemical and oxidative damage, reduce light-induced toxicity, and thereby help preserve retinal health, improve visual comfort/function, and potentially slow or lessen AMD-related vision loss.","Tinted visors reduce glare, improving vision for AMD patients.",0.46190274753780924,,0.9245945452605846,1.0,0.9999999999,0.0
What is the effect of AMD on surface recognition?,"['Age-related macular degeneration damages central vision and produces visual impairment, and especially in advanced stages it degrades face, object and color recognition; consequently people with AMD have reduced ability to perceive and recognize surfaces, textures and other fine visual details, though restoring or substituting central vision can partially improve recognition.']","Age-related macular degeneration impairs surface recognition by degrading central vision and reducing the ability to perceive and recognize surfaces, textures, and fine visual details, particularly in advanced stages.",AMD impairs surface recognition by blurring central texture details.,0.7172356189404243,0.915082094854711,0.8688807627587359,1.0,0.9999999999,1.0
What is the purpose of dark adaptation testing in AMD?,"['Dark adaptation testing evaluates low-light (night) retinal function and is useful in AMD for detecting early functional loss—often reflecting retinal pigment epithelium and photoreceptor dysfunction and associations like subretinal drusenoid deposits—helping diagnose impaired retinal function, track disease progression, and assess response to treatments that can improve dark adaptation.']","Dark adaptation testing in AMD assesses low-light (night) retinal function to detect early functional loss—often from RPE and photoreceptor dysfunction and associations like subretinal drusenoid deposits—helping diagnose impaired retinal function, monitor disease progression, and evaluate treatment responses that improve dark adaptation.",Dark adaptation testing evaluates rod function in AMD.,0.8586258105615805,0.960154007999809,0.9342517300360664,1.0,0.0,0.0
What is the role of caffeine in AMD risk?,"['Some evidence suggests that higher caffeine intake may be protective against age-related macular degeneration, potentially lowering the risk of developing this common cause of central vision loss and visual impairment in older adults; however, more research is needed to confirm causality and optimal intake.']","Some evidence suggests higher caffeine intake may modestly reduce the risk of age-related macular degeneration, but causality, optimal dose, and long-term effects remain unconfirmed and require further prospective and mechanistic studies.",Excessive caffeine may increase AMD risk by raising oxidative stress.,0.7651941220296573,0.0,0.8789583063004475,1.0,0.0,0.0
What is a typical adaptation for AMD patients in socializing?,"['People with age-related macular degeneration often adopt a compensatory eye‑movement strategy—making quick, targeted eye jumps to use clearer peripheral retinal areas instead of the damaged center—so they can better locate faces, pick up social cues, and maintain conversations despite central vision loss.']","A typical adaptation is that people with AMD use compensatory eye‑movement strategies—making quick, targeted saccades to clearer peripheral retinal areas—to better locate faces, pick up social cues, and maintain conversations despite central vision loss.",A typical adaptation is relying on verbal cues over visual ones.,0.20723172681903443,,0.8289269072761377,1.0,0.0,0.0
What is the benefit of head-mounted displays for AMD?,"['Head-mounted displays can compensate for the central vision loss and scotomas caused by age-related macular degeneration, improving reading and other near tasks, enhancing spatial perception and mobility, reducing dependence on others, and helping restore safer, more functional everyday vision.']","Head-mounted displays can compensate for central vision loss and scotomas in AMD, improving reading and near tasks, spatial perception and mobility, reducing dependence on others, and restoring safer, more functional everyday vision.",Head-mounted displays enhance vision with magnification for AMD patients.,0.35617928830325263,0.9538341869099534,0.9247758816695496,1.0,0.9999999999,0.0
What is the effect of AMD on object localization?,"['Age-related macular degeneration primarily damages central vision, producing blurred or lost central sight and reduced spatial perception that impairs the ability to locate and recognize objects. This leads to more observation and targeting errors, poorer mobility and driving performance, and a reliance on less precise peripheral cues that only partially compensates for the loss of accurate foveal localization.']","Age-related macular degeneration impairs object localization by damaging central (foveal) vision, causing blurred or lost central sight that leads to more observation and targeting errors, reduced spatial precision, poorer mobility and driving performance, and reliance on less accurate peripheral cues that only partially compensate.",AMD impairs object localization by distorting central vision.,0.3699294430868293,0.9055634734149697,0.879717772347317,1.0,0.9999999999,1.0
What is the purpose of retinal prosthetics in AMD research?,"['Retinal prosthetics in AMD research are designed to restore useful vision by replacing or bypassing damaged photoreceptors and electrically stimulating surviving retinal neurons, with the goal of reducing central vision loss and irreversible visual impairment that can lead to dependence or blindness.']",Retinal prosthetics in AMD research aim to restore useful vision by replacing or bypassing damaged photoreceptors and electrically stimulating surviving retinal neurons to reduce central vision loss and prevent irreversible visual impairment.,Retinal prosthetics aim to restore vision by stimulating remaining cells in AMD.,0.902741384232994,0.9834770718629616,0.944298870265309,1.0,0.9999999999,1.0
What is the role of high blood pressure in AMD?,"['High blood pressure is a contributing risk factor for age-related macular degeneration: it can reduce blood flow to the back of the eye and disturb vascular homeostasis, impairing retinal health and promoting AMD development and progression, so controlling hypertension can help lower the risk of retinal disease.']","High blood pressure contributes to the development and progression of age-related macular degeneration by reducing blood flow and disturbing vascular homeostasis in the retina, impairing retinal health, and therefore controlling hypertension can help lower AMD risk.","High blood pressure damages retinal vessels, increasing AMD risk.",0.9822145815706803,0.9053988856962086,0.9288583262827211,1.0,0.9999999999,1.0
What is a common obstacle for AMD patients in crowds?,"['People with AMD often struggle to detect and avoid obstacles in crowded environments because central vision loss and impaired spatial perception make it hard to see and accurately judge objects and moving people directly in front of them, leading to difficulty navigating and frequent bumping or collisions.']","A common obstacle for people with AMD in crowded environments is detecting and accurately judging the position of objects and moving people directly ahead, causing difficulty navigating and frequent bumping or collisions.",A common obstacle is identifying individuals in crowds.,0.2167753831922738,0.9705309334252578,0.8671015327690952,1.0,0.9999999999,1.0
What is the benefit of raised markers for AMD patients?,"['Raised markers in AMD patients serve as indicators of disease presence and progression, enabling earlier diagnosis and closer monitoring so treatments can be started or adjusted sooner—helping to improve visual and clinical outcomes and potentially reduce treatment burden by optimizing therapies.']","Raised markers in AMD patients indicate disease presence and progression, enabling earlier diagnosis and closer monitoring so treatments can be started or adjusted sooner to improve visual and clinical outcomes and potentially reduce treatment burden by optimizing therapies.","Raised markers provide tactile guidance, aiding AMD patients.",0.3797513801549284,0.9487245517639465,0.9190055206197134,1.0,0.0,0.0
What is the effect of AMD on visual concentration?,"['Age-related macular degeneration damages central vision and visual acuity, producing blurred or missing central sight and often preventing people from seeing what they are directly looking at; this undermines visual concentration, making reading and driving difficult, increasing observation and navigation errors, reducing spatial perception and mobility, and contributing to dependence, emotional distress, and overall progressive visual impairment up to blindness.']","Age-related macular degeneration impairs visual concentration by damaging central vision and visual acuity—producing blurred or missing central sight that prevents focused viewing, undermines the ability to see what one is directly looking at, and thereby makes tasks requiring sustained visual attention (e.g., reading, driving) difficult and error-prone.",AMD reduces visual concentration by impairing central focus.,0.3443528353685881,0.9216904349898863,0.8774113414743523,1.0,0.9999999999,1.0
What is the purpose of environmental modifications in AMD?,"['Environmental modifications in AMD are intended to reduce risk and slow disease progression, minimize vision-related disability, and support daily functioning and safety—helping preserve central vision for reading and driving, maintain independence, and improve acceptance of monitoring and care alongside medical and lifestyle interventions.']","Environmental modifications in AMD aim to reduce risk and slow progression, minimize vision-related disability, and support daily functioning and safety—helping preserve central vision for tasks like reading and driving, maintain independence, and improve acceptance of monitoring and care alongside medical and lifestyle interventions.",Environmental modifications enhance safety and accessibility for AMD patients.,0.6784105096410122,0.969108719571075,0.9136420385640494,1.0,0.9999999999,0.0
What is the role of rest in AMD management?,"['Rest offers little if any disease-modifying benefit in age-related macular degeneration; while short-term eye rest may reduce discomfort or eye strain, it does not prevent progression or restore damaged central vision. AMD is a progressive, often irreversible cause of central vision loss that requires medical management, monitoring, and supportive measures (including specific therapies for neovascular disease, interventions under investigation, and rehabilitation to address reading, mobility, driving, and emotional impacts) rather than relying on rest alone.']","Rest provides little if any disease-modifying benefit in age-related macular degeneration—while short-term eye rest may reduce discomfort or strain, AMD progression and central vision loss require medical treatment, monitoring, and supportive/rehabilitative measures rather than rest alone.","Rest supports retinal recovery, aiding AMD management.",0.21938571788750516,0.8872505655326285,0.8774753863971525,1.0,0.0,0.0
What is a typical retinal alteration in late dry AMD?,"['In late dry AMD the retina typically develops geographic atrophy characterized by loss and dysfunction of the retinal pigment epithelium with overlying photoreceptor degeneration, often accompanied by drusen or pseudodrusen (subretinal drusenoid deposits) and drusenoid pigment epithelial detachments.']","A typical retinal alteration in late dry AMD is geographic atrophy with loss and dysfunction of the retinal pigment epithelium and overlying photoreceptor degeneration, often accompanied by drusen or pseudodrusen and drusenoid pigment epithelial detachments.",A typical retinal alteration in late dry AMD is geographic atrophy.,0.48886055375112175,0.9999999999999997,0.955442215004487,1.0,0.9999999999,1.0
What is the benefit of glare shields for AMD patients?,"['Glare shields that reduce bright and short-wavelength (blue) light can lessen photopic glare and related visual disturbances in people with AMD, improving comfort, contrast perception and functional vision for everyday tasks such as reading, mobility and driving.']","Glare shields that reduce bright and short-wavelength (blue) light can lessen photopic glare and related visual disturbances in AMD patients, thereby improving comfort, contrast perception and functional vision for tasks such as reading, mobility, and driving.","Glare shields minimize light scatter, improving vision for AMD patients.",0.48495375424178067,0.981700412449306,0.9398150169671226,1.0,0.9999999999,0.0
What is the effect of AMD on spatial mapping?,"['Age-related macular degeneration primarily impairs central vision and the ability to see what one is directly looking at, producing blurred or lost central sight that weakens spatial perception and the sense of spatial presence; this degradation undermines spatial mapping, making orientation, wayfinding, mobility and driving more difficult and increasing observation errors, lane‑keeping and gap‑selection mistakes and reliance on others.']","Age-related macular degeneration degrades central vision and spatial presence, impairing spatial mapping and therefore making orientation, wayfinding, mobility and driving (e.g., lane‑keeping, gap selection) more difficult and increasing observation errors and reliance on others.",AMD disrupts spatial mapping by impairing central vision cues.,0.33616204670625927,0.8331995001976539,0.8831097252865756,1.0,0.9999999999,1.0
What is the purpose of retinal function testing in AMD?,"['Retinal function testing in AMD is used to detect and quantify disease-related loss of retinal and central vision (for example reduced sensitivity and delayed dark adaptation), track progression and treatment response, guide clinical decisions and the evaluation of new therapies, and inform patients about how monitoring relates to everyday impacts like reading and driving.']","Retinal function testing in AMD is used to detect and quantify disease-related loss of retinal and central vision (e.g., reduced sensitivity and delayed dark adaptation), track progression and treatment response, guide clinical decisions and evaluation of new therapies, and inform patients about impacts on everyday activities like reading and driving.",Retinal function testing assesses photoreceptor health in AMD.,0.23414401751647435,0.9999999999999996,0.9365760700658974,1.0,0.0,0.0
What is the role of anxiety in AMD progression?,"['Anxiety is common in people with AMD—especially in those with wet disease and around intravitreal injection treatment—and often arises from vision loss and treatment-related stress. While anxiety itself is not shown here to directly drive the biological progression of AMD, it can reduce uptake or regularity of recommended treatments (such as intravitreal injections) and hinder engagement with low-vision care, so it may indirectly affect outcomes. Addressing anxiety through clear communication, low-vision support, and psychosocial or cognitive-behavioral interventions can improve wellbeing and treatment adherence, which could help limit disease worsening.']","Anxiety in AMD—particularly around vision loss, wet disease, and injections—does not appear to directly drive biological progression but can indirectly worsen outcomes by reducing adherence to intravitreal treatments and engagement with low-vision care, so addressing anxiety through communication, psychosocial support, and CBT may improve adherence and potentially limit disease worsening.",Chronic anxiety may worsen AMD by increasing systemic inflammation.,0.4897273523446384,0.951553531397809,0.8680003184694626,1.0,0.0,0.0
What is a common navigation challenge for AMD patients?,"['People with age-related macular degeneration often have central vision loss and impaired spatial perception that make navigation difficult; common challenges include trouble with mobility and driving—such as keeping lanes, judging gaps, noticing traffic lights and hazards—which increases observation errors, reduces driving safety, and can lead to greater dependence on others.']","A common navigation challenge for people with age-related macular degeneration is impaired central vision that makes mobility and driving difficult—e.g., keeping lanes, judging gaps, and noticing traffic lights and hazards.",A common navigation challenge is avoiding obstacles due to vision loss.,0.2271992272421437,0.9075388694219416,0.9087969089685748,1.0,0.9999999999,0.0
What is the benefit of color-enhanced lenses for AMD?,"['Color-enhanced lenses for people with age-related macular degeneration can improve visual acuity and contrast to make everyday tasks (reading, driving, recognizing faces) easier, reduce glare and eye fatigue for greater comfort, and by filtering blue and ultraviolet light may help protect the retina from photochemical and photo-oxidative damage.']","Color-enhanced lenses for people with AMD can improve visual acuity and contrast for everyday tasks (reading, driving, recognizing faces), reduce glare and eye fatigue for greater comfort, and may help protect the retina by filtering blue and UV light.","Color-enhanced lenses boost contrast, aiding AMD patients’ vision.",0.5366745875802459,0.9821612426257454,0.9466983503209836,1.0,0.9999999999,1.0
What is the effect of AMD on visual flow?,"['Age-related macular degeneration causes central and progressive loss of vision and blurring that disrupts visual flow and motion perception, increasing motion sensitivity and impairing spatial awareness; as a result, everyday tasks that depend on coherent visual flow—such as reading, mobility and driving—become more difficult, leading to observation, lane‑keeping and gap‑selection errors and greater reliance on others.']","AMD disrupts visual flow by causing central, progressive vision loss and blurring that increase motion sensitivity and impair spatial awareness, leading to difficulties in perceiving coherent motion and performing tasks like reading, mobility, and driving.",AMD disrupts visual flow with central vision gaps.,0.3582696584577038,0.9203553923463206,0.9330786338308152,1.0,0.9999999999,1.0
What is the purpose of community support for AMD patients?,"['Community support for people with age-related macular degeneration is meant to enable timely diagnosis and ongoing monitoring via accessible local eye services, improve the acceptability, convenience and safety of care pathways, encourage adherence to monitoring and treatment, and provide practical and emotional help—including family support—to help manage central vision loss, daily activities and loss of independence.']","The purpose of community support for people with age-related macular degeneration is to enable timely diagnosis and ongoing monitoring through accessible local eye services, improve acceptability, convenience and safety of care pathways, encourage adherence to monitoring and treatment, and provide practical and emotional (including family) support to help manage central vision loss, daily activities and loss of independence.",Community support provides resources and encouragement for AMD patients.,0.21091148880478322,0.8934181940934578,0.8436459552191329,1.0,0.9999999999,0.0
What is the role of UV light in AMD development?,"['Solar and other UV exposure is implicated in age‑related ocular disease and has been associated with early AMD; high or cumulative UV can damage the retina and contribute to visual impairment through phototoxic effects. At the same time, limited intermittent UV exposure has been reported to improve certain cellular and functional features in high‑risk RPE cells, indicating a nuanced role. Overall, excessive UV appears harmful while modest, controlled exposure may have modulatory effects.']","Excessive or cumulative UV exposure contributes to retinal phototoxicity and is associated with early AMD and visual impairment, whereas limited, controlled intermittent UV may have modulatory or potentially protective effects in certain high‑risk RPE cell models, indicating a nuanced dose‑dependent role that requires further in vivo and longitudinal data to define safe/beneficial exposures.","UV light causes retinal damage, contributing to AMD development.",0.6345633320691952,0.0,0.9018896919131447,0.6666666666666666,0.9999999999,1.0
What is a typical psychological impact of AMD diagnosis?,"['A diagnosis of age-related macular degeneration (AMD) often causes significant emotional distress—including anxiety, frustration and lowered psychological well‑being—driven by progressive central vision loss that makes reading, driving and everyday tasks difficult; this loss of independence and increased reliance on others can lead to social withdrawal and a reduced quality of life.']","A typical psychological impact of an AMD diagnosis is significant emotional distress—commonly anxiety, frustration, and lowered psychological well‑being—driven by progressive central vision loss that impairs reading, driving and daily independence, often leading to social withdrawal and reduced quality of life.",A typical psychological impact of AMD diagnosis is worry about future vision.,0.2358958131807602,0.9790257027741746,0.9435832527230408,1.0,0.9999999999,0.0
What is the benefit of clip-on magnifiers for AMD patients?,"['For people with age-related macular degeneration, clip-on magnifiers improve central near vision and reading ability, helping compensate for the central vision loss that causes difficulty reading, reduced independence, and impaired mobility; by magnifying tasks they preserve everyday visual function and reduce reliance on others.']","Clip-on magnifiers improve central near vision and reading ability in people with age-related macular degeneration, helping them compensate for central vision loss, preserve everyday visual function, and reduce reliance on others.",Clip-on magnifiers enhance close-up vision for AMD patients.,0.9811024456539473,0.9190983369367624,0.9243787964532573,1.0,0.9999999999,1.0
What is the effect of AMD on motion perception speed?,"['Age-related macular degeneration impairs motion sensitivity and produces motion artifacts, degrading the ability to perceive and track moving objects and to judge speed; this slowed or impaired motion perception contributes to poorer spatial perception, reduced mobility and driving performance, and increased driving errors.']","Age-related macular degeneration slows and impairs motion perception—producing motion artifacts that degrade the ability to perceive, track, and judge the speed of moving objects, which contributes to poorer spatial perception, reduced mobility, and increased driving errors.",AMD slows motion perception speed by impairing central vision.,0.47158463261513794,0.9113922285380262,0.886300005386111,1.0,0.9999999999,1.0
What is the main task of the retina in the eye?,"[""The retina's main task is to detect light and convert it into neural signals via its photoreceptors and support cells, initiating visual processing and encoding visual information. Those signals are transmitted toward the brain (via the optic nerve) so images can be perceived. Because it performs this fundamental transduction, retinal integrity is essential for vision—damage or disease of the retina directly impairs visual function.""]","The retina's main task is to detect light with photoreceptors, convert it into neural signals via support cells, and transmit those signals toward the brain (via the optic nerve) so images can be perceived.",The retina captures light and sends visual signals to the brain.,0.6593299421442438,,0.9230340542912605,0.75,0.9999999999,1.0
What is the initial indicator of AMD on examination?,"['The earliest finding on examination is drusenoid deposits in the macula—often seen as small yellowish/subretinal drusenoid deposits on color fundus imaging or ophthalmoscopy—while functional testing (e.g., microperimetry) and OCT/OCT-A can reveal early sensitivity loss or structural changes before overt exudation, neovascularization, or central vision loss.']","The initial indicator of AMD on examination is the presence of drusenoid deposits in the macula—typically seen as small yellowish/subretinal drusenoid deposits on color fundus imaging or ophthalmoscopy, often accompanied by early sensitivity loss or structural changes detectable with microperimetry and OCT/OCT-A.",The initial indicator of AMD is small yellowish drusen.,0.7334123665479131,0.9999999999999997,0.9336494661916521,0.5,0.9999999999,1.0
What is the hallmark symptom of wet AMD?,"['The hallmark symptom of wet age-related macular degeneration is sudden central vision loss and distortion caused by abnormal blood vessel growth beneath the macula (choroidal neovascularization), leading to rapid decline in visual acuity and potentially severe or irreversible vision loss.']","The hallmark symptom of wet AMD is sudden central vision loss and distortion caused by abnormal blood vessel growth beneath the macula (choroidal neovascularization), leading to rapid decline in visual acuity and potential severe or irreversible vision loss.",The hallmark symptom of wet AMD is distorted or wavy central vision.,0.5688987777534747,0.9999999999999996,0.9422617776805654,1.0,0.9999999999,1.0
What is the primary aim of the AREDS studies?,['The primary aim of the AREDS studies was to evaluate whether nutritional supplements can slow or prevent progression to advanced age-related macular degeneration—including geographic atrophy—and thereby reduce vision loss.'],The primary aim of the AREDS studies was to evaluate whether nutritional supplements can slow or prevent progression to advanced age-related macular degeneration—including geographic atrophy—and thereby reduce vision loss.,The primary aim of the AREDS studies is to evaluate nutrients for AMD prevention.,0.4848204972771119,0.9941881101853248,0.9392819891084476,1.0,0.9999999999,1.0
What is the most effective method to detect AMD?,"['The most effective approach for detecting age‑related macular degeneration is multimodal retinal imaging led by optical coherence tomography (OCT) and OCT‑angiography, supplemented by color fundus photography; these imaging tests reveal drusen, retinal pigment epithelium changes, subretinal deposits, exudation and neovascularization, and when combined with automated deep‑learning analysis enable earlier, more accurate diagnosis.']","The most effective method to detect AMD is multimodal retinal imaging—primarily optical coherence tomography (OCT) and OCT-angiography, supplemented by color fundus photography—which reveals drusen, RPE changes, subretinal deposits, exudation and neovascularization and, when combined with automated deep-learning analysis, enables earlier and more accurate diagnosis.",The most effective method to detect AMD is optical coherence tomography (OCT).,0.23446006722650867,,0.9378402689060347,1.0,0.9999999999,0.0
What is the typical duration of early AMD progression?,"['Early AMD usually progresses slowly over a period of years rather than months, with advancement to atrophic or neovascular stages often taking several years and varying by individual; the course is tracked with fundus imaging and visual acuity testing and can be influenced by drusen changes and interventions such as nutritional supplementation or agents that may slow conversion.']","Early AMD typically progresses slowly over several years (often many years) rather than months, with time to atrophic or neovascular conversion varying by individual and influenced by drusen changes and interventions.",Early AMD progression typically spans years without noticeable symptoms.,0.651458613739607,0.926674269855326,0.8915343267165743,1.0,0.9999999999,1.0
What is the role of the optic nerve in relation to the macula?,"['The optic nerve is the output pathway of the retina, carrying visual signals from the macula to the brain; its integrity influences retinal structure and thickness and therefore macular function. Damage or disease of the optic nerve—such as optic neuritis, atrophy, or glaucomatous injury—can impair central vision and worsen the visual deficits caused by macular disorders.']","The optic nerve serves as the retina's output pathway that carries visual signals from the macula to the brain, and its integrity directly influences retinal structure, thickness, and macular function such that optic nerve damage (e.g., neuritis, atrophy, glaucoma) can impair central vision and exacerbate visual deficits from macular disorders.",The optic nerve transmits macular visual signals to the brain.,0.4137436196068289,0.9099613261204113,0.9049501084133971,1.0,0.9999999999,1.0
What is the purpose of using an Amsler grid at home?,"['Using an Amsler grid at home lets people—especially those with or at risk for age-related macular degeneration—regularly check for new or worsening central visual distortions or blind spots; this simple self-monitoring can reveal early changes, prompt timely clinical assessment and management, improve access to care, and help preserve vision and visual outcomes.']",Using an Amsler grid at home allows people—particularly those with or at risk for age-related macular degeneration—to regularly detect new or worsening central visual distortions or scotomas so they can seek timely clinical assessment and treatment to help preserve vision.,Using an Amsler grid at home helps detect vision changes from AMD.,0.9019960468466698,0.9999999999999997,0.9413175207200123,0.8,0.9999999999,1.0
What is the main effect of photodynamic therapy in wet AMD?,"['Photodynamic therapy for wet AMD targets the disease’s neovascular (choroidal neovascularization) component, helping to treat the abnormal vessels and thereby preserve or improve visual acuity and reduce the risk of moderate-to-severe vision loss.']","Photodynamic therapy for wet AMD primarily targets and treats the abnormal choroidal neovascular vessels, helping to preserve or improve visual acuity and reduce the risk of moderate-to-severe vision loss.",The main effect of photodynamic therapy in wet AMD is reducing vessel leakage.,0.22894850493154248,0.9299234147202124,0.9157940197261699,1.0,0.0,0.0
What is the predominant demographic for AMD onset?,"['Age-related macular degeneration predominantly begins in older adults, with risk rising sharply with advancing age; its onset is most common among the elderly and is further influenced by ethnicity and other demographic and socio-economic risk factors.']","Age-related macular degeneration predominantly begins in older adults, with onset most common among the elderly and risk rising sharply with advancing age, and further influenced by ethnicity and socio-economic factors.",The predominant demographic for AMD onset is individuals over 55.,0.7793306775955671,0.8616149299251911,0.8673537561976712,1.0,0.9999999999,0.0
What is the role of polyphenols in AMD prevention?,"['Polyphenols—such as those in green tea and lutein-containing formulations—may help prevent AMD by scavenging reactive oxygen species and reducing oxidative stress in the macula and retinal pigment epithelium, thereby protecting retinal cells, limiting deposit-related damage and exudation, and slowing progression toward central vision loss.']","Polyphenols (e.g., in green tea and lutein-containing formulations) may help prevent AMD by scavenging reactive oxygen species and reducing oxidative stress in the macula and retinal pigment epithelium, thereby protecting retinal cells, limiting deposit-related damage and exudation, and slowing progression toward central vision loss.","Polyphenols reduce oxidative stress, aiding AMD prevention.",0.6429812124417255,0.9509846721594813,0.9355612134032656,1.0,0.9999999999,1.0
What is a frequent visual problem in advanced AMD?,"['A frequent visual problem in advanced AMD is loss of central vision, which makes it hard to see what one is directly looking at and leads to impaired object, face and color recognition and reduced contrast sensitivity, potentially progressing to severe vision loss or blindness.']","A frequent visual problem in advanced AMD is loss of central vision, causing difficulty seeing what one directly looks at and impairing object, face and color recognition and contrast sensitivity, potentially progressing to severe vision loss or blindness.",A frequent visual problem in advanced AMD is missing central vision patches.,0.38289941126608074,0.9420723941040099,0.9315976450643227,1.0,0.9999999999,0.0
What is the purpose of bioptic lenses in AMD?,"['Bioptic lenses in AMD are used as low-vision aids to improve visual acuity and compensate for central-vision loss so patients can better see details they cannot view directly, helping with reading, driving and other daily tasks and reducing dependence and mobility difficulties.']","Bioptic lenses in AMD are low-vision aids designed to improve or compensate for central-vision loss by enhancing visual acuity for tasks like reading and driving, thereby reducing dependence and mobility difficulties.",Bioptic lenses enhance distance vision for AMD patients.,0.5365245978033146,0.9614158409102421,0.9460983912132581,1.0,0.0,0.0
What is the leading modifiable risk factor for AMD?,"['Smoking is the leading modifiable risk factor for age-related macular degeneration; lifestyle and other changeable health factors can influence AMD development and progression, so addressing them can reduce risk and slow disease progression.']",Smoking is the leading modifiable risk factor for age-related macular degeneration.,The leading modifiable risk factor for AMD is cigarette smoking.,0.7332487040313362,0.9617232993338539,0.932994816125345,1.0,0.9999999999,1.0
What is the characteristic appearance of dry AMD on scans?,"['On retinal imaging—especially OCT and fundus photos—dry age‑related macular degeneration typically shows accumulations of drusen (large soft drusen and bluish‑white pseudodrusen), drusenoid pigment‑epithelial detachments producing elevations and a layered appearance, irregularity and thinning/atrophy of the retinal pigment epithelium with subfoveal geographic atrophy, and loss of the overlying photoreceptor layer; OCT often highlights an irregular RPE band and measurable drusen volume changes.']","Dry AMD on retinal imaging characteristically shows accumulations of drusen (large soft drusen and reticular/pseudodrusen), drusenoid RPE detachments with layered/elevated appearance, irregularity and thinning/atrophy of the RPE often with subfoveal geographic atrophy and loss of overlying photoreceptors, with OCT demonstrating an irregular RPE band and measurable drusen volume changes.",Dry AMD characteristically shows drusen and retinal thinning on scans.,0.5341239917425269,0.9387512546681601,0.9364959669701076,0.875,0.9999999999,1.0
What is the benefit of green-tinted glasses for AMD patients?,"['Green-tinted glasses filter out blue light, reducing photochemical and oxidative damage and photo‑induced cytotoxicity to retinal cells, which can help protect the retinal pigment epithelium and may slow damage or improve comfort and visual outcomes for people with AMD.']","Green-tinted glasses filter blue light, which reduces photochemical/oxidative damage and photo-induced cytotoxicity to retinal cells, helping protect the retinal pigment epithelium and potentially slowing damage or improving comfort and visual outcomes in people with AMD.","Green-tinted glasses enhance contrast, benefiting AMD patients.",0.23311845465792846,0.9829539215611579,0.9324738186317139,1.0,0.9999999999,0.0
What is the primary blood supply for retinal cells?,"['The outer retina and photoreceptors receive their primary blood supply from the choroidal circulation (choriocapillaris) via the retinal pigment epithelium, which provides most of the oxygen and nutrients, while the inner retinal layers are supplied by the retinal (central retinal artery) circulation.']","The outer retina and photoreceptors receive their primary blood supply from the choroidal circulation (choriocapillaris) via the retinal pigment epithelium, while the inner retinal layers are supplied by the retinal (central retinal artery) circulation.",The primary blood supply for retinal cells is the choroidal vasculature.,0.4808543438915185,0.9234640962434005,0.923417375566074,1.0,0.9999999999,1.0
What is the effect of AMD on grid pattern perception?,"['Age-related macular degeneration impairs central vision and can cause blurred vision and an inability to see what one is looking at directly, which disrupts perception of grid patterns—patients may fail to see or accurately judge grid lines, changes that are commonly detected with an Amsler grid, particularly in intermediate AMD.']","AMD impairs central vision and can cause blurred or distorted perception of grid patterns—patients often fail to see or accurately judge Amsler grid lines, especially in intermediate AMD.","AMD distorts grid patterns, making them appear irregular.",0.5511993836938642,0.8744788637287337,0.871503814852352,1.0,0.9999999999,1.0
What is the role of genetic mutations in AMD?,"['Genetic mutations play a central role in age-related macular degeneration by altering proteins and cellular functions in the retina, sometimes disrupting protective roles in the retinal pigment epithelium and in other cases changing binding or activity to drive photoreceptor death and progressive central vision loss. Different mutations can produce similar disease outcomes, and common genetic variants (for example in APOE) modify risk. Because specific mutations can be causative, gene-targeted approaches such as CRISPR-based correction are being explored as potential ways to prevent or treat genetically driven forms of AMD.']","Genetic mutations in AMD alter retinal proteins and cellular functions—sometimes impairing protective roles of the retinal pigment epithelium or changing binding/activity to drive photoreceptor death and central vision loss—while common variants (e.g., APOE) modify risk and gene-targeted therapies like CRISPR are being explored for causative mutations.",Genetic mutations increase AMD risk by altering retinal function.,0.5303758558027207,0.9355522679390275,0.9215034232108827,1.0,0.9999999999,1.0
What is a common injectable drug for wet AMD?,"['A common injectable treatment for wet age-related macular degeneration is intravitreal anti-VEGF therapy, with ranibizumab being widely used and aflibercept and bevacizumab also commonly administered.']",A common injectable drug for wet age-related macular degeneration is the intravitreal anti-VEGF agent ranibizumab (with aflibercept and bevacizumab also commonly used).,A common injectable drug for wet AMD is aflibercept.,0.6087624179777759,0.9522842515833454,0.9350496719111034,1.0,0.9999999999,1.0
What is the purpose of vitamin C in AMD care?,"['Vitamin C is used in AMD care mainly as a preventive, supportive nutrient: higher dietary intake or supplementation has been linked to lower risk of developing AMD and to reduced progression to neovascular (wet) forms, while low vitamin C levels are associated with greater risk; however, evidence is mixed and some reports suggest supplementation could be harmful, so it is viewed as an adjunctive measure rather than a standalone treatment.']","Vitamin C in AMD care is used mainly as a preventive and supportive nutrient—higher intake or supplementation is associated with lower risk of developing AMD and reduced progression to wet AMD, though evidence is mixed and it is considered adjunctive rather than a standalone treatment.","Vitamin C acts as an antioxidant, protecting the retina in AMD care.",0.56358726057663,0.0,0.9210157089731864,1.0,0.9999999999,0.0
What is the effect of AMD on shadow perception?,"['Age-related macular degeneration impairs central vision and overall visual perception, diminishing the ability to detect shadows and subtle visual details; this reduction in spatial and motion perception leads to blurred vision, difficulty reading and driving, increased observation errors, and greater dependence for mobility.']","AMD reduces shadow perception by impairing central spatial and motion vision, leading to diminished ability to detect shadows and subtle visual details and increased observation errors.",AMD blurs shadow perception by impairing central vision contrast.,0.5320457313215985,0.9648756419054488,0.9281829252863936,1.0,0.9999999999,0.0
What is the role of the vitreous in retinal support?,"['The vitreous provides structural and biological support for the retina and macula, and its condition strongly influences retinal health: changes in the vitreous can contribute to retinal and vitreoretinal diseases (including effects on age‑related macular degeneration and other retinal pathologies), produce floaters and opacities, and broadly affect ocular tissues, which is why many therapies and delivery approaches target or interact with the vitreous to manage retinal disorders.']","The vitreous provides critical structural and biological support for the retina and macula—maintaining retinal apposition, delivering biochemical and mechanical support, and influencing retinal health and disease (including AMD) so that vitreous changes can contribute to retinal and vitreoretinal pathologies and affect therapeutic approaches.",The vitreous provides structural support and stability to the retina.,0.3584925581842855,0.9213445203198917,0.933970232737142,0.6,0.9999999999,1.0
What is a prominent sign of early dry AMD?,"['A prominent sign of early dry age-related macular degeneration is the presence of drusen—yellowish deposits beneath the retinal pigment epithelium; these can range from small hard drusen to larger soft drusen and drusenoid pigment epithelial detachments, which indicate higher risk of progression.']","A prominent sign of early dry age-related macular degeneration is the presence of drusen—yellowish deposits beneath the retinal pigment epithelium, ranging from small hard drusen to larger soft drusen and drusenoid pigment epithelial detachments that signal higher progression risk.",A prominent sign of early dry AMD is subtle central vision blurring.,0.21935973051704383,0.9376335687565934,0.8774389220681753,1.0,0.0,0.0
What is the benefit of handheld readers for AMD patients?,"['Handheld readers can significantly help people with AMD by making text easier to see and read despite central vision loss, reducing frustration and dependence on others, and improving everyday functioning and quality of life through magnification and clearer contrast.']","Handheld readers benefit people with AMD by magnifying text and enhancing contrast to make reading easier despite central vision loss, thereby reducing frustration and dependence on others and improving daily functioning and quality of life.","Handheld readers magnify text, aiding AMD patients with reading.",0.3894295755709308,0.9576567130412004,0.957718302283723,1.0,0.9999999999,1.0
What is the main habit to avoid for AMD prevention?,"['Avoid heavy alcohol consumption—heavy drinking raises the risk of age-related macular degeneration, which can cause central and overall vision loss, blurred vision, difficulty reading and driving, and may progress to irreversible blindness and greater dependence.']","Avoid heavy alcohol consumption, as heavy drinking increases the risk of age-related macular degeneration and related vision loss.",The main habit to avoid for AMD prevention is smoking.,0.21395061520677777,0.8250273647391632,0.8558024608271111,1.0,0.0,0.0
What is the effect of AMD on reading small print?,"['Age-related macular degeneration damages central vision and fine-detail perception, so people with AMD commonly have trouble reading small print — they read more slowly, less accurately, and often need larger print or magnification; this difficulty can reduce independence and quality of life, though low-vision aids, training, and some prosthetic or adaptive devices can partially improve reading ability.']","Age-related macular degeneration impairs central and fine-detail vision, causing people to read small print more slowly, less accurately, and often requiring larger print, magnification, or adaptive aids to read effectively.",AMD makes reading small print difficult by blurring central vision.,0.972217055852655,0.8444520874209415,0.88886822341062,1.0,0.9999999999,1.0
What is the role of berries in AMD prevention?,"['Certain berries—most notably goji berries—appear to help prevent age-related macular degeneration by supplying carotenoids like zeaxanthin that increase macular pigment and carotenoid levels, supporting macular health and potentially reducing risk or slowing AMD development.']","Certain berries—especially goji berries—may help prevent AMD by supplying carotenoids like zeaxanthin that increase macular pigment and carotenoid levels, which support macular health and could reduce risk or slow AMD progression, though further controlled clinical trials are needed to confirm magnitude and optimal intake.",Berries provide antioxidants that protect retinal cells in AMD prevention.,0.7763129519170615,0.0,0.9234336258500646,0.75,0.0,0.0
What is a common digital tool for AMD patients?,"['Telehealth is a common digital tool for AMD patients, enabling remote monitoring and access to ophthalmic services and improving patient-focused outcomes, often complemented by AI-driven diagnostic support.']","Telehealth is a common digital tool for AMD patients, enabling remote monitoring, access to ophthalmic services, and often supplemented by AI-driven diagnostic support.",A common digital tool for AMD patients is a screen reader.,0.22078213198199712,0.8746366961237201,0.8831285279279885,1.0,0.0,0.0
What is the purpose of anti-VEGF therapy in AMD?,"['Anti-VEGF therapy for age-related macular degeneration—especially the neovascular (wet/exudative) form—is given locally to block abnormal blood-vessel growth and leakage, reduce subretinal and intraretinal fluid, and improve retinal anatomy, with the goal of preserving and often improving visual acuity and preventing progression to blindness; effectiveness is monitored over time and some patients may have partial or no response or experience adverse effects.']","The purpose of anti-VEGF therapy in AMD—particularly neovascular (wet) AMD—is to locally inhibit abnormal blood-vessel growth and leakage, reduce subretinal and intraretinal fluid, and thereby improve retinal anatomy to preserve and often improve visual acuity and prevent progression to blindness.",Anti-VEGF therapy prevents abnormal vessel growth in wet AMD.,0.8319429392188398,,0.9277717568753585,1.0,0.9999999999,1.0
What is the effect of AMD on outline recognition?,"['Age-related macular degeneration markedly impairs outline recognition: loss of central vision, blurred vision and reduced spatial and contrast sensitivity make it harder to detect and identify shapes, faces and objects, with advanced disease producing pronounced deficits in object and face recognition, reading and other tasks that rely on clear contour perception.']","Age-related macular degeneration substantially impairs outline recognition, causing loss of central vision, blur, and reduced spatial and contrast sensitivity that hinder detection and identification of shapes, faces, and objects—especially in advanced stages where object and face recognition and reading are markedly affected.",AMD impairs outline recognition by distorting central vision clarity.,0.31206847211245037,0.8450302954101069,0.8732738884498015,1.0,0.9999999999,1.0
What is the role of relaxation techniques in AMD?,"['Age-related macular degeneration often causes central and general vision loss that leads to reading and driving difficulty, frustration, emotional distress, reduced independence and impaired mobility; relaxation techniques do not treat or reverse the underlying disease but can be a valuable supportive strategy to reduce stress and anxiety, improve mood, enhance coping and concentration, and thereby help people adapt to functional limitations and maintain quality of life.']","Relaxation techniques do not treat or reverse AMD but can reduce stress and anxiety, improve mood, concentration, and coping, and thus help people adapt to vision-related functional limitations and maintain quality of life.","Relaxation techniques reduce stress, potentially aiding AMD management.",0.5360092414302569,0.0,0.9440369657210275,1.0,0.9999999999,1.0
What is a frequent observation in late AMD imaging?,"['Imaging of late AMD commonly shows drusen, including soft cholesterol-containing drusen and pseudodrusen (reticular or subretinal drusenoid deposits).']","A frequent observation in late AMD imaging is the presence of drusen, particularly soft cholesterol-containing drusen and pseudodrusen (reticular or subretinal drusenoid deposits).",A frequent observation in late AMD imaging is significant retinal atrophy.,0.2312600886177142,0.9754473142525252,0.9250403544708568,1.0,0.0,0.0
What is the benefit of auditory books for AMD patients?,"['For people with AMD who have central vision loss and difficulty reading that can lead to dependence, frustration, and emotional distress, audiobooks provide an accessible way to continue enjoying books and information, helping maintain independence, reduce frustration, and support emotional well‑being and quality of life.']","Audiobooks help people with AMD who have central vision loss by enabling continued access to books and information, thereby supporting independence, reducing frustration, and improving emotional well‑being and quality of life.",Auditory books allow AMD patients to enjoy literature without visual effort.,0.9802547556247798,0.9359451145275371,0.9210190224991194,1.0,0.9999999999,1.0
What is the main hurdle in reversing AMD damage?,"['The main hurdle in reversing AMD is that it produces permanent structural damage to the macula and its supporting retinal cells, causing irreversible central vision loss that current treatments cannot fully restore.']","The main hurdle in reversing AMD damage is that it causes permanent structural loss and dysfunction of the macula and supporting retinal cells, producing irreversible central vision loss that current treatments cannot fully restore.",The main hurdle in reversing AMD damage is regenerating lost photoreceptors.,0.2310134363654588,0.9999999999999997,0.9240537454618352,1.0,0.0,0.0
What is the role of vascular health in AMD?,"['Vascular health plays a central role in AMD: dysfunction of the choroidal and retinal vessels and abnormal new vessel growth underlie the neovascular (“wet”) forms of the disease, producing leakage, exudation and rapid central vision loss. Systemic vascular-related factors such as inflammation (elevated CRP), changes in the extracellular matrix, and even conditions like periodontal disease influence risk and progression, and retinal vascular pathology is a recognized component of the AMD spectrum. Because vascular dysfunction contributes directly to tissue damage and vision loss, vascular-targeted approaches are important both for understanding disease mechanisms and for therapy.']","Vascular health is central to AMD pathogenesis and progression, as dysfunction of choroidal and retinal vessels, abnormal neovascular growth (in wet AMD), and systemic vascular-related factors (e.g., inflammation, extracellular matrix changes, periodontal disease) drive leakage, exudation, tissue damage and rapid central vision loss, making vascular-targeted approaches essential for understanding and treating the disease.","Vascular health ensures retinal blood flow, influencing AMD risk.",0.5286133131752435,0.9598196965094495,0.9144532527009739,1.0,0.9999999999,0.0
What is a common visual defect in late wet AMD?,['A common visual defect in late (wet) AMD is loss of central vision—often experienced as a central scotoma or a blurred/distorted patch in the middle of the visual field that makes reading and seeing what you are directly looking at difficult.'],"A common visual defect in late (wet) AMD is loss of central vision, typically experienced as a central scotoma or a blurred/distorted patch in the middle of the visual field that impairs reading and seeing what you directly look at.",A common visual defect in late wet AMD is a large central scotoma.,0.4526083083323522,0.9947673544104295,0.9532903761865518,1.0,0.9999999999,0.0
What is the purpose of glare testing in AMD?,"['Glare testing in AMD quantifies how bright or short‑wavelength light worsens central visual function—affecting reading, mobility and driving—by measuring photopic glare disability; it identifies sensitivity to blue light, tracks functional impairment and disease impact, and helps evaluate and guide interventions (for example blue‑light‑filtering lenses or macular pigment supplementation) and patient counseling.']","Glare testing in AMD measures how bright or short‑wavelength (blue) light worsens central visual function—quantifying photopic glare disability to identify blue‑light sensitivity, track functional impairment and disease impact, and guide interventions (e.g., blue‑light‑filtering lenses, macular pigment supplementation) and patient counseling.",Glare testing evaluates light sensitivity changes in AMD.,0.5641964614172617,0.9575541936196313,0.9234525123357133,1.0,0.9999999999,1.0
What is the effect of AMD on moving object perception?,"['Age-related macular degeneration reduces motion sensitivity and central vision, impairing the ability to detect and recognize moving objects and worsening spatial perception and mobility. This leads to poorer driving performance and increased observation, lane‑keeping and intersection errors, and greater reliance on others. Some assistive devices and emerging visual therapies can partially mitigate these deficits.']","AMD reduces motion sensitivity and central vision, impairing detection and recognition of moving objects, worsening spatial perception and mobility, and contributing to poorer driving performance and increased observation, lane‑keeping and intersection errors (partially mitigable by some assistive devices and emerging visual therapies).",AMD impairs moving object perception by reducing central clarity.,0.4570171734846224,,0.9049917708615665,1.0,0.9999999999,1.0
What is the role of grandparents in AMD risk evaluation?,"[""Grandparents' eye health is an important piece of AMD risk evaluation because familial and genetic factors contribute to the disease; a history of macular degeneration in grandparents raises suspicion of inherited susceptibility and, combined with other risk factors like age, ethnicity, smoking, cardiovascular conditions and inflammation, supports earlier monitoring, lifestyle counseling, and consideration of genetic or targeted assessments to detect and manage disease sooner.""]","Grandparents' eye health is relevant to AMD risk evaluation because a family history of macular degeneration suggests inherited susceptibility which, when combined with age, ethnicity, smoking, cardiovascular disease, and inflammation, supports earlier monitoring, lifestyle counseling, and consideration of genetic or targeted assessments.",Grandparents’ AMD history suggests genetic risk for descendants.,0.60261774482646,0.9354892977259645,0.9104553248418474,1.0,0.9999999999,1.0
What is a typical feature of early wet AMD on OCT?,"['Early wet AMD typically shows choroidal neovascularization with associated macular fluid on OCT, manifesting as subretinal and/or intraretinal fluid.']","A typical feature of early wet AMD on OCT is choroidal neovascularization-associated macular fluid, appearing as subretinal and/or intraretinal fluid.",A typical feature of early wet AMD on OCT is minor subretinal fluid.,0.5396732094018138,0.9999999999999997,0.9586928376072553,0.3333333333333333,0.0,0.0
What is the benefit of computer accessibility tools for AMD?,"['Computer accessibility tools help people with AMD continue to use computers despite central and general vision loss and reading difficulties, supporting communication, information access and daily tasks, reducing dependence on others and frustration, and improving overall independence and quality of life; AI-driven accessibility advances further enhance these benefits.']","Computer accessibility tools, including AI-driven features, enable people with AMD to continue using computers for communication, information access, and daily tasks despite vision loss, thereby reducing dependence, frustration, and improving independence and quality of life.",Computer accessibility tools like voice commands aid AMD patients.,0.6922143825488022,0.9699915678845755,0.9227036840413629,0.9,0.9999999999,1.0
What is the effect of AMD on light contrast perception?,"['Age-related macular degeneration damages the macula and central retina, leading to central and overall vision loss and a marked reduction in contrast sensitivity; people with AMD have trouble detecting differences in light and contrast, which causes blurred vision, difficulty reading, impaired motion perception, poorer driving performance and increased dependence, although some implants, devices and therapies can partially improve light perception and contrast.']","AMD markedly reduces contrast sensitivity and impairs detection of differences in light and contrast, causing blurred vision, difficulty reading, poorer motion perception and reduced performance in tasks like driving, though some implants, devices, and therapies can partially restore light perception and contrast.",AMD reduces light contrast perception by damaging macular cells.,0.47305156046410374,0.8760671555047429,0.892206241856415,0.75,0.9999999999,1.0
What is the purpose of adaptive living training in AMD?,"['Adaptive living training helps people with AMD compensate for central vision loss by teaching practical strategies to maintain daily activities, mobility and reading. It boosts confidence and functional performance—for example improving word recognition and task performance—reducing reliance on others and frustration. It also supports engagement with monitoring and treatment, helping patients manage their condition more effectively.']","Adaptive living training for people with AMD teaches practical strategies to compensate for central vision loss—improving daily activities, mobility, reading, confidence, functional performance (e.g., word recognition and task completion), and engagement with monitoring and treatment to reduce reliance on others and frustration.",Adaptive living training teaches AMD patients to manage daily tasks.,0.4621415081820426,0.9575416150804029,0.9254891096512471,1.0,0.9999999999,1.0
What is the role of whole grains in AMD prevention?,"['Whole grains are a useful component of AMD prevention because they supply phytochemicals with antioxidant, anti‑inflammatory, and neuroprotective actions that help counter oxidative stress and chronic inflammation and protect retinal cells, thereby reducing risk of or slowing the neurodegenerative processes that lead to age‑related macular degeneration.']","Whole grains may help prevent or slow age-related macular degeneration by supplying phytochemicals with antioxidant, anti‑inflammatory, and neuroprotective effects that reduce oxidative stress and chronic inflammation and protect retinal cells.",Whole grains provide nutrients that support retinal health in AMD prevention.,0.4438060051047795,0.8970289602740774,0.9180811632762609,1.0,0.9999999999,1.0
What is a common consequence of untreated wet AMD?,"['Left untreated, wet age-related macular degeneration commonly causes irreversible loss of central vision, resulting in severe visual impairment and potentially blindness.']","Left untreated, wet age-related macular degeneration commonly leads to irreversible loss of central vision, causing severe visual impairment and potential blindness.",A common consequence of untreated wet AMD is irreversible vision loss.,0.6065954323281739,0.9428340761967648,0.9263817293126958,1.0,0.9999999999,1.0
What is the benefit of UV-blocking hats for AMD patients?,"['Wearing UV-blocking hats helps shield the eyes from ultraviolet radiation, reducing cumulative UV exposure that is linked to age-related ocular disease and early macular degeneration; this protection can lower the risk of vision impairment and may help slow progression of AMD, preserving central vision.']","Wearing UV-blocking hats reduces cumulative ultraviolet exposure to the eyes, which is linked to early macular degeneration and vision impairment, and thus may lower risk and help slow progression of AMD, preserving central vision.","UV-blocking hats shield eyes, reducing retinal damage for AMD patients.",0.8568590339351358,0.9146365269780373,0.9274361357405434,1.0,0.9999999999,1.0
What is the effect of AMD on boundary detection?,"['Age-related macular degeneration disrupts boundary detection by altering retinal structure—features like drusen and geographic atrophy create local boundary irregularities and change tissue remodeling, which impairs rod and cone function and light detection. These retinal changes lead to central and blurred vision loss, reduced spatial perception, motion sensitivity, and more observation errors, all of which degrade the ability to perceive edges and boundaries.']","AMD impairs boundary detection by causing retinal structural changes (e.g., drusen, geographic atrophy) and photoreceptor dysfunction that produce local boundary irregularities, reduced rod/cone function, and consequent loss of edge, spatial and motion sensitivity leading to blurred and central vision deficits.",AMD impairs boundary detection by blurring central vision edges.,0.36058694350869924,0.9661925172344557,0.9423477740347971,1.0,0.9999999999,1.0
What is the role of sugar intake in AMD risk?,"['Higher sugar intake and chronically elevated blood glucose are linked to increased risk of age-related macular degeneration, in part because persistent hyperglycemia promotes accumulation of harmful sugar-derived byproducts and metabolic damage in the retina; alongside other vascular risk factors, poor glycemic control appears to contribute to AMD development, so maintaining good blood‑sugar control may help reduce risk of retinal disease.']","Higher sugar intake and chronic hyperglycemia are associated with increased AMD risk because persistent high blood glucose promotes accumulation of harmful sugar-derived byproducts and metabolic/vascular damage in the retina, so maintaining good glycemic control may help reduce risk.",High sugar intake may increase AMD risk by promoting inflammation.,0.5641859898659538,0.8990499246755074,0.9234106261304821,0.8333333333333334,0.9999999999,0.0
What is a typical adaptation for AMD patients in eating?,"['Many people with AMD adapt their eating by simplifying routines and relying more on help from others—using pre-cut or prepared foods, high‑contrast plates and utensils, brighter lighting, and strategies to use peripheral vision (scanning or eye‑movement training) to locate food and read labels.']","A typical adaptation for people with AMD is simplifying meal routines and relying on help and assistive strategies—such as using pre-cut or prepared foods, high‑contrast plates and utensils, brighter lighting, and peripheral-vision scanning or eye-movement techniques—to locate and handle food and read labels.",A typical adaptation is using high-contrast plates for visibility.,0.35729117822745193,0.9393974875947125,0.8291647129098076,1.0,0.9999999999,1.0
What is the benefit of wearable tech for AMD patients?,"['Wearable technology can help people with age-related macular degeneration by compensating for central vision loss and its practical consequences—improving reading and visual tasks, aiding navigation and spatial awareness, reducing mobility and driving errors, and thereby restoring greater independence and emotional well‑being.']","Wearable technology for people with age-related macular degeneration can compensate for central vision loss to improve reading and other visual tasks, aid navigation and spatial awareness, reduce mobility and driving errors, and thereby enhance independence and emotional well‑being.",Wearable tech provides real-time magnification for AMD patients.,0.5513386943500661,0.9289750769676178,0.8720545977141371,1.0,0.0,0.0
What is the effect of AMD on item placement perception?,"['Age-related macular degeneration substantially impairs perception of where objects are located: by damaging central vision and reducing spatial perception, it causes blurred or missing detail that makes judging item placement difficult, leads to observation and motion‑sensitivity errors, and contributes to problems with everyday tasks, mobility, driving, dependence on others, and frustration.']","AMD impairs item placement perception by damaging central vision and spatial perception—causing blurred or missing detail, observation and motion‑sensitivity errors, and resulting difficulties judging object locations that affect everyday tasks, mobility, driving, and independence.",AMD distorts item placement perception by impairing central vision.,0.4776385221524045,0.9862940964389564,0.910554088609618,1.0,0.9999999999,1.0
What is the purpose of artificial retina research in AMD?,"['Artificial retina research in AMD aims to restore or preserve central visual function lost when the macula and retinal cells are damaged, offering alternatives where current therapies are limited, preventing progression to blindness, and improving reading, mobility, independence, and overall quality of life for affected patients.']","Artificial retina research in AMD aims to restore or preserve central visual function lost when the macula and retinal cells are damaged—offering alternatives where current therapies are limited, preventing progression to blindness, and improving reading, mobility, independence, and overall quality of life for affected patients.",Artificial retina research aims to restore sight in AMD via implants.,0.5067256102203097,0.9665473869265914,0.9359933499721482,1.0,0.9999999999,0.0
What is the role of arterial health in AMD?,"['Arterial health plays a key role in age-related macular degeneration (AMD): both high and low blood pressure and other arterial problems can promote choroidal ischemia, thrombosis, hemorrhage and arterial macroaneurysms, which in turn drive neovascular changes and submacular bleeding that worsen macular damage. Impaired arterial circulation therefore increases the risk of progressive central vision loss and irreversible vision impairment in AMD.']","Arterial health critically influences AMD progression because both hypertension and hypotension and other arterial pathologies can cause choroidal ischemia, thrombosis, hemorrhage and macroaneurysms that drive neovascularization and submacular bleeding, increasing risk of progressive central vision loss and irreversible impairment.","Arterial health supports retinal circulation, affecting AMD progression.",0.3665123340617684,0.9731731553015365,0.9205947907925282,1.0,0.9999999999,0.0
What is a common barrier for AMD patients in stores?,"['A common barrier for people with AMD in stores is loss of central and clear vision, which makes it hard to see what they are looking at, read labels or prices, and accurately judge and reach for products, leading to difficulty locating items, navigating aisles, and increased reliance on others.']","A common barrier for people with AMD in stores is loss of central and clear vision, which makes reading labels and prices, locating and reaching for products, and navigating aisles difficult, increasing reliance on others.",A common barrier is reading labels due to vision loss.,0.9767839657127249,0.9661520117442106,0.9071358628508994,1.0,0.9999999999,1.0
What is the benefit of textured guides for AMD patients?,"['Textured guides can help people with age-related macular degeneration by providing tactile and high-contrast cues that compensate for central vision loss and poor spatial perception, making it easier to locate items, align reading materials, and perform everyday tasks; this improves independence and mobility, reduces frustration and reliance on others, and can enhance confidence and emotional well-being.']","Textured guides provide tactile and high-contrast cues that help people with age-related macular degeneration compensate for central vision loss—making it easier to locate items, align reading materials, perform daily tasks, and thereby improving independence, mobility, and emotional well‑being.",Textured guides offer tactile navigation cues for AMD patients.,0.49981989186736864,0.9093384272564738,0.9083704765603838,1.0,0.9999999999,1.0
What is the effect of AMD on visual precision?,"['Age-related macular degeneration markedly impairs visual precision by damaging the macula and central vision, causing blurred or lost central sight, reduced fine-detail acuity and spatial perception, difficulty reading and driving, increased observation and lane-keeping errors, heightened motion sensitivity, progressive visual impairment, and in severe cases blindness.']","Age-related macular degeneration significantly reduces visual precision by damaging the macula and central vision, leading to blurred or lost central sight, decreased fine-detail acuity and spatial perception, difficulty with reading and driving, increased observation and lane-keeping errors, heightened motion sensitivity, progressive visual impairment, and potentially blindness.",AMD reduces visual precision by impairing central macular function.,0.8776137595192653,0.8542144371023311,0.8854550380770609,1.0,0.9999999999,1.0
What is the purpose of home organization in AMD?,"['Home-based monitoring and organization for AMD are intended to detect early changes in the disease at home, complement conventional hospital assessment, improve access and timeliness of care, optimize clinic visits, and thereby help preserve visual acuity and overall visual outcomes; their benefits and acceptability also depend on clear patient understanding and integration into healthcare delivery.']","The purpose of home organization in AMD is to support early detection of disease changes, complement hospital assessments, improve access and timeliness of care, optimize clinic visits, and help preserve visual acuity and overall visual outcomes when clearly understood and integrated into healthcare delivery.",Home organization simplifies navigation for AMD patients with vision loss.,0.4993873948091323,1.0,0.9066404883274385,1.0,0.0,0.0
What is the role of hydration in AMD management?,"['Fluid accumulation and changes in hydration play a central role in AMD by contributing to drusen swelling, subretinal and intraretinal fluid accumulation, and RPE dysfunction, all of which signal disease activity and can drive progression to neovascular disease, geographic atrophy, and worse central vision. Clinically, detection and monitoring of retinal and drusenoid fluid with imaging guide management decisions—most notably treatments that resolve exudation in neovascular AMD—while approaches that protect RPE health and modulate pathological hydration are being explored to slow progression. Controlling hydration is therefore an important therapeutic and monitoring target rather than a standalone cure.']","Hydration changes drive drusen swelling, subretinal/intraretinal fluid and RPE dysfunction that signal AMD activity and progression, so monitoring and controlling retinal/drusenoid fluid with imaging-guided therapies (and developing treatments that protect RPE and modulate pathological hydration) is a key therapeutic and monitoring target to slow progression and preserve vision, though it is not a standalone cure.","Hydration supports overall eye health, aiding AMD management.",0.29819738888356595,0.8814227019605122,0.8770000818500533,0.9375,0.9999999999,0.0
What is a typical retinal shift in intermediate AMD?,"['A typical retinal shift seen in intermediate AMD is a hypsochromic (blue) spectral shift, reflecting a blue‑ward change in the retinal spectral response.']","A typical retinal shift in intermediate AMD is a hypsochromic (blue‑ward) spectral shift, indicating a blue change in the retinal spectral response.",A typical retinal shift in intermediate AMD is increased drusen size.,0.2261785602206266,0.9999999999999997,0.9047142408825064,1.0,0.0,0.0
What is the benefit of light filters for AMD patients?,"['Light filters can reduce exposure to potentially harmful light that contributes to retinal damage and age-related macular degeneration, decreasing glare and light sensitivity and improving visual comfort, contrast and reading ability; by limiting phototoxic wavelengths they may also help protect remaining central vision and slow further vision loss.']","Light filters can reduce exposure to potentially phototoxic wavelengths, decreasing glare and light sensitivity while improving visual comfort, contrast, reading ability, and potentially protecting remaining central vision to help slow further vision loss in AMD patients.","Light filters reduce glare, improving comfort for AMD patients.",0.5704571087623991,0.9876245428200265,0.948551057033659,1.0,0.9999999999,1.0
What is the effect of AMD on spatial relationship perception?,"['Age-related macular degeneration markedly impairs spatial perception and the sense of spatial presence by degrading central vision, leading to poor mobility and reduced ability to judge positions and motion. As a result people with AMD experience difficulty with tasks that rely on spatial relationships—such as navigating, maintaining lanes, selecting gaps, detecting traffic signals and moving objects—resulting in increased observation errors, reduced driving performance and greater dependence on others.']","Age-related macular degeneration degrades central vision and markedly impairs spatial relationship perception—reducing the ability to judge positions, motion, and distances—leading to poorer navigation, lane maintenance, gap selection, object and signal detection, and increased dependence on others.",AMD impairs spatial relationship perception by distorting central cues.,0.8996659823624743,0.8426974702465945,0.87139120217717,0.9090909090909091,0.9999999999,1.0
What is the purpose of retinal pigment evaluation in AMD?,"['Retinal pigment evaluation assesses the health and integrity of the retinal pigment epithelium to help diagnose and stage age-related macular degeneration, detect drusen, subretinal deposits, exudation and neovascular or polypoidal changes, and monitor progression toward geographic atrophy or central vision loss; this information guides treatment decisions, predicts visual decline, and complements imaging and remote monitoring for ongoing surveillance and therapeutic planning.']","Retinal pigment evaluation in AMD assesses the health and integrity of the retinal pigment epithelium to detect and stage drusen, subretinal deposits, exudation, neovascular or polypoidal changes, and progression toward geographic atrophy or central vision loss, thereby guiding treatment decisions, predicting visual decline, and complementing imaging and remote monitoring for surveillance and therapeutic planning.",Retinal pigment evaluation assesses damage progression in AMD.,0.3601973126702615,0.9794435477630019,0.940789250681046,1.0,0.9999999999,0.0
What is the role of depression in AMD outcomes?,"['Depression is common among people with age-related macular degeneration and both results from and amplifies the condition’s negative effects: central vision loss and late-stage disease increase depressive symptoms, which in turn undermine psychological well‑being, quality of life, independence and everyday functioning (reading, driving, mobility). Treating or mitigating depression—through low‑vision services, rehabilitation, psychosocial interventions and appropriate medical care—can improve mood and related outcomes, and some ocular treatments and care pathways also influence depressive symptoms.']","Depression is both a consequence and amplifier of AMD—central vision loss and late-stage disease increase depressive symptoms, which in turn worsen psychological well‑being, quality of life, independence, and everyday functioning, but targeted treatments (low‑vision services, rehabilitation, psychosocial interventions, and some ocular care pathways) can mitigate these effects.",Depression may worsen AMD outcomes by reducing self-care adherence.,0.9409469996016833,0.9301433784661727,0.8941896474776656,1.0,0.9999999999,0.0
What is a common outdoor challenge for AMD patients?,"['A common outdoor challenge for people with AMD is impaired driving and mobility: central vision loss and reduced motion sensitivity lead to poor spatial perception, increased observation and lane-keeping errors, difficulty judging gaps and responding at intersections, and greater dependence on others for safe navigation.']","A common outdoor challenge for people with AMD is impaired driving and mobility due to central vision loss and reduced motion sensitivity, causing poor spatial perception, lane-keeping and observation errors, difficulty judging gaps and intersections, and greater dependence on others.",A common outdoor challenge is spotting uneven terrain.,0.2075594843403235,0.9631254700990451,0.830237937361294,1.0,0.0,0.0
What is the benefit of tinted filters for AMD patients?,"['Tinted filters reduce blue‑light exposure and thereby help prevent light‑induced photochemical and oxidative damage and photo‑induced cytotoxicity to retinal cells (including the retinal pigment epithelium), which can protect retinal tissue, potentially slow further damage, and improve visual comfort for patients with AMD.']","Tinted filters reduce blue‑light exposure, which can lessen light‑induced photochemical and oxidative damage to retinal cells (including the RPE), potentially protecting retinal tissue, slowing further damage, and improving visual comfort for AMD patients.",Tinted filters enhance visual clarity for AMD patients.,0.3824797021621159,0.9889471663275912,0.9299188086484635,1.0,0.0,0.0
What is the effect of AMD on visual rhythm?,"['Age-related macular degeneration damages the macula and retina, producing central and overall visual impairment (blurred vision, loss of fine detail and motion sensitivity); by reducing the eye’s ability to detect and process light and visual cues, AMD can interfere with visual input that helps entrain circadian/visual rhythms, potentially disrupting sleep–wake timing and other light-dependent rhythmic functions.']","AMD impairs the macula and retina, reducing the eye’s ability to detect and process light and visual cues that help entrain circadian and visual rhythms, which can disrupt sleep–wake timing and other light-dependent rhythmic functions.",AMD disrupts visual rhythm with central vision interruptions.,0.37028031323046995,0.893410191224378,0.8811212529218798,1.0,0.9999999999,1.0
What is the purpose of family support for AMD patients?,"['Family support helps people with AMD cope with progressive central and general vision loss by assisting with daily tasks like reading, mobility and driving, ensuring safety and access to care, supporting adaptation to increasing dependence, and providing emotional comfort to reduce frustration and maintain quality of life.']","Family support for people with AMD helps them cope with progressive central and general vision loss by assisting with daily tasks (e.g., reading, mobility, driving), ensuring safety and access to care, supporting adaptation to increasing dependence, and providing emotional comfort to reduce frustration and maintain quality of life.",Family support provides practical and emotional help for AMD patients.,0.9792516259615425,0.9441467867089203,0.9170065038461699,1.0,0.9999999999,1.0
What is the role of infrared light in AMD risk?,"['Infrared light is mainly used as an imaging tool to detect and monitor age-related macular degeneration—near‑infrared reflectance and other infrared modalities help reveal features such as reticular pseudodrusen—rather than being identified as a direct causal risk factor; although broad light exposure can harm retinal tissues and contribute to AMD, infrared imaging itself is valued for diagnosis and surveillance, not implicated as a proven driver of disease risk.']","Infrared light is primarily used for imaging (e.g., near‑infrared reflectance) to detect and monitor AMD features such as reticular pseudodrusen and is not established as a direct causal risk factor for AMD, although broad-spectrum light exposure in general can damage retinal tissues.","Infrared light may contribute to retinal stress, increasing AMD risk.",0.22775035468134042,0.9416074541958968,0.9111681874074047,1.0,0.0,0.0
What is a typical mental impact of AMD progression?,"['As AMD progresses, people commonly experience worsening mental health—most notably increased depression, anxiety, emotional distress, social isolation, and a reduced quality of life—often requiring low-vision rehabilitation or AMD-specific behavioral and self-management support to help mitigate these impacts.']","A typical mental impact of AMD progression is increased depression, anxiety, emotional distress, social isolation, and reduced quality of life, often necessitating low-vision rehabilitation or AMD-specific behavioral and self-management support.",A typical mental impact of AMD progression is anxiety over independence.,0.3994961866205323,0.9843342921587149,0.9313636313084203,1.0,0.9999999999,0.0
What is the benefit of desktop magnifiers for AMD patients?,"['Desktop magnifiers help people with age-related macular degeneration by compensating for central vision loss and making reading and other near tasks easier, which improves visual function, reduces dependence on others, and supports greater independence and quality of life.']","Desktop magnifiers help people with age-related macular degeneration by compensating for central vision loss to make reading and other near tasks easier, thereby improving visual function, reducing dependence on others, and supporting greater independence and quality of life.","Desktop magnifiers enlarge visuals, aiding AMD patients with tasks.",0.5274316409985522,0.9115145790724798,0.9097265639942088,1.0,0.9999999999,1.0
What is the effect of AMD on motion tracking speed?,"['Age-related macular degeneration impairs motion perception and reduces peak tracking speed, producing more motion artifacts and degraded tracking performance; associated central vision loss and poorer spatial perception further slow or compromise motion tracking and increase observation and driving errors.']","Age-related macular degeneration reduces peak motion-tracking speed, producing more motion artifacts and degraded tracking performance due to central vision loss and poorer spatial perception.",AMD slows motion tracking speed by impairing central vision.,0.6538471073221034,0.9158987693779818,0.9011027150026992,1.0,0.9999999999,1.0
What is the chief function of the macula in vision?,"['The macula is the small central area of the retina responsible for sharp, high‑resolution central and color vision used for tasks like reading and recognizing faces; it contains a high concentration of cone photoreceptors and yellow pigments (lutein/zeaxanthin) that support this detail‑and‑color function, and damage or degeneration of the macula causes loss of central vision.']","The macula's chief function is to provide sharp, high‑resolution central and color vision—used for tasks like reading and recognizing faces—via a high concentration of cone photoreceptors and supporting pigments (lutein/zeaxanthin), with its damage causing loss of central vision.",The macula provides detailed central vision for activities like reading.,0.8740682432445575,0.9864882264189919,0.9248444015496584,1.0,0.9999999999,1.0
What is the primary visual change in advanced AMD?,"['The hallmark of advanced age-related macular degeneration is loss of central vision—the inability to see what one is directly looking at—which impairs reading, face and object recognition and reduces visual acuity, contrast and color perception, and can progress to irreversible vision loss or blindness.']","The primary visual change in advanced age-related macular degeneration is loss of central vision, causing impaired reading, face/object recognition and reduced visual acuity, contrast and color perception that can progress to irreversible vision loss.",The primary visual change in advanced AMD is loss of central vision.,0.4151566357365014,0.9318639748854554,0.9106265429460056,1.0,0.9999999999,1.0
What is the core goal of the AREDS2 study?,"['The core goal of the AREDS2 study is to determine whether modified vitamin and mineral formulations can slow the progression of age-related macular degeneration and reduce the development of advanced AMD, informing prevention strategies and improving outcomes for future patients.']",The core goal of the AREDS2 study is to determine whether modified vitamin and mineral formulations can slow progression of age-related macular degeneration and reduce development of advanced AMD to inform prevention strategies and improve patient outcomes.,The core goal of the AREDS2 study is to improve nutrient formulas for AMD.,0.7353817214189584,1.0000000000000004,0.9415268856758335,1.0,0.9999999999,0.0
What is the preferred imaging method for AMD diagnosis?,"['Optical coherence tomography (OCT) is the preferred imaging modality for diagnosing age-related macular degeneration, offering high-resolution cross-sectional views that reveal retinal layer structure, drusen, retinal pigment epithelium changes and subretinal fluid; OCT angiography is a useful adjunct for detecting and characterizing neovascularization, with color fundus photography and other imaging methods serving as complementary tools.']","Optical coherence tomography (OCT) is the preferred imaging method for diagnosing age-related macular degeneration, providing high-resolution cross-sectional views of retinal layers, drusen, RPE changes, and subretinal fluid, with OCT angiography as a useful adjunct for neovascular detection.",The preferred imaging method for AMD diagnosis is optical coherence tomography.,0.4408529493776823,0.9390895534054953,0.9062689403678722,1.0,0.9999999999,1.0
What is the usual pace of wet AMD development?,"['Wet AMD usually develops rapidly—often over days to weeks—with sudden central vision loss from abnormal new blood vessels and fluid or bleeding, so prompt treatment with anti‑VEGF injections is important to limit severe or permanent vision loss.']",Wet (neovascular) AMD typically develops rapidly—often over days to weeks—causing sudden central vision loss from abnormal new blood vessels with fluid or bleeding.,Wet AMD usually develops rapidly over weeks to months.,0.8499348354243144,0.880087883327497,0.8997393416972572,0.8333333333333334,0.0,0.0
What is the purpose of the retinal pigment epithelium?,"['The retinal pigment epithelium (RPE) is a pigmented cell layer in the outer retina that nourishes and supports photoreceptors by transporting nutrients (including glucose), removing waste and shed photoreceptor outer segments, and helping maintain the blood–retina barrier and overall retinal homeostasis. When the RPE is damaged or dysfunctional, retinal function is impaired and photoreceptor loss can occur, contributing to disorders such as age‑related macular degeneration, geographic atrophy, and other blinding retinopathies.']","The retinal pigment epithelium (RPE) is a pigmented cell layer that nourishes and supports photoreceptors by transporting nutrients (including glucose), removing waste and shed photoreceptor outer segments, maintaining the blood–retina barrier, and preserving overall retinal homeostasis, with dysfunction leading to photoreceptor loss and diseases such as AMD and geographic atrophy.",The retinal pigment epithelium nourishes and supports photoreceptors.,0.3994846424597843,0.9648314418829264,0.9312719031724708,1.0,0.9999999999,1.0
What is the benefit of the Amsler grid for AMD patients?,"['The Amsler grid helps people with AMD monitor their central vision by revealing new or worsening visual distortions—such as waviness, blurring, or blank spots—so changes can be detected early, prompting timely evaluation and treatment that can help preserve vision and track disease progression.']","The Amsler grid helps AMD patients monitor central vision by revealing new or worsening visual distortions—such as waviness, blurring, or blank spots—so changes can be detected early and prompt timely evaluation and treatment to help preserve vision and track disease progression.",The Amsler grid helps AMD patients spot vision distortions early.,0.5731889680359348,,0.9594225388104054,1.0,0.9999999999,1.0
What is the key outcome of anti-VEGF injections in wet AMD?,['The key outcome of anti‑VEGF injections for wet AMD is preservation and often improvement of vision—notably increased visual acuity (including best‑corrected acuity) and reduced macular fluid/thickness—thereby preventing progression to severe visual impairment.'],The key outcome of anti‑VEGF injections in wet AMD is preservation and often improvement of vision—most notably increased visual acuity (including best‑corrected acuity) and reduced macular fluid/thickness—thereby preventing progression to severe visual impairment.,The key outcome of anti-VEGF injections is reduced vessel leakage in wet AMD.,0.23134314512180848,0.9999999999999997,0.9255341704889565,1.0,0.0,0.0
